Source Name	Characteristics[organism]	Characteristics[organism part]	Characteristics[age]	Characteristics[cell line]	Characteristics[cell type]	Characteristics[developmental stage]	Characteristics[ancestry category]	Characteristics[sex]	Characteristics[disease]	Characteristics[synthetic peptide]	Characteristics[individual]	Material Type	assay name	Technology Type	comment[data file]	comment[fractionation method]	comment[fraction identifier]	comment[MS2 mass analyzer]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[cleavage agent details]	comment[label]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[organism part]
Sample 1	Homo sapiens	Colon	53Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-A6-3807	tissue	run 1	proteomic profiling by mass spectrometry	TCGA-A6-3807-01A-22_W_VU_20121019_A0218_4I_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 1	Homo sapiens	Colon	53Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-A6-3807	tissue	run 2	proteomic profiling by mass spectrometry	TCGA-A6-3807-01A-22_W_VU_20121019_A0218_4I_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 1	Homo sapiens	Colon	53Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-A6-3807	tissue	run 3	proteomic profiling by mass spectrometry	TCGA-A6-3807-01A-22_W_VU_20121019_A0218_4I_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 1	Homo sapiens	Colon	53Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-A6-3807	tissue	run 4	proteomic profiling by mass spectrometry	TCGA-A6-3807-01A-22_W_VU_20121019_A0218_4I_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 1	Homo sapiens	Colon	53Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-A6-3807	tissue	run 5	proteomic profiling by mass spectrometry	TCGA-A6-3807-01A-22_W_VU_20121019_A0218_4I_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 1	Homo sapiens	Colon	53Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-A6-3807	tissue	run 6	proteomic profiling by mass spectrometry	TCGA-A6-3807-01A-22_W_VU_20121019_A0218_4I_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 1	Homo sapiens	Colon	53Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-A6-3807	tissue	run 7	proteomic profiling by mass spectrometry	TCGA-A6-3807-01A-22_W_VU_20121019_A0218_4I_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 1	Homo sapiens	Colon	53Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-A6-3807	tissue	run 8	proteomic profiling by mass spectrometry	TCGA-A6-3807-01A-22_W_VU_20121019_A0218_4I_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 1	Homo sapiens	Colon	53Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-A6-3807	tissue	run 9	proteomic profiling by mass spectrometry	TCGA-A6-3807-01A-22_W_VU_20121019_A0218_4I_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 1	Homo sapiens	Colon	53Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-A6-3807	tissue	run 10	proteomic profiling by mass spectrometry	TCGA-A6-3807-01A-22_W_VU_20121019_A0218_4I_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 1	Homo sapiens	Colon	53Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-A6-3807	tissue	run 11	proteomic profiling by mass spectrometry	TCGA-A6-3807-01A-22_W_VU_20121020_A0218_4I_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 1	Homo sapiens	Colon	53Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-A6-3807	tissue	run 12	proteomic profiling by mass spectrometry	TCGA-A6-3807-01A-22_W_VU_20121020_A0218_4I_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 1	Homo sapiens	Colon	53Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-A6-3807	tissue	run 13	proteomic profiling by mass spectrometry	TCGA-A6-3807-01A-22_W_VU_20121020_A0218_4I_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 1	Homo sapiens	Colon	53Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-A6-3807	tissue	run 14	proteomic profiling by mass spectrometry	TCGA-A6-3807-01A-22_W_VU_20121020_A0218_4I_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 1	Homo sapiens	Colon	53Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-A6-3807	tissue	run 15	proteomic profiling by mass spectrometry	TCGA-A6-3807-01A-22_W_VU_20121020_A0218_4I_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 2	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-A6-3808	tissue	run 16	proteomic profiling by mass spectrometry	TCGA-A6-3808-01A-22_W_VU_20121205_A0218_7D_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 2	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-A6-3808	tissue	run 17	proteomic profiling by mass spectrometry	TCGA-A6-3808-01A-22_W_VU_20121206_A0218_7D_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 2	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-A6-3808	tissue	run 18	proteomic profiling by mass spectrometry	TCGA-A6-3808-01A-22_W_VU_20121206_A0218_7D_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 2	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-A6-3808	tissue	run 19	proteomic profiling by mass spectrometry	TCGA-A6-3808-01A-22_W_VU_20121206_A0218_7D_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 2	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-A6-3808	tissue	run 20	proteomic profiling by mass spectrometry	TCGA-A6-3808-01A-22_W_VU_20121206_A0218_7D_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 2	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-A6-3808	tissue	run 21	proteomic profiling by mass spectrometry	TCGA-A6-3808-01A-22_W_VU_20121206_A0218_7D_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 2	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-A6-3808	tissue	run 22	proteomic profiling by mass spectrometry	TCGA-A6-3808-01A-22_W_VU_20121206_A0218_7D_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 2	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-A6-3808	tissue	run 23	proteomic profiling by mass spectrometry	TCGA-A6-3808-01A-22_W_VU_20121206_A0218_7D_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 2	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-A6-3808	tissue	run 24	proteomic profiling by mass spectrometry	TCGA-A6-3808-01A-22_W_VU_20121206_A0218_7D_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 2	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-A6-3808	tissue	run 25	proteomic profiling by mass spectrometry	TCGA-A6-3808-01A-22_W_VU_20121206_A0218_7D_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 2	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-A6-3808	tissue	run 26	proteomic profiling by mass spectrometry	TCGA-A6-3808-01A-22_W_VU_20121206_A0218_7D_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 2	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-A6-3808	tissue	run 27	proteomic profiling by mass spectrometry	TCGA-A6-3808-01A-22_W_VU_20121206_A0218_7D_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 2	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-A6-3808	tissue	run 28	proteomic profiling by mass spectrometry	TCGA-A6-3808-01A-22_W_VU_20121206_A0218_7D_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 2	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-A6-3808	tissue	run 29	proteomic profiling by mass spectrometry	TCGA-A6-3808-01A-22_W_VU_20121206_A0218_7D_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 2	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-A6-3808	tissue	run 30	proteomic profiling by mass spectrometry	TCGA-A6-3808-01A-22_W_VU_20121206_A0218_7D_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 3	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-A6-3810	tissue	run 31	proteomic profiling by mass spectrometry	TCGA-A6-3810-01A-22_W_VU_20121029_A0218_5E_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 3	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-A6-3810	tissue	run 32	proteomic profiling by mass spectrometry	TCGA-A6-3810-01A-22_W_VU_20121029_A0218_5E_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 3	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-A6-3810	tissue	run 33	proteomic profiling by mass spectrometry	TCGA-A6-3810-01A-22_W_VU_20121029_A0218_5E_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 3	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-A6-3810	tissue	run 34	proteomic profiling by mass spectrometry	TCGA-A6-3810-01A-22_W_VU_20121029_A0218_5E_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 3	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-A6-3810	tissue	run 35	proteomic profiling by mass spectrometry	TCGA-A6-3810-01A-22_W_VU_20121029_A0218_5E_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 3	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-A6-3810	tissue	run 36	proteomic profiling by mass spectrometry	TCGA-A6-3810-01A-22_W_VU_20121029_A0218_5E_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 3	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-A6-3810	tissue	run 37	proteomic profiling by mass spectrometry	TCGA-A6-3810-01A-22_W_VU_20121029_A0218_5E_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 3	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-A6-3810	tissue	run 38	proteomic profiling by mass spectrometry	TCGA-A6-3810-01A-22_W_VU_20121029_A0218_5E_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 3	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-A6-3810	tissue	run 39	proteomic profiling by mass spectrometry	TCGA-A6-3810-01A-22_W_VU_20121029_A0218_5E_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 3	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-A6-3810	tissue	run 40	proteomic profiling by mass spectrometry	TCGA-A6-3810-01A-22_W_VU_20121029_A0218_5E_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 3	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-A6-3810	tissue	run 41	proteomic profiling by mass spectrometry	TCGA-A6-3810-01A-22_W_VU_20121029_A0218_5E_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 3	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-A6-3810	tissue	run 42	proteomic profiling by mass spectrometry	TCGA-A6-3810-01A-22_W_VU_20121029_A0218_5E_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 3	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-A6-3810	tissue	run 43	proteomic profiling by mass spectrometry	TCGA-A6-3810-01A-22_W_VU_20121029_A0218_5E_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 3	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-A6-3810	tissue	run 44	proteomic profiling by mass spectrometry	TCGA-A6-3810-01A-22_W_VU_20121029_A0218_5E_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 3	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-A6-3810	tissue	run 45	proteomic profiling by mass spectrometry	TCGA-A6-3810-01A-22_W_VU_20121030_A0218_5E_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 4	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3518	tissue	run 46	proteomic profiling by mass spectrometry	TCGA-AA-3518-01A-11_W_VU_20120915_A0218_3F_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 4	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3518	tissue	run 47	proteomic profiling by mass spectrometry	TCGA-AA-3518-01A-11_W_VU_20120915_A0218_3F_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 4	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3518	tissue	run 48	proteomic profiling by mass spectrometry	TCGA-AA-3518-01A-11_W_VU_20120915_A0218_3F_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 4	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3518	tissue	run 49	proteomic profiling by mass spectrometry	TCGA-AA-3518-01A-11_W_VU_20120915_A0218_3F_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 4	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3518	tissue	run 50	proteomic profiling by mass spectrometry	TCGA-AA-3518-01A-11_W_VU_20120915_A0218_3F_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 4	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3518	tissue	run 51	proteomic profiling by mass spectrometry	TCGA-AA-3518-01A-11_W_VU_20120915_A0218_3F_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 4	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3518	tissue	run 52	proteomic profiling by mass spectrometry	TCGA-AA-3518-01A-11_W_VU_20120915_A0218_3F_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 4	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3518	tissue	run 53	proteomic profiling by mass spectrometry	TCGA-AA-3518-01A-11_W_VU_20120916_A0218_3F_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 4	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3518	tissue	run 54	proteomic profiling by mass spectrometry	TCGA-AA-3518-01A-11_W_VU_20120916_A0218_3F_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 4	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3518	tissue	run 55	proteomic profiling by mass spectrometry	TCGA-AA-3518-01A-11_W_VU_20120916_A0218_3F_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 4	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3518	tissue	run 56	proteomic profiling by mass spectrometry	TCGA-AA-3518-01A-11_W_VU_20120916_A0218_3F_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 4	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3518	tissue	run 57	proteomic profiling by mass spectrometry	TCGA-AA-3518-01A-11_W_VU_20120916_A0218_3F_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 4	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3518	tissue	run 58	proteomic profiling by mass spectrometry	TCGA-AA-3518-01A-11_W_VU_20120916_A0218_3F_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 4	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3518	tissue	run 59	proteomic profiling by mass spectrometry	TCGA-AA-3518-01A-11_W_VU_20120916_A0218_3F_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 4	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3518	tissue	run 60	proteomic profiling by mass spectrometry	TCGA-AA-3518-01A-11_W_VU_20120916_A0218_3F_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 5	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3525	tissue	run 61	proteomic profiling by mass spectrometry	TCGA-AA-3525-01A-12_W_VU_20121209_A0218_7F_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 5	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3525	tissue	run 62	proteomic profiling by mass spectrometry	TCGA-AA-3525-01A-12_W_VU_20121209_A0218_7F_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 5	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3525	tissue	run 63	proteomic profiling by mass spectrometry	TCGA-AA-3525-01A-12_W_VU_20121210_A0218_7F_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 5	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3525	tissue	run 64	proteomic profiling by mass spectrometry	TCGA-AA-3525-01A-12_W_VU_20121210_A0218_7F_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 5	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3525	tissue	run 65	proteomic profiling by mass spectrometry	TCGA-AA-3525-01A-12_W_VU_20121210_A0218_7F_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 5	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3525	tissue	run 66	proteomic profiling by mass spectrometry	TCGA-AA-3525-01A-12_W_VU_20121210_A0218_7F_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 5	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3525	tissue	run 67	proteomic profiling by mass spectrometry	TCGA-AA-3525-01A-12_W_VU_20121210_A0218_7F_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 5	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3525	tissue	run 68	proteomic profiling by mass spectrometry	TCGA-AA-3525-01A-12_W_VU_20121210_A0218_7F_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 5	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3525	tissue	run 69	proteomic profiling by mass spectrometry	TCGA-AA-3525-01A-12_W_VU_20121210_A0218_7F_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 5	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3525	tissue	run 70	proteomic profiling by mass spectrometry	TCGA-AA-3525-01A-12_W_VU_20121210_A0218_7F_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 5	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3525	tissue	run 71	proteomic profiling by mass spectrometry	TCGA-AA-3525-01A-12_W_VU_20121210_A0218_7F_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 5	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3525	tissue	run 72	proteomic profiling by mass spectrometry	TCGA-AA-3525-01A-12_W_VU_20121210_A0218_7F_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 5	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3525	tissue	run 73	proteomic profiling by mass spectrometry	TCGA-AA-3525-01A-12_W_VU_20121210_A0218_7F_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 5	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3525	tissue	run 74	proteomic profiling by mass spectrometry	TCGA-AA-3525-01A-12_W_VU_20121210_A0218_7F_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 5	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3525	tissue	run 75	proteomic profiling by mass spectrometry	TCGA-AA-3525-01A-12_W_VU_20121210_A0218_7F_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 6	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3526	tissue	run 76	proteomic profiling by mass spectrometry	TCGA-AA-3526-01A-11_W_VU_20130106_A0218_8J_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 6	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3526	tissue	run 77	proteomic profiling by mass spectrometry	TCGA-AA-3526-01A-11_W_VU_20130106_A0218_8J_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 6	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3526	tissue	run 78	proteomic profiling by mass spectrometry	TCGA-AA-3526-01A-11_W_VU_20130106_A0218_8J_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 6	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3526	tissue	run 79	proteomic profiling by mass spectrometry	TCGA-AA-3526-01A-11_W_VU_20130106_A0218_8J_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 6	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3526	tissue	run 80	proteomic profiling by mass spectrometry	TCGA-AA-3526-01A-11_W_VU_20130106_A0218_8J_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 6	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3526	tissue	run 81	proteomic profiling by mass spectrometry	TCGA-AA-3526-01A-11_W_VU_20130106_A0218_8J_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 6	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3526	tissue	run 82	proteomic profiling by mass spectrometry	TCGA-AA-3526-01A-11_W_VU_20130106_A0218_8J_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 6	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3526	tissue	run 83	proteomic profiling by mass spectrometry	TCGA-AA-3526-01A-11_W_VU_20130106_A0218_8J_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 6	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3526	tissue	run 84	proteomic profiling by mass spectrometry	TCGA-AA-3526-01A-11_W_VU_20130106_A0218_8J_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 6	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3526	tissue	run 85	proteomic profiling by mass spectrometry	TCGA-AA-3526-01A-11_W_VU_20130106_A0218_8J_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 6	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3526	tissue	run 86	proteomic profiling by mass spectrometry	TCGA-AA-3526-01A-11_W_VU_20130106_A0218_8J_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 6	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3526	tissue	run 87	proteomic profiling by mass spectrometry	TCGA-AA-3526-01A-11_W_VU_20130106_A0218_8J_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 6	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3526	tissue	run 88	proteomic profiling by mass spectrometry	TCGA-AA-3526-01A-11_W_VU_20130106_A0218_8J_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 6	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3526	tissue	run 89	proteomic profiling by mass spectrometry	TCGA-AA-3526-01A-11_W_VU_20130106_A0218_8J_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 6	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3526	tissue	run 90	proteomic profiling by mass spectrometry	TCGA-AA-3526-01A-11_W_VU_20130107_A0218_8J_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 7	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3529	tissue	run 91	proteomic profiling by mass spectrometry	TCGA-AA-3529-01A-12_W_VU_20121203_A0218_7B_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 7	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3529	tissue	run 92	proteomic profiling by mass spectrometry	TCGA-AA-3529-01A-12_W_VU_20121203_A0218_7B_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 7	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3529	tissue	run 93	proteomic profiling by mass spectrometry	TCGA-AA-3529-01A-12_W_VU_20121203_A0218_7B_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 7	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3529	tissue	run 94	proteomic profiling by mass spectrometry	TCGA-AA-3529-01A-12_W_VU_20121203_A0218_7B_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 7	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3529	tissue	run 95	proteomic profiling by mass spectrometry	TCGA-AA-3529-01A-12_W_VU_20121203_A0218_7B_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 7	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3529	tissue	run 96	proteomic profiling by mass spectrometry	TCGA-AA-3529-01A-12_W_VU_20121203_A0218_7B_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 7	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3529	tissue	run 97	proteomic profiling by mass spectrometry	TCGA-AA-3529-01A-12_W_VU_20121203_A0218_7B_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 7	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3529	tissue	run 98	proteomic profiling by mass spectrometry	TCGA-AA-3529-01A-12_W_VU_20121203_A0218_7B_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 7	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3529	tissue	run 99	proteomic profiling by mass spectrometry	TCGA-AA-3529-01A-12_W_VU_20121203_A0218_7B_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 7	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3529	tissue	run 100	proteomic profiling by mass spectrometry	TCGA-AA-3529-01A-12_W_VU_20121203_A0218_7B_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 7	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3529	tissue	run 101	proteomic profiling by mass spectrometry	TCGA-AA-3529-01A-12_W_VU_20121203_A0218_7B_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 7	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3529	tissue	run 102	proteomic profiling by mass spectrometry	TCGA-AA-3529-01A-12_W_VU_20121204_A0218_7B_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 7	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3529	tissue	run 103	proteomic profiling by mass spectrometry	TCGA-AA-3529-01A-12_W_VU_20121204_A0218_7B_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 7	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3529	tissue	run 104	proteomic profiling by mass spectrometry	TCGA-AA-3529-01A-12_W_VU_20121204_A0218_7B_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 7	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3529	tissue	run 105	proteomic profiling by mass spectrometry	TCGA-AA-3529-01A-12_W_VU_20121204_A0218_7B_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 8	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3531	tissue	run 106	proteomic profiling by mass spectrometry	TCGA-AA-3531-01A-22_W_VU_20130101_A0218_8G_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 8	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3531	tissue	run 107	proteomic profiling by mass spectrometry	TCGA-AA-3531-01A-22_W_VU_20130101_A0218_8G_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 8	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3531	tissue	run 108	proteomic profiling by mass spectrometry	TCGA-AA-3531-01A-22_W_VU_20130101_A0218_8G_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 8	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3531	tissue	run 109	proteomic profiling by mass spectrometry	TCGA-AA-3531-01A-22_W_VU_20130101_A0218_8G_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 8	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3531	tissue	run 110	proteomic profiling by mass spectrometry	TCGA-AA-3531-01A-22_W_VU_20130101_A0218_8G_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 8	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3531	tissue	run 111	proteomic profiling by mass spectrometry	TCGA-AA-3531-01A-22_W_VU_20130101_A0218_8G_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 8	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3531	tissue	run 112	proteomic profiling by mass spectrometry	TCGA-AA-3531-01A-22_W_VU_20130102_A0218_8G_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 8	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3531	tissue	run 113	proteomic profiling by mass spectrometry	TCGA-AA-3531-01A-22_W_VU_20130102_A0218_8G_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 8	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3531	tissue	run 114	proteomic profiling by mass spectrometry	TCGA-AA-3531-01A-22_W_VU_20130102_A0218_8G_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 8	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3531	tissue	run 115	proteomic profiling by mass spectrometry	TCGA-AA-3531-01A-22_W_VU_20130102_A0218_8G_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 8	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3531	tissue	run 116	proteomic profiling by mass spectrometry	TCGA-AA-3531-01A-22_W_VU_20130102_A0218_8G_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 8	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3531	tissue	run 117	proteomic profiling by mass spectrometry	TCGA-AA-3531-01A-22_W_VU_20130102_A0218_8G_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 8	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3531	tissue	run 118	proteomic profiling by mass spectrometry	TCGA-AA-3531-01A-22_W_VU_20130102_A0218_8G_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 8	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3531	tissue	run 119	proteomic profiling by mass spectrometry	TCGA-AA-3531-01A-22_W_VU_20130102_A0218_8G_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 8	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3531	tissue	run 120	proteomic profiling by mass spectrometry	TCGA-AA-3531-01A-22_W_VU_20130102_A0218_8G_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 9	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3534	tissue	run 121	proteomic profiling by mass spectrometry	TCGA-AA-3534-01A-22_W_VU_20130208_A0218_10B_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 9	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3534	tissue	run 122	proteomic profiling by mass spectrometry	TCGA-AA-3534-01A-22_W_VU_20130208_A0218_10B_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 9	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3534	tissue	run 123	proteomic profiling by mass spectrometry	TCGA-AA-3534-01A-22_W_VU_20130208_A0218_10B_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 9	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3534	tissue	run 124	proteomic profiling by mass spectrometry	TCGA-AA-3534-01A-22_W_VU_20130208_A0218_10B_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 9	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3534	tissue	run 125	proteomic profiling by mass spectrometry	TCGA-AA-3534-01A-22_W_VU_20130208_A0218_10B_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 9	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3534	tissue	run 126	proteomic profiling by mass spectrometry	TCGA-AA-3534-01A-22_W_VU_20130208_A0218_10B_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 9	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3534	tissue	run 127	proteomic profiling by mass spectrometry	TCGA-AA-3534-01A-22_W_VU_20130208_A0218_10B_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 9	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3534	tissue	run 128	proteomic profiling by mass spectrometry	TCGA-AA-3534-01A-22_W_VU_20130208_A0218_10B_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 9	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3534	tissue	run 129	proteomic profiling by mass spectrometry	TCGA-AA-3534-01A-22_W_VU_20130208_A0218_10B_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 9	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3534	tissue	run 130	proteomic profiling by mass spectrometry	TCGA-AA-3534-01A-22_W_VU_20130209_A0218_10B_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 9	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3534	tissue	run 131	proteomic profiling by mass spectrometry	TCGA-AA-3534-01A-22_W_VU_20130209_A0218_10B_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 9	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3534	tissue	run 132	proteomic profiling by mass spectrometry	TCGA-AA-3534-01A-22_W_VU_20130209_A0218_10B_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 9	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3534	tissue	run 133	proteomic profiling by mass spectrometry	TCGA-AA-3534-01A-22_W_VU_20130209_A0218_10B_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 9	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3534	tissue	run 134	proteomic profiling by mass spectrometry	TCGA-AA-3534-01A-22_W_VU_20130209_A0218_10B_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 9	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3534	tissue	run 135	proteomic profiling by mass spectrometry	TCGA-AA-3534-01A-22_W_VU_20130209_A0218_10B_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 10	Homo sapiens	Colon	85Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3552	tissue	run 136	proteomic profiling by mass spectrometry	TCGA-AA-3552-01A-22_W_VU_20130125_A0218_9F_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 10	Homo sapiens	Colon	85Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3552	tissue	run 137	proteomic profiling by mass spectrometry	TCGA-AA-3552-01A-22_W_VU_20130125_A0218_9F_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 10	Homo sapiens	Colon	85Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3552	tissue	run 138	proteomic profiling by mass spectrometry	TCGA-AA-3552-01A-22_W_VU_20130125_A0218_9F_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 10	Homo sapiens	Colon	85Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3552	tissue	run 139	proteomic profiling by mass spectrometry	TCGA-AA-3552-01A-22_W_VU_20130125_A0218_9F_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 10	Homo sapiens	Colon	85Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3552	tissue	run 140	proteomic profiling by mass spectrometry	TCGA-AA-3552-01A-22_W_VU_20130125_A0218_9F_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 10	Homo sapiens	Colon	85Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3552	tissue	run 141	proteomic profiling by mass spectrometry	TCGA-AA-3552-01A-22_W_VU_20130125_A0218_9F_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 10	Homo sapiens	Colon	85Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3552	tissue	run 142	proteomic profiling by mass spectrometry	TCGA-AA-3552-01A-22_W_VU_20130126_A0218_9F_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 10	Homo sapiens	Colon	85Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3552	tissue	run 143	proteomic profiling by mass spectrometry	TCGA-AA-3552-01A-22_W_VU_20130126_A0218_9F_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 10	Homo sapiens	Colon	85Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3552	tissue	run 144	proteomic profiling by mass spectrometry	TCGA-AA-3552-01A-22_W_VU_20130126_A0218_9F_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 10	Homo sapiens	Colon	85Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3552	tissue	run 145	proteomic profiling by mass spectrometry	TCGA-AA-3552-01A-22_W_VU_20130126_A0218_9F_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 10	Homo sapiens	Colon	85Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3552	tissue	run 146	proteomic profiling by mass spectrometry	TCGA-AA-3552-01A-22_W_VU_20130126_A0218_9F_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 10	Homo sapiens	Colon	85Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3552	tissue	run 147	proteomic profiling by mass spectrometry	TCGA-AA-3552-01A-22_W_VU_20130126_A0218_9F_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 10	Homo sapiens	Colon	85Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3552	tissue	run 148	proteomic profiling by mass spectrometry	TCGA-AA-3552-01A-22_W_VU_20130126_A0218_9F_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 10	Homo sapiens	Colon	85Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3552	tissue	run 149	proteomic profiling by mass spectrometry	TCGA-AA-3552-01A-22_W_VU_20130126_A0218_9F_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 10	Homo sapiens	Colon	85Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3552	tissue	run 150	proteomic profiling by mass spectrometry	TCGA-AA-3552-01A-22_W_VU_20130126_A0218_9F_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 11	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3554	tissue	run 151	proteomic profiling by mass spectrometry	TCGA-AA-3554-01A-22_W_VU_20121122_A0218_6G_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 11	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3554	tissue	run 152	proteomic profiling by mass spectrometry	TCGA-AA-3554-01A-22_W_VU_20121122_A0218_6G_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 11	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3554	tissue	run 153	proteomic profiling by mass spectrometry	TCGA-AA-3554-01A-22_W_VU_20121122_A0218_6G_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 11	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3554	tissue	run 154	proteomic profiling by mass spectrometry	TCGA-AA-3554-01A-22_W_VU_20121123_A0218_6G_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 11	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3554	tissue	run 155	proteomic profiling by mass spectrometry	TCGA-AA-3554-01A-22_W_VU_20121123_A0218_6G_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 11	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3554	tissue	run 156	proteomic profiling by mass spectrometry	TCGA-AA-3554-01A-22_W_VU_20121123_A0218_6G_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 11	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3554	tissue	run 157	proteomic profiling by mass spectrometry	TCGA-AA-3554-01A-22_W_VU_20121123_A0218_6G_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 11	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3554	tissue	run 158	proteomic profiling by mass spectrometry	TCGA-AA-3554-01A-22_W_VU_20121123_A0218_6G_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 11	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3554	tissue	run 159	proteomic profiling by mass spectrometry	TCGA-AA-3554-01A-22_W_VU_20121123_A0218_6G_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 11	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3554	tissue	run 160	proteomic profiling by mass spectrometry	TCGA-AA-3554-01A-22_W_VU_20121123_A0218_6G_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 11	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3554	tissue	run 161	proteomic profiling by mass spectrometry	TCGA-AA-3554-01A-22_W_VU_20121123_A0218_6G_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 11	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3554	tissue	run 162	proteomic profiling by mass spectrometry	TCGA-AA-3554-01A-22_W_VU_20121123_A0218_6G_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 11	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3554	tissue	run 163	proteomic profiling by mass spectrometry	TCGA-AA-3554-01A-22_W_VU_20121123_A0218_6G_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 11	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3554	tissue	run 164	proteomic profiling by mass spectrometry	TCGA-AA-3554-01A-22_W_VU_20121123_A0218_6G_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 11	Homo sapiens	Colon	62Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3554	tissue	run 165	proteomic profiling by mass spectrometry	TCGA-AA-3554-01A-22_W_VU_20121123_A0218_6G_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 12	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3558	tissue	run 166	proteomic profiling by mass spectrometry	TCGA-AA-3558-01A-22_W_VU_20121112_A0218_6A_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 12	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3558	tissue	run 167	proteomic profiling by mass spectrometry	TCGA-AA-3558-01A-22_W_VU_20121112_A0218_6A_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 12	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3558	tissue	run 168	proteomic profiling by mass spectrometry	TCGA-AA-3558-01A-22_W_VU_20121112_A0218_6A_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 12	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3558	tissue	run 169	proteomic profiling by mass spectrometry	TCGA-AA-3558-01A-22_W_VU_20121112_A0218_6A_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 12	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3558	tissue	run 170	proteomic profiling by mass spectrometry	TCGA-AA-3558-01A-22_W_VU_20121112_A0218_6A_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 12	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3558	tissue	run 171	proteomic profiling by mass spectrometry	TCGA-AA-3558-01A-22_W_VU_20121112_A0218_6A_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 12	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3558	tissue	run 172	proteomic profiling by mass spectrometry	TCGA-AA-3558-01A-22_W_VU_20121112_A0218_6A_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 12	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3558	tissue	run 173	proteomic profiling by mass spectrometry	TCGA-AA-3558-01A-22_W_VU_20121112_A0218_6A_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 12	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3558	tissue	run 174	proteomic profiling by mass spectrometry	TCGA-AA-3558-01A-22_W_VU_20121113_A0218_6A_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 12	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3558	tissue	run 175	proteomic profiling by mass spectrometry	TCGA-AA-3558-01A-22_W_VU_20121113_A0218_6A_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 12	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3558	tissue	run 176	proteomic profiling by mass spectrometry	TCGA-AA-3558-01A-22_W_VU_20121113_A0218_6A_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 12	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3558	tissue	run 177	proteomic profiling by mass spectrometry	TCGA-AA-3558-01A-22_W_VU_20121113_A0218_6A_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 12	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3558	tissue	run 178	proteomic profiling by mass spectrometry	TCGA-AA-3558-01A-22_W_VU_20121113_A0218_6A_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 12	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3558	tissue	run 179	proteomic profiling by mass spectrometry	TCGA-AA-3558-01A-22_W_VU_20121113_A0218_6A_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 12	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3558	tissue	run 180	proteomic profiling by mass spectrometry	TCGA-AA-3558-01A-22_W_VU_20121113_A0218_6A_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 13	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3561	tissue	run 181	proteomic profiling by mass spectrometry	TCGA-AA-3561-01A-22_W_VU_20120808_A0218_1I_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 13	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3561	tissue	run 182	proteomic profiling by mass spectrometry	TCGA-AA-3561-01A-22_W_VU_20120808_A0218_1I_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 13	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3561	tissue	run 183	proteomic profiling by mass spectrometry	TCGA-AA-3561-01A-22_W_VU_20120808_A0218_1I_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 13	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3561	tissue	run 184	proteomic profiling by mass spectrometry	TCGA-AA-3561-01A-22_W_VU_20120808_A0218_1I_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 13	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3561	tissue	run 185	proteomic profiling by mass spectrometry	TCGA-AA-3561-01A-22_W_VU_20120808_A0218_1I_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 13	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3561	tissue	run 186	proteomic profiling by mass spectrometry	TCGA-AA-3561-01A-22_W_VU_20120808_A0218_1I_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 13	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3561	tissue	run 187	proteomic profiling by mass spectrometry	TCGA-AA-3561-01A-22_W_VU_20120808_A0218_1I_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 13	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3561	tissue	run 188	proteomic profiling by mass spectrometry	TCGA-AA-3561-01A-22_W_VU_20120808_A0218_1I_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 13	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3561	tissue	run 189	proteomic profiling by mass spectrometry	TCGA-AA-3561-01A-22_W_VU_20120808_A0218_1I_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 13	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3561	tissue	run 190	proteomic profiling by mass spectrometry	TCGA-AA-3561-01A-22_W_VU_20120808_A0218_1I_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 13	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3561	tissue	run 191	proteomic profiling by mass spectrometry	TCGA-AA-3561-01A-22_W_VU_20120809_A0218_1I_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 13	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3561	tissue	run 192	proteomic profiling by mass spectrometry	TCGA-AA-3561-01A-22_W_VU_20120809_A0218_1I_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 13	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3561	tissue	run 193	proteomic profiling by mass spectrometry	TCGA-AA-3561-01A-22_W_VU_20120809_A0218_1I_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 13	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3561	tissue	run 194	proteomic profiling by mass spectrometry	TCGA-AA-3561-01A-22_W_VU_20120809_A0218_1I_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 13	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3561	tissue	run 195	proteomic profiling by mass spectrometry	TCGA-AA-3561-01A-22_W_VU_20120809_A0218_1I_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 14	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3664	tissue	run 196	proteomic profiling by mass spectrometry	TCGA-AA-3664-01A-22_W_VU_20130123_A0218_9C_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 14	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3664	tissue	run 197	proteomic profiling by mass spectrometry	TCGA-AA-3664-01A-22_W_VU_20130123_A0218_9C_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 14	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3664	tissue	run 198	proteomic profiling by mass spectrometry	TCGA-AA-3664-01A-22_W_VU_20130123_A0218_9C_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 14	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3664	tissue	run 199	proteomic profiling by mass spectrometry	TCGA-AA-3664-01A-22_W_VU_20130123_A0218_9C_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 14	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3664	tissue	run 200	proteomic profiling by mass spectrometry	TCGA-AA-3664-01A-22_W_VU_20130123_A0218_9C_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 14	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3664	tissue	run 201	proteomic profiling by mass spectrometry	TCGA-AA-3664-01A-22_W_VU_20130123_A0218_9C_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 14	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3664	tissue	run 202	proteomic profiling by mass spectrometry	TCGA-AA-3664-01A-22_W_VU_20130123_A0218_9C_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 14	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3664	tissue	run 203	proteomic profiling by mass spectrometry	TCGA-AA-3664-01A-22_W_VU_20130123_A0218_9C_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 14	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3664	tissue	run 204	proteomic profiling by mass spectrometry	TCGA-AA-3664-01A-22_W_VU_20130124_A0218_9C_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 14	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3664	tissue	run 205	proteomic profiling by mass spectrometry	TCGA-AA-3664-01A-22_W_VU_20130124_A0218_9C_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 14	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3664	tissue	run 206	proteomic profiling by mass spectrometry	TCGA-AA-3664-01A-22_W_VU_20130124_A0218_9C_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 14	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3664	tissue	run 207	proteomic profiling by mass spectrometry	TCGA-AA-3664-01A-22_W_VU_20130124_A0218_9C_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 14	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3664	tissue	run 208	proteomic profiling by mass spectrometry	TCGA-AA-3664-01A-22_W_VU_20130124_A0218_9C_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 14	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3664	tissue	run 209	proteomic profiling by mass spectrometry	TCGA-AA-3664-01A-22_W_VU_20130124_A0218_9C_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 14	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3664	tissue	run 210	proteomic profiling by mass spectrometry	TCGA-AA-3664-01A-22_W_VU_20130124_A0218_9C_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 15	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3666	tissue	run 211	proteomic profiling by mass spectrometry	TCGA-AA-3666-01A-31_W_VU_20121101_A0218_5F_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 15	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3666	tissue	run 212	proteomic profiling by mass spectrometry	TCGA-AA-3666-01A-31_W_VU_20121101_A0218_5F_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 15	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3666	tissue	run 213	proteomic profiling by mass spectrometry	TCGA-AA-3666-01A-31_W_VU_20121101_A0218_5F_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 15	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3666	tissue	run 214	proteomic profiling by mass spectrometry	TCGA-AA-3666-01A-31_W_VU_20121101_A0218_5F_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 15	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3666	tissue	run 215	proteomic profiling by mass spectrometry	TCGA-AA-3666-01A-31_W_VU_20121101_A0218_5F_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 15	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3666	tissue	run 216	proteomic profiling by mass spectrometry	TCGA-AA-3666-01A-31_W_VU_20121101_A0218_5F_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 15	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3666	tissue	run 217	proteomic profiling by mass spectrometry	TCGA-AA-3666-01A-31_W_VU_20121102_A0218_5F_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 15	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3666	tissue	run 218	proteomic profiling by mass spectrometry	TCGA-AA-3666-01A-31_W_VU_20121102_A0218_5F_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 15	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3666	tissue	run 219	proteomic profiling by mass spectrometry	TCGA-AA-3666-01A-31_W_VU_20121102_A0218_5F_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 15	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3666	tissue	run 220	proteomic profiling by mass spectrometry	TCGA-AA-3666-01A-31_W_VU_20121102_A0218_5F_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 15	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3666	tissue	run 221	proteomic profiling by mass spectrometry	TCGA-AA-3666-01A-31_W_VU_20121102_A0218_5F_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 15	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3666	tissue	run 222	proteomic profiling by mass spectrometry	TCGA-AA-3666-01A-31_W_VU_20121102_A0218_5F_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 15	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3666	tissue	run 223	proteomic profiling by mass spectrometry	TCGA-AA-3666-01A-31_W_VU_20121102_A0218_5F_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 15	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3666	tissue	run 224	proteomic profiling by mass spectrometry	TCGA-AA-3666-01A-31_W_VU_20121102_A0218_5F_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 15	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3666	tissue	run 225	proteomic profiling by mass spectrometry	TCGA-AA-3666-01A-31_W_VU_20121102_A0218_5F_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 16	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3672	tissue	run 226	proteomic profiling by mass spectrometry	TCGA-AA-3672-01A-22_W_VU_20121217_A0218_7J_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 16	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3672	tissue	run 227	proteomic profiling by mass spectrometry	TCGA-AA-3672-01A-22_W_VU_20121217_A0218_7J_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 16	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3672	tissue	run 228	proteomic profiling by mass spectrometry	TCGA-AA-3672-01A-22_W_VU_20121217_A0218_7J_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 16	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3672	tissue	run 229	proteomic profiling by mass spectrometry	TCGA-AA-3672-01A-22_W_VU_20121217_A0218_7J_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 16	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3672	tissue	run 230	proteomic profiling by mass spectrometry	TCGA-AA-3672-01A-22_W_VU_20121217_A0218_7J_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 16	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3672	tissue	run 231	proteomic profiling by mass spectrometry	TCGA-AA-3672-01A-22_W_VU_20121217_A0218_7J_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 16	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3672	tissue	run 232	proteomic profiling by mass spectrometry	TCGA-AA-3672-01A-22_W_VU_20121217_A0218_7J_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 16	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3672	tissue	run 233	proteomic profiling by mass spectrometry	TCGA-AA-3672-01A-22_W_VU_20121217_A0218_7J_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 16	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3672	tissue	run 234	proteomic profiling by mass spectrometry	TCGA-AA-3672-01A-22_W_VU_20121217_A0218_7J_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 16	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3672	tissue	run 235	proteomic profiling by mass spectrometry	TCGA-AA-3672-01A-22_W_VU_20121218_A0218_7J_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 16	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3672	tissue	run 236	proteomic profiling by mass spectrometry	TCGA-AA-3672-01A-22_W_VU_20121218_A0218_7J_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 16	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3672	tissue	run 237	proteomic profiling by mass spectrometry	TCGA-AA-3672-01A-22_W_VU_20121218_A0218_7J_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 16	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3672	tissue	run 238	proteomic profiling by mass spectrometry	TCGA-AA-3672-01A-22_W_VU_20121218_A0218_7J_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 16	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3672	tissue	run 239	proteomic profiling by mass spectrometry	TCGA-AA-3672-01A-22_W_VU_20121218_A0218_7J_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 16	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3672	tissue	run 240	proteomic profiling by mass spectrometry	TCGA-AA-3672-01A-22_W_VU_20121218_A0218_7J_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 17	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-3684	tissue	run 241	proteomic profiling by mass spectrometry	TCGA-AA-3684-01A-31_W_VU_20121018_A0218_4H_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 17	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-3684	tissue	run 242	proteomic profiling by mass spectrometry	TCGA-AA-3684-01A-31_W_VU_20121018_A0218_4H_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 17	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-3684	tissue	run 243	proteomic profiling by mass spectrometry	TCGA-AA-3684-01A-31_W_VU_20121018_A0218_4H_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 17	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-3684	tissue	run 244	proteomic profiling by mass spectrometry	TCGA-AA-3684-01A-31_W_VU_20121018_A0218_4H_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 17	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-3684	tissue	run 245	proteomic profiling by mass spectrometry	TCGA-AA-3684-01A-31_W_VU_20121018_A0218_4H_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 17	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-3684	tissue	run 246	proteomic profiling by mass spectrometry	TCGA-AA-3684-01A-31_W_VU_20121018_A0218_4H_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 17	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-3684	tissue	run 247	proteomic profiling by mass spectrometry	TCGA-AA-3684-01A-31_W_VU_20121018_A0218_4H_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 17	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-3684	tissue	run 248	proteomic profiling by mass spectrometry	TCGA-AA-3684-01A-31_W_VU_20121018_A0218_4H_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 17	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-3684	tissue	run 249	proteomic profiling by mass spectrometry	TCGA-AA-3684-01A-31_W_VU_20121018_A0218_4H_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 17	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-3684	tissue	run 250	proteomic profiling by mass spectrometry	TCGA-AA-3684-01A-31_W_VU_20121018_A0218_4H_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 17	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-3684	tissue	run 251	proteomic profiling by mass spectrometry	TCGA-AA-3684-01A-31_W_VU_20121018_A0218_4H_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 17	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-3684	tissue	run 252	proteomic profiling by mass spectrometry	TCGA-AA-3684-01A-31_W_VU_20121018_A0218_4H_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 17	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-3684	tissue	run 253	proteomic profiling by mass spectrometry	TCGA-AA-3684-01A-31_W_VU_20121018_A0218_4H_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 17	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-3684	tissue	run 254	proteomic profiling by mass spectrometry	TCGA-AA-3684-01A-31_W_VU_20121018_A0218_4H_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 17	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-3684	tissue	run 255	proteomic profiling by mass spectrometry	TCGA-AA-3684-01A-31_W_VU_20121018_A0218_4H_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 18	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3695	tissue	run 256	proteomic profiling by mass spectrometry	TCGA-AA-3695-01A-22_W_VU_20130131_A0218_9I_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 18	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3695	tissue	run 257	proteomic profiling by mass spectrometry	TCGA-AA-3695-01A-22_W_VU_20130131_A0218_9I_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 18	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3695	tissue	run 258	proteomic profiling by mass spectrometry	TCGA-AA-3695-01A-22_W_VU_20130131_A0218_9I_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 18	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3695	tissue	run 259	proteomic profiling by mass spectrometry	TCGA-AA-3695-01A-22_W_VU_20130131_A0218_9I_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 18	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3695	tissue	run 260	proteomic profiling by mass spectrometry	TCGA-AA-3695-01A-22_W_VU_20130131_A0218_9I_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 18	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3695	tissue	run 261	proteomic profiling by mass spectrometry	TCGA-AA-3695-01A-22_W_VU_20130131_A0218_9I_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 18	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3695	tissue	run 262	proteomic profiling by mass spectrometry	TCGA-AA-3695-01A-22_W_VU_20130131_A0218_9I_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 18	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3695	tissue	run 263	proteomic profiling by mass spectrometry	TCGA-AA-3695-01A-22_W_VU_20130131_A0218_9I_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 18	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3695	tissue	run 264	proteomic profiling by mass spectrometry	TCGA-AA-3695-01A-22_W_VU_20130131_A0218_9I_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 18	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3695	tissue	run 265	proteomic profiling by mass spectrometry	CGA-AA-3695-01A-22_W_VU_20130201_A0218_9I_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 18	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3695	tissue	run 266	proteomic profiling by mass spectrometry	TCGA-AA-3695-01A-22_W_VU_20130131_A0218_9I_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 18	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3695	tissue	run 267	proteomic profiling by mass spectrometry	TCGA-AA-3695-01A-22_W_VU_20130131_A0218_9I_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 18	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3695	tissue	run 268	proteomic profiling by mass spectrometry	TCGA-AA-3695-01A-22_W_VU_20130131_A0218_9I_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 18	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3695	tissue	run 269	proteomic profiling by mass spectrometry	TCGA-AA-3695-01A-22_W_VU_20130131_A0218_9I_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 18	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3695	tissue	run 270	proteomic profiling by mass spectrometry	TCGA-AA-3695-01A-22_W_VU_20130131_A0218_9I_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 19	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3710	tissue	run 271	proteomic profiling by mass spectrometry	TCGA-AA-3710-01A-22_W_VU_20120827_A0218_2H_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 19	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3710	tissue	run 272	proteomic profiling by mass spectrometry	TCGA-AA-3710-01A-22_W_VU_20120827_A0218_2H_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 19	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3710	tissue	run 273	proteomic profiling by mass spectrometry	TCGA-AA-3710-01A-22_W_VU_20120827_A0218_2H_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 19	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3710	tissue	run 274	proteomic profiling by mass spectrometry	TCGA-AA-3710-01A-22_W_VU_20120827_A0218_2H_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 19	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3710	tissue	run 275	proteomic profiling by mass spectrometry	TCGA-AA-3710-01A-22_W_VU_20120827_A0218_2H_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 19	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3710	tissue	run 276	proteomic profiling by mass spectrometry	TCGA-AA-3710-01A-22_W_VU_20120827_A0218_2H_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 19	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3710	tissue	run 277	proteomic profiling by mass spectrometry	TCGA-AA-3710-01A-22_W_VU_20120827_A0218_2H_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 19	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3710	tissue	run 278	proteomic profiling by mass spectrometry	TCGA-AA-3710-01A-22_W_VU_20120827_A0218_2H_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 19	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3710	tissue	run 279	proteomic profiling by mass spectrometry	TCGA-AA-3710-01A-22_W_VU_20120827_A0218_2H_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 19	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3710	tissue	run 280	proteomic profiling by mass spectrometry	TCGA-AA-3710-01A-22_W_VU_20120827_A0218_2H_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 19	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3710	tissue	run 281	proteomic profiling by mass spectrometry	TCGA-AA-3710-01A-22_W_VU_20120827_A0218_2H_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 19	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3710	tissue	run 282	proteomic profiling by mass spectrometry	TCGA-AA-3710-01A-22_W_VU_20120827_A0218_2H_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 19	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3710	tissue	run 283	proteomic profiling by mass spectrometry	TCGA-AA-3710-01A-22_W_VU_20120827_A0218_2H_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 19	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3710	tissue	run 284	proteomic profiling by mass spectrometry	TCGA-AA-3710-01A-22_W_VU_20120827_A0218_2H_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 19	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3710	tissue	run 285	proteomic profiling by mass spectrometry	TCGA-AA-3710-01A-22_W_VU_20120827_A0218_2H_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 20	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3715	tissue	run 286	proteomic profiling by mass spectrometry	TCGA-AA-3715-01A-22_W_VU_20120821_A0218_2E_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 20	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3715	tissue	run 287	proteomic profiling by mass spectrometry	TCGA-AA-3715-01A-22_W_VU_20120821_A0218_2E_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 20	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3715	tissue	run 288	proteomic profiling by mass spectrometry	TCGA-AA-3715-01A-22_W_VU_20120821_A0218_2E_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 20	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3715	tissue	run 289	proteomic profiling by mass spectrometry	TCGA-AA-3715-01A-22_W_VU_20120821_A0218_2E_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 20	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3715	tissue	run 290	proteomic profiling by mass spectrometry	TCGA-AA-3715-01A-22_W_VU_20120822_A0218_2E_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 20	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3715	tissue	run 291	proteomic profiling by mass spectrometry	TCGA-AA-3715-01A-22_W_VU_20120822_A0218_2E_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 20	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3715	tissue	run 292	proteomic profiling by mass spectrometry	TCGA-AA-3715-01A-22_W_VU_20120822_A0218_2E_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 20	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3715	tissue	run 293	proteomic profiling by mass spectrometry	TCGA-AA-3715-01A-22_W_VU_20120822_A0218_2E_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 20	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3715	tissue	run 294	proteomic profiling by mass spectrometry	TCGA-AA-3715-01A-22_W_VU_20120822_A0218_2E_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 20	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3715	tissue	run 295	proteomic profiling by mass spectrometry	TCGA-AA-3715-01A-22_W_VU_20120822_A0218_2E_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 20	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3715	tissue	run 296	proteomic profiling by mass spectrometry	TCGA-AA-3715-01A-22_W_VU_20120822_A0218_2E_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 20	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3715	tissue	run 297	proteomic profiling by mass spectrometry	TCGA-AA-3715-01A-22_W_VU_20120822_A0218_2E_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 20	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3715	tissue	run 298	proteomic profiling by mass spectrometry	TCGA-AA-3715-01A-22_W_VU_20120822_A0218_2E_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 20	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3715	tissue	run 299	proteomic profiling by mass spectrometry	TCGA-AA-3715-01A-22_W_VU_20120822_A0218_2E_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 20	Homo sapiens	Colon	77Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3715	tissue	run 300	proteomic profiling by mass spectrometry	TCGA-AA-3715-01A-22_W_VU_20120822_A0218_2E_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 21	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3818	tissue	run 301	proteomic profiling by mass spectrometry	TCGA-AA-3818-01A-22_W_VU_20130210_A0218_10C_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 21	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3818	tissue	run 302	proteomic profiling by mass spectrometry	TCGA-AA-3818-01A-22_W_VU_20130210_A0218_10C_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 21	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3818	tissue	run 303	proteomic profiling by mass spectrometry	TCGA-AA-3818-01A-22_W_VU_20130210_A0218_10C_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 21	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3818	tissue	run 304	proteomic profiling by mass spectrometry	TCGA-AA-3818-01A-22_W_VU_20130210_A0218_10C_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 21	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3818	tissue	run 305	proteomic profiling by mass spectrometry	TCGA-AA-3818-01A-22_W_VU_20130210_A0218_10C_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 21	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3818	tissue	run 306	proteomic profiling by mass spectrometry	TCGA-AA-3818-01A-22_W_VU_20130210_A0218_10C_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 21	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3818	tissue	run 307	proteomic profiling by mass spectrometry	TCGA-AA-3818-01A-22_W_VU_20130210_A0218_10C_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 21	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3818	tissue	run 308	proteomic profiling by mass spectrometry	TCGA-AA-3818-01A-22_W_VU_20130210_A0218_10C_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 21	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3818	tissue	run 309	proteomic profiling by mass spectrometry	TCGA-AA-3818-01A-22_W_VU_20130210_A0218_10C_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 21	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3818	tissue	run 310	proteomic profiling by mass spectrometry	TCGA-AA-3818-01A-22_W_VU_20130210_A0218_10C_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 21	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3818	tissue	run 311	proteomic profiling by mass spectrometry	TCGA-AA-3818-01A-22_W_VU_20130210_A0218_10C_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 21	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3818	tissue	run 312	proteomic profiling by mass spectrometry	TCGA-AA-3818-01A-22_W_VU_20130210_A0218_10C_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 21	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3818	tissue	run 313	proteomic profiling by mass spectrometry	TCGA-AA-3818-01A-22_W_VU_20130210_A0218_10C_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 21	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3818	tissue	run 314	proteomic profiling by mass spectrometry	TCGA-AA-3818-01A-22_W_VU_20130210_A0218_10C_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 21	Homo sapiens	Colon	78Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3818	tissue	run 315	proteomic profiling by mass spectrometry	TCGA-AA-3818-01A-22_W_VU_20130210_A0218_10C_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 22	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3848	tissue	run 316	proteomic profiling by mass spectrometry	TCGA-AA-3848-01A-22_W_VU_20121204_A0218_7C_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 22	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3848	tissue	run 317	proteomic profiling by mass spectrometry	TCGA-AA-3848-01A-22_W_VU_20121204_A0218_7C_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 22	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3848	tissue	run 318	proteomic profiling by mass spectrometry	TCGA-AA-3848-01A-22_W_VU_20121204_A0218_7C_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 22	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3848	tissue	run 319	proteomic profiling by mass spectrometry	TCGA-AA-3848-01A-22_W_VU_20121204_A0218_7C_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 22	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3848	tissue	run 320	proteomic profiling by mass spectrometry	TCGA-AA-3848-01A-22_W_VU_20121204_A0218_7C_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 22	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3848	tissue	run 321	proteomic profiling by mass spectrometry	TCGA-AA-3848-01A-22_W_VU_20121204_A0218_7C_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 22	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3848	tissue	run 322	proteomic profiling by mass spectrometry	TCGA-AA-3848-01A-22_W_VU_20121205_A0218_7C_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 22	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3848	tissue	run 323	proteomic profiling by mass spectrometry	TCGA-AA-3848-01A-22_W_VU_20121205_A0218_7C_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 22	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3848	tissue	run 324	proteomic profiling by mass spectrometry	TCGA-AA-3848-01A-22_W_VU_20121205_A0218_7C_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 22	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3848	tissue	run 325	proteomic profiling by mass spectrometry	TCGA-AA-3848-01A-22_W_VU_20121205_A0218_7C_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 22	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3848	tissue	run 326	proteomic profiling by mass spectrometry	TCGA-AA-3848-01A-22_W_VU_20121205_A0218_7C_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 22	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3848	tissue	run 327	proteomic profiling by mass spectrometry	TCGA-AA-3848-01A-22_W_VU_20121205_A0218_7C_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 22	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3848	tissue	run 328	proteomic profiling by mass spectrometry	TCGA-AA-3848-01A-22_W_VU_20121205_A0218_7C_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 22	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3848	tissue	run 329	proteomic profiling by mass spectrometry	TCGA-AA-3848-01A-22_W_VU_20121205_A0218_7C_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 22	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-3848	tissue	run 330	proteomic profiling by mass spectrometry	TCGA-AA-3848-01A-22_W_VU_20121205_A0218_7C_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 23	Homo sapiens	Colon	71Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3864	tissue	run 331	proteomic profiling by mass spectrometry	TCGA-AA-3864-01A-22_W_VU_20121226_A0218_8D_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 23	Homo sapiens	Colon	71Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3864	tissue	run 332	proteomic profiling by mass spectrometry	TCGA-AA-3864-01A-22_W_VU_20121226_A0218_8D_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 23	Homo sapiens	Colon	71Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3864	tissue	run 333	proteomic profiling by mass spectrometry	TCGA-AA-3864-01A-22_W_VU_20121226_A0218_8D_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 23	Homo sapiens	Colon	71Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3864	tissue	run 334	proteomic profiling by mass spectrometry	TCGA-AA-3864-01A-22_W_VU_20121226_A0218_8D_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 23	Homo sapiens	Colon	71Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3864	tissue	run 335	proteomic profiling by mass spectrometry	TCGA-AA-3864-01A-22_W_VU_20121226_A0218_8D_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 23	Homo sapiens	Colon	71Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3864	tissue	run 336	proteomic profiling by mass spectrometry	TCGA-AA-3864-01A-22_W_VU_20121226_A0218_8D_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 23	Homo sapiens	Colon	71Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3864	tissue	run 337	proteomic profiling by mass spectrometry	TCGA-AA-3864-01A-22_W_VU_20121226_A0218_8D_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 23	Homo sapiens	Colon	71Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3864	tissue	run 338	proteomic profiling by mass spectrometry	TCGA-AA-3864-01A-22_W_VU_20121226_A0218_8D_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 23	Homo sapiens	Colon	71Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3864	tissue	run 339	proteomic profiling by mass spectrometry	TCGA-AA-3864-01A-22_W_VU_20121226_A0218_8D_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 23	Homo sapiens	Colon	71Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3864	tissue	run 340	proteomic profiling by mass spectrometry	TCGA-AA-3864-01A-22_W_VU_20121226_A0218_8D_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 23	Homo sapiens	Colon	71Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3864	tissue	run 341	proteomic profiling by mass spectrometry	TCGA-AA-3864-01A-22_W_VU_20121226_A0218_8D_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 23	Homo sapiens	Colon	71Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3864	tissue	run 342	proteomic profiling by mass spectrometry	TCGA-AA-3864-01A-22_W_VU_20121226_A0218_8D_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 23	Homo sapiens	Colon	71Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3864	tissue	run 343	proteomic profiling by mass spectrometry	TCGA-AA-3864-01A-22_W_VU_20121226_A0218_8D_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 23	Homo sapiens	Colon	71Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3864	tissue	run 344	proteomic profiling by mass spectrometry	TCGA-AA-3864-01A-22_W_VU_20121227_A0218_8D_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 23	Homo sapiens	Colon	71Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3864	tissue	run 345	proteomic profiling by mass spectrometry	TCGA-AA-3864-01A-22_W_VU_20121227_A0218_8D_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 24	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3986	tissue	run 346	proteomic profiling by mass spectrometry	TCGA-AA-3986-01A-12_W_VU_20130116_A0218_9B_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 24	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3986	tissue	run 347	proteomic profiling by mass spectrometry	TCGA-AA-3986-01A-12_W_VU_20130116_A0218_9B_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 24	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3986	tissue	run 348	proteomic profiling by mass spectrometry	TCGA-AA-3986-01A-12_W_VU_20130116_A0218_9B_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 24	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3986	tissue	run 349	proteomic profiling by mass spectrometry	TCGA-AA-3986-01A-12_W_VU_20130116_A0218_9B_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 24	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3986	tissue	run 350	proteomic profiling by mass spectrometry	TCGA-AA-3986-01A-12_W_VU_20130116_A0218_9B_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 24	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3986	tissue	run 351	proteomic profiling by mass spectrometry	TCGA-AA-3986-01A-12_W_VU_20130116_A0218_9B_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 24	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3986	tissue	run 352	proteomic profiling by mass spectrometry	TCGA-AA-3986-01A-12_W_VU_20130116_A0218_9B_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 24	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3986	tissue	run 353	proteomic profiling by mass spectrometry	TCGA-AA-3986-01A-12_W_VU_20130116_A0218_9B_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 24	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3986	tissue	run 354	proteomic profiling by mass spectrometry	TCGA-AA-3986-01A-12_W_VU_20130116_A0218_9B_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 24	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3986	tissue	run 355	proteomic profiling by mass spectrometry	TCGA-AA-3986-01A-12_W_VU_20130116_A0218_9B_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 24	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3986	tissue	run 356	proteomic profiling by mass spectrometry	TCGA-AA-3986-01A-12_W_VU_20130116_A0218_9B_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 24	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3986	tissue	run 357	proteomic profiling by mass spectrometry	TCGA-AA-3986-01A-12_W_VU_20130116_A0218_9B_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 24	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3986	tissue	run 358	proteomic profiling by mass spectrometry	TCGA-AA-3986-01A-12_W_VU_20130116_A0218_9B_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 24	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3986	tissue	run 359	proteomic profiling by mass spectrometry	TCGA-AA-3986-01A-12_W_VU_20130117_A0218_9B_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 24	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3986	tissue	run 360	proteomic profiling by mass spectrometry	TCGA-AA-3986-01A-12_W_VU_20130117_A0218_9B_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 25	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3989	tissue	run 361	proteomic profiling by mass spectrometry	TCGA-AA-3989-01A-22_W_VU_20121114_A0218_6B_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 25	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3989	tissue	run 362	proteomic profiling by mass spectrometry	TCGA-AA-3989-01A-22_W_VU_20121114_A0218_6B_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 25	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3989	tissue	run 363	proteomic profiling by mass spectrometry	TCGA-AA-3989-01A-22_W_VU_20121114_A0218_6B_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 25	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3989	tissue	run 364	proteomic profiling by mass spectrometry	TCGA-AA-3989-01A-22_W_VU_20121114_A0218_6B_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 25	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3989	tissue	run 365	proteomic profiling by mass spectrometry	TCGA-AA-3989-01A-22_W_VU_20121114_A0218_6B_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 25	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3989	tissue	run 366	proteomic profiling by mass spectrometry	TCGA-AA-3989-01A-22_W_VU_20121114_A0218_6B_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 25	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3989	tissue	run 367	proteomic profiling by mass spectrometry	TCGA-AA-3989-01A-22_W_VU_20121114_A0218_6B_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 25	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3989	tissue	run 368	proteomic profiling by mass spectrometry	TCGA-AA-3989-01A-22_W_VU_20121114_A0218_6B_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 25	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3989	tissue	run 369	proteomic profiling by mass spectrometry	TCGA-AA-3989-01A-22_W_VU_20121114_A0218_6B_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 25	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3989	tissue	run 370	proteomic profiling by mass spectrometry	TCGA-AA-3989-01A-22_W_VU_20121114_A0218_6B_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 25	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3989	tissue	run 371	proteomic profiling by mass spectrometry	TCGA-AA-3989-01A-22_W_VU_20121114_A0218_6B_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 25	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3989	tissue	run 372	proteomic profiling by mass spectrometry	TCGA-AA-3989-01A-22_W_VU_20121115_A0218_6B_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 25	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3989	tissue	run 373	proteomic profiling by mass spectrometry	TCGA-AA-3989-01A-22_W_VU_20121115_A0218_6B_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 25	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3989	tissue	run 374	proteomic profiling by mass spectrometry	TCGA-AA-3989-01A-22_W_VU_20121115_A0218_6B_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 25	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-3989	tissue	run 375	proteomic profiling by mass spectrometry	TCGA-AA-3989-01A-22_W_VU_20121115_A0218_6B_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 26	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 376	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-22_W_VU_20121221_A0218_8A_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 26	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 377	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-22_W_VU_20121221_A0218_8A_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 26	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 378	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-22_W_VU_20121221_A0218_8A_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 26	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 379	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-22_W_VU_20121221_A0218_8A_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 26	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 380	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-22_W_VU_20121221_A0218_8A_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 26	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 381	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-22_W_VU_20121221_A0218_8A_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 26	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 382	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-22_W_VU_20121221_A0218_8A_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 26	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 383	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-22_W_VU_20121221_A0218_8A_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 26	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 384	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-22_W_VU_20121221_A0218_8A_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 26	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 385	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-22_W_VU_20121221_A0218_8A_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 26	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 386	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-22_W_VU_20121221_A0218_8A_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 26	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 387	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-22_W_VU_20121221_A0218_8A_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 26	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 388	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-22_W_VU_20121222_A0218_8A_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 26	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 389	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-22_W_VU_20121222_A0218_8A_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 26	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 390	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-22_W_VU_20121222_A0218_8A_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 27	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 391	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-41_W_VU_20130120_A0218_9E_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 27	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 392	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-41_W_VU_20130120_A0218_9E_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 27	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 393	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-41_W_VU_20130120_A0218_9E_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 27	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 394	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-41_W_VU_20130120_A0218_9E_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 27	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 395	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-41_W_VU_20130120_A0218_9E_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 27	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 396	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-41_W_VU_20130120_A0218_9E_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 27	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 397	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-41_W_VU_20130120_A0218_9E_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 27	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 398	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-41_W_VU_20130120_A0218_9E_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 27	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 399	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-41_W_VU_20130120_A0218_9E_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 27	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 400	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-41_W_VU_20130120_A0218_9E_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 27	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 401	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-41_W_VU_20130120_A0218_9E_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 27	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 402	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-41_W_VU_20130120_A0218_9E_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 27	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 403	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-41_W_VU_20130120_A0218_9E_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 27	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 404	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-41_W_VU_20130120_A0218_9E_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 27	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00A	tissue	run 405	proteomic profiling by mass spectrometry	TCGA-AA-A00A-01A-41_W_VU_20130120_A0218_9E_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 28	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00E	tissue	run 406	proteomic profiling by mass spectrometry	TCGA-AA-A00E-01A-31_W_VU_20121012_A0218_4E_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 28	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00E	tissue	run 407	proteomic profiling by mass spectrometry	TCGA-AA-A00E-01A-31_W_VU_20121012_A0218_4E_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 28	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00E	tissue	run 408	proteomic profiling by mass spectrometry	TCGA-AA-A00E-01A-31_W_VU_20121012_A0218_4E_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 28	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00E	tissue	run 409	proteomic profiling by mass spectrometry	TCGA-AA-A00E-01A-31_W_VU_20121012_A0218_4E_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 28	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00E	tissue	run 410	proteomic profiling by mass spectrometry	TCGA-AA-A00E-01A-31_W_VU_20121012_A0218_4E_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 28	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00E	tissue	run 411	proteomic profiling by mass spectrometry	TCGA-AA-A00E-01A-31_W_VU_20121012_A0218_4E_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 28	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00E	tissue	run 412	proteomic profiling by mass spectrometry	TCGA-AA-A00E-01A-31_W_VU_20121012_A0218_4E_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 28	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00E	tissue	run 413	proteomic profiling by mass spectrometry	TCGA-AA-A00E-01A-31_W_VU_20121012_A0218_4E_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 28	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00E	tissue	run 414	proteomic profiling by mass spectrometry	TCGA-AA-A00E-01A-31_W_VU_20121012_A0218_4E_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 28	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00E	tissue	run 415	proteomic profiling by mass spectrometry	TCGA-AA-A00E-01A-31_W_VU_20121013_A0218_4E_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 28	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00E	tissue	run 416	proteomic profiling by mass spectrometry	TCGA-AA-A00E-01A-31_W_VU_20121013_A0218_4E_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 28	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00E	tissue	run 417	proteomic profiling by mass spectrometry	TCGA-AA-A00E-01A-31_W_VU_20121013_A0218_4E_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 28	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00E	tissue	run 418	proteomic profiling by mass spectrometry	TCGA-AA-A00E-01A-31_W_VU_20121013_A0218_4E_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 28	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00E	tissue	run 419	proteomic profiling by mass spectrometry	TCGA-AA-A00E-01A-31_W_VU_20121013_A0218_4E_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 28	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00E	tissue	run 420	proteomic profiling by mass spectrometry	TCGA-AA-A00E-01A-31_W_VU_20121013_A0218_4E_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 29	Homo sapiens	Colon	66Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00F	tissue	run 421	proteomic profiling by mass spectrometry	TCGA-AA-A00F-01A-31_W_VU_20121222_A0218_8B_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 29	Homo sapiens	Colon	66Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00F	tissue	run 422	proteomic profiling by mass spectrometry	TCGA-AA-A00F-01A-31_W_VU_20121222_A0218_8B_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 29	Homo sapiens	Colon	66Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00F	tissue	run 423	proteomic profiling by mass spectrometry	TCGA-AA-A00F-01A-31_W_VU_20121222_A0218_8B_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 29	Homo sapiens	Colon	66Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00F	tissue	run 424	proteomic profiling by mass spectrometry	TCGA-AA-A00F-01A-31_W_VU_20121223_A0218_8B_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 29	Homo sapiens	Colon	66Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00F	tissue	run 425	proteomic profiling by mass spectrometry	TCGA-AA-A00F-01A-31_W_VU_20121223_A0218_8B_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 29	Homo sapiens	Colon	66Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00F	tissue	run 426	proteomic profiling by mass spectrometry	TCGA-AA-A00F-01A-31_W_VU_20121223_A0218_8B_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 29	Homo sapiens	Colon	66Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00F	tissue	run 427	proteomic profiling by mass spectrometry	TCGA-AA-A00F-01A-31_W_VU_20121223_A0218_8B_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 29	Homo sapiens	Colon	66Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00F	tissue	run 428	proteomic profiling by mass spectrometry	TCGA-AA-A00F-01A-31_W_VU_20121223_A0218_8B_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 29	Homo sapiens	Colon	66Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00F	tissue	run 429	proteomic profiling by mass spectrometry	TCGA-AA-A00F-01A-31_W_VU_20121223_A0218_8B_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 29	Homo sapiens	Colon	66Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00F	tissue	run 430	proteomic profiling by mass spectrometry	TCGA-AA-A00F-01A-31_W_VU_20121223_A0218_8B_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 29	Homo sapiens	Colon	66Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00F	tissue	run 431	proteomic profiling by mass spectrometry	TCGA-AA-A00F-01A-31_W_VU_20121223_A0218_8B_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 29	Homo sapiens	Colon	66Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00F	tissue	run 432	proteomic profiling by mass spectrometry	TCGA-AA-A00F-01A-31_W_VU_20121223_A0218_8B_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 29	Homo sapiens	Colon	66Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00F	tissue	run 433	proteomic profiling by mass spectrometry	TCGA-AA-A00F-01A-31_W_VU_20121223_A0218_8B_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 29	Homo sapiens	Colon	66Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00F	tissue	run 434	proteomic profiling by mass spectrometry	TCGA-AA-A00F-01A-31_W_VU_20121223_A0218_8B_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 29	Homo sapiens	Colon	66Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00F	tissue	run 435	proteomic profiling by mass spectrometry	TCGA-AA-A00F-01A-31_W_VU_20121223_A0218_8B_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 30	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00J	tissue	run 436	proteomic profiling by mass spectrometry	TCGA-AA-A00J-01A-12_W_VU_20120804_A0218_1F_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 30	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00J	tissue	run 437	proteomic profiling by mass spectrometry	TCGA-AA-A00J-01A-12_W_VU_20120804_A0218_1F_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 30	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00J	tissue	run 438	proteomic profiling by mass spectrometry	TCGA-AA-A00J-01A-12_W_VU_20120804_A0218_1F_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 30	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00J	tissue	run 439	proteomic profiling by mass spectrometry	TCGA-AA-A00J-01A-12_W_VU_20120804_A0218_1F_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 30	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00J	tissue	run 440	proteomic profiling by mass spectrometry	TCGA-AA-A00J-01A-12_W_VU_20120804_A0218_1F_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 30	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00J	tissue	run 441	proteomic profiling by mass spectrometry	TCGA-AA-A00J-01A-12_W_VU_20120804_A0218_1F_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 30	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00J	tissue	run 442	proteomic profiling by mass spectrometry	TCGA-AA-A00J-01A-12_W_VU_20120804_A0218_1F_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 30	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00J	tissue	run 443	proteomic profiling by mass spectrometry	TCGA-AA-A00J-01A-12_W_VU_20120804_A0218_1F_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 30	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00J	tissue	run 444	proteomic profiling by mass spectrometry	TCGA-AA-A00J-01A-12_W_VU_20120804_A0218_1F_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 30	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00J	tissue	run 445	proteomic profiling by mass spectrometry	TCGA-AA-A00J-01A-12_W_VU_20120805_A0218_1F_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 30	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00J	tissue	run 446	proteomic profiling by mass spectrometry	TCGA-AA-A00J-01A-12_W_VU_20120805_A0218_1F_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 30	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00J	tissue	run 447	proteomic profiling by mass spectrometry	TCGA-AA-A00J-01A-12_W_VU_20120805_A0218_1F_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 30	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00J	tissue	run 448	proteomic profiling by mass spectrometry	TCGA-AA-A00J-01A-12_W_VU_20120805_A0218_1F_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 30	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00J	tissue	run 449	proteomic profiling by mass spectrometry	TCGA-AA-A00J-01A-12_W_VU_20120805_A0218_1F_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 30	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00J	tissue	run 450	proteomic profiling by mass spectrometry	TCGA-AA-A00J-01A-12_W_VU_20120805_A0218_1F_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 31	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 451	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-12_W_VU_20121213_A0218_7H_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 31	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 452	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-12_W_VU_20121213_A0218_7H_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 31	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 453	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-12_W_VU_20121213_A0218_7H_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 31	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 454	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-12_W_VU_20121213_A0218_7H_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 31	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 455	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-12_W_VU_20121213_A0218_7H_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 31	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 456	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-12_W_VU_20121213_A0218_7H_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 31	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 457	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-12_W_VU_20121213_A0218_7H_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 31	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 458	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-12_W_VU_20121213_A0218_7H_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 31	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 459	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-12_W_VU_20121213_A0218_7H_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 31	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 460	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-12_W_VU_20121213_A0218_7H_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 31	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 461	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-12_W_VU_20121213_A0218_7H_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 31	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 462	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-12_W_VU_20121213_A0218_7H_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 31	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 463	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-12_W_VU_20121213_A0218_7H_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 31	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 464	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-12_W_VU_20121214_A0218_7H_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 31	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 465	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-12_W_VU_20121214_A0218_7H_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 32	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 466	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-31_W_VU_20120912_A0218_3E_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 32	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 467	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-31_W_VU_20120912_A0218_3E_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 32	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 468	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-31_W_VU_20120912_A0218_3E_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 32	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 469	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-31_W_VU_20120912_A0218_3E_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 32	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 470	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-31_W_VU_20120912_A0218_3E_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 32	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 471	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-31_W_VU_20120912_A0218_3E_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 32	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 472	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-31_W_VU_20120912_A0218_3E_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 32	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 473	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-31_W_VU_20120913_A0218_3E_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 32	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 474	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-31_W_VU_20120913_A0218_3E_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 32	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 475	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-31_W_VU_20120913_A0218_3E_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 32	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 476	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-31_W_VU_20120913_A0218_3E_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 32	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 477	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-31_W_VU_20120913_A0218_3E_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 32	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 478	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-31_W_VU_20120913_A0218_3E_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 32	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 479	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-31_W_VU_20120913_A0218_3E_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 32	Homo sapiens	Colon	79Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00K	tissue	run 480	proteomic profiling by mass spectrometry	TCGA-AA-A00K-01A-31_W_VU_20120913_A0218_3E_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 33	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 481	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-32_W_VU_20121027_A0218_5D_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 33	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 482	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-32_W_VU_20121027_A0218_5D_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 33	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 483	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-32_W_VU_20121027_A0218_5D_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 33	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 484	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-32_W_VU_20121027_A0218_5D_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 33	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 485	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-32_W_VU_20121027_A0218_5D_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 33	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 486	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-32_W_VU_20121028_A0218_5D_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 33	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 487	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-32_W_VU_20121028_A0218_5D_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 33	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 488	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-32_W_VU_20121028_A0218_5D_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 33	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 489	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-32_W_VU_20121028_A0218_5D_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 33	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 490	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-32_W_VU_20121028_A0218_5D_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 33	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 491	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-32_W_VU_20121028_A0218_5D_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 33	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 492	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-32_W_VU_20121028_A0218_5D_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 33	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 493	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-32_W_VU_20121028_A0218_5D_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 33	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 494	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-32_W_VU_20121028_A0218_5D_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 33	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 495	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-32_W_VU_20121028_A0218_5D_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 34	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 496	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-41_W_VU_20121127_A0218_6J_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 34	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 497	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-41_W_VU_20121127_A0218_6J_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 34	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 498	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-41_W_VU_20121127_A0218_6J_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 34	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 499	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-41_W_VU_20121127_A0218_6J_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 34	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 500	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-41_W_VU_20121127_A0218_6J_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 34	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 501	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-41_W_VU_20121127_A0218_6J_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 34	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 502	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-41_W_VU_20121127_A0218_6J_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 34	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 503	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-41_W_VU_20121127_A0218_6J_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 34	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 504	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-41_W_VU_20121128_A0218_6J_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 34	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 505	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-41_W_VU_20121128_A0218_6J_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 34	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 506	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-41_W_VU_20121128_A0218_6J_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 34	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 507	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-41_W_VU_20121128_A0218_6J_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 34	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 508	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-41_W_VU_20121128_A0218_6J_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 34	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 509	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-41_W_VU_20121128_A0218_6J_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 34	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A00N	tissue	run 510	proteomic profiling by mass spectrometry	TCGA-AA-A00N-01A-41_W_VU_20121128_A0218_6J_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 35	Homo sapiens	Colon	83Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00O	tissue	run 511	proteomic profiling by mass spectrometry	TCGA-AA-A00O-01A-13_W_VU_20120816_A0218_2A_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 35	Homo sapiens	Colon	83Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00O	tissue	run 512	proteomic profiling by mass spectrometry	TCGA-AA-A00O-01A-13_W_VU_20120816_A0218_2A_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 35	Homo sapiens	Colon	83Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00O	tissue	run 513	proteomic profiling by mass spectrometry	TCGA-AA-A00O-01A-13_W_VU_20120816_A0218_2A_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 35	Homo sapiens	Colon	83Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00O	tissue	run 514	proteomic profiling by mass spectrometry	TCGA-AA-A00O-01A-13_W_VU_20120816_A0218_2A_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 35	Homo sapiens	Colon	83Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00O	tissue	run 515	proteomic profiling by mass spectrometry	TCGA-AA-A00O-01A-13_W_VU_20120816_A0218_2A_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 35	Homo sapiens	Colon	83Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00O	tissue	run 516	proteomic profiling by mass spectrometry	TCGA-AA-A00O-01A-13_W_VU_20120816_A0218_2A_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 35	Homo sapiens	Colon	83Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00O	tissue	run 517	proteomic profiling by mass spectrometry	TCGA-AA-A00O-01A-13_W_VU_20120816_A0218_2A_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 35	Homo sapiens	Colon	83Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00O	tissue	run 518	proteomic profiling by mass spectrometry	TCGA-AA-A00O-01A-13_W_VU_20120816_A0218_2A_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 35	Homo sapiens	Colon	83Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00O	tissue	run 519	proteomic profiling by mass spectrometry	TCGA-AA-A00O-01A-13_W_VU_20120817_A0218_2A_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 35	Homo sapiens	Colon	83Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00O	tissue	run 520	proteomic profiling by mass spectrometry	TCGA-AA-A00O-01A-13_W_VU_20120817_A0218_2A_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 35	Homo sapiens	Colon	83Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00O	tissue	run 521	proteomic profiling by mass spectrometry	TCGA-AA-A00O-01A-13_W_VU_20120817_A0218_2A_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 35	Homo sapiens	Colon	83Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00O	tissue	run 522	proteomic profiling by mass spectrometry	TCGA-AA-A00O-01A-13_W_VU_20120817_A0218_2A_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 35	Homo sapiens	Colon	83Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00O	tissue	run 523	proteomic profiling by mass spectrometry	TCGA-AA-A00O-01A-13_W_VU_20120817_A0218_2A_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 35	Homo sapiens	Colon	83Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00O	tissue	run 524	proteomic profiling by mass spectrometry	TCGA-AA-A00O-01A-13_W_VU_20120817_A0218_2A_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 35	Homo sapiens	Colon	83Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00O	tissue	run 525	proteomic profiling by mass spectrometry	TCGA-AA-A00O-01A-13_W_VU_20120817_A0218_2A_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 36	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 526	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-22_W_VU_20121103_A0218_5G_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 36	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 527	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-22_W_VU_20121103_A0218_5G_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 36	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 528	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-22_W_VU_20121103_A0218_5G_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 36	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 529	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-22_W_VU_20121103_A0218_5G_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 36	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 530	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-22_W_VU_20121103_A0218_5G_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 36	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 531	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-22_W_VU_20121103_A0218_5G_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 36	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 532	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-22_W_VU_20121103_A0218_5G_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 36	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 533	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-22_W_VU_20121103_A0218_5G_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 36	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 534	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-22_W_VU_20121103_A0218_5G_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 36	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 535	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-22_W_VU_20121103_A0218_5G_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 36	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 536	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-22_W_VU_20121103_A0218_5G_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 36	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 537	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-22_W_VU_20121103_A0218_5G_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 36	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 538	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-22_W_VU_20121103_A0218_5G_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 36	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 539	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-22_W_VU_20121103_A0218_5G_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 36	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 540	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-22_W_VU_20121103_A0218_5G_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 37	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 541	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-31_W_VU_20121227_A0218_8E_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 37	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 542	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-31_W_VU_20121227_A0218_8E_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 37	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 543	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-31_W_VU_20121227_A0218_8E_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 37	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 544	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-31_W_VU_20121227_A0218_8E_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 37	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 545	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-31_W_VU_20121228_A0218_8E_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 37	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 546	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-31_W_VU_20121228_A0218_8E_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 37	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 547	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-31_W_VU_20121228_A0218_8E_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 37	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 548	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-31_W_VU_20121228_A0218_8E_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 37	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 549	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-31_W_VU_20121228_A0218_8E_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 37	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 550	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-31_W_VU_20121228_A0218_8E_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 37	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 551	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-31_W_VU_20121228_A0218_8E_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 37	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 552	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-31_W_VU_20121228_A0218_8E_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 37	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 553	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-31_W_VU_20121228_A0218_8E_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 37	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 554	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-31_W_VU_20121228_A0218_8E_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 37	Homo sapiens	Colon	64Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00R	tissue	run 555	proteomic profiling by mass spectrometry	TCGA-AA-A00R-01A-31_W_VU_20121228_A0218_8E_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 38	Homo sapiens	Colon	50Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00U	tissue	run 556	proteomic profiling by mass spectrometry	TCGA-AA-A00U-01A-41_W_VU_20130201_A0218_9J_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 38	Homo sapiens	Colon	50Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00U	tissue	run 557	proteomic profiling by mass spectrometry	TCGA-AA-A00U-01A-41_W_VU_20130201_A0218_9J_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 38	Homo sapiens	Colon	50Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00U	tissue	run 558	proteomic profiling by mass spectrometry	TCGA-AA-A00U-01A-41_W_VU_20130201_A0218_9J_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 38	Homo sapiens	Colon	50Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00U	tissue	run 559	proteomic profiling by mass spectrometry	TCGA-AA-A00U-01A-41_W_VU_20130201_A0218_9J_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 38	Homo sapiens	Colon	50Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00U	tissue	run 560	proteomic profiling by mass spectrometry	TCGA-AA-A00U-01A-41_W_VU_20130201_A0218_9J_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 38	Homo sapiens	Colon	50Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00U	tissue	run 561	proteomic profiling by mass spectrometry	TCGA-AA-A00U-01A-41_W_VU_20130201_A0218_9J_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 38	Homo sapiens	Colon	50Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00U	tissue	run 562	proteomic profiling by mass spectrometry	TCGA-AA-A00U-01A-41_W_VU_20130201_A0218_9J_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 38	Homo sapiens	Colon	50Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00U	tissue	run 563	proteomic profiling by mass spectrometry	TCGA-AA-A00U-01A-41_W_VU_20130201_A0218_9J_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 38	Homo sapiens	Colon	50Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00U	tissue	run 564	proteomic profiling by mass spectrometry	TCGA-AA-A00U-01A-41_W_VU_20130201_A0218_9J_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 38	Homo sapiens	Colon	50Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00U	tissue	run 565	proteomic profiling by mass spectrometry	TCGA-AA-A00U-01A-41_W_VU_20130201_A0218_9J_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 38	Homo sapiens	Colon	50Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00U	tissue	run 566	proteomic profiling by mass spectrometry	TCGA-AA-A00U-01A-41_W_VU_20130202_A0218_9J_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 38	Homo sapiens	Colon	50Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00U	tissue	run 567	proteomic profiling by mass spectrometry	TCGA-AA-A00U-01A-41_W_VU_20130202_A0218_9J_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 38	Homo sapiens	Colon	50Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00U	tissue	run 568	proteomic profiling by mass spectrometry	TCGA-AA-A00U-01A-41_W_VU_20130202_A0218_9J_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 38	Homo sapiens	Colon	50Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00U	tissue	run 569	proteomic profiling by mass spectrometry	TCGA-AA-A00U-01A-41_W_VU_20130202_A0218_9J_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 38	Homo sapiens	Colon	50Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A00U	tissue	run 570	proteomic profiling by mass spectrometry	TCGA-AA-A00U-01A-41_W_VU_20130202_A0218_9J_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 39	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A004	tissue	run 571	proteomic profiling by mass spectrometry	TCGA-AA-A004-01A-22_W_VU_20121020_A0218_4J_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 39	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A004	tissue	run 572	proteomic profiling by mass spectrometry	TCGA-AA-A004-01A-22_W_VU_20121020_A0218_4J_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 39	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A004	tissue	run 573	proteomic profiling by mass spectrometry	TCGA-AA-A004-01A-22_W_VU_20121020_A0218_4J_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 39	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A004	tissue	run 574	proteomic profiling by mass spectrometry	TCGA-AA-A004-01A-22_W_VU_20121020_A0218_4J_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 39	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A004	tissue	run 575	proteomic profiling by mass spectrometry	TCGA-AA-A004-01A-22_W_VU_20121020_A0218_4J_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 39	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A004	tissue	run 576	proteomic profiling by mass spectrometry	TCGA-AA-A004-01A-22_W_VU_20121021_A0218_4J_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 39	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A004	tissue	run 577	proteomic profiling by mass spectrometry	TCGA-AA-A004-01A-22_W_VU_20121021_A0218_4J_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 39	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A004	tissue	run 578	proteomic profiling by mass spectrometry	TCGA-AA-A004-01A-22_W_VU_20121021_A0218_4J_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 39	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A004	tissue	run 579	proteomic profiling by mass spectrometry	TCGA-AA-A004-01A-22_W_VU_20121021_A0218_4J_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 39	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A004	tissue	run 580	proteomic profiling by mass spectrometry	TCGA-AA-A004-01A-22_W_VU_20121021_A0218_4J_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 39	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A004	tissue	run 581	proteomic profiling by mass spectrometry	TCGA-AA-A004-01A-22_W_VU_20121021_A0218_4J_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 39	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A004	tissue	run 582	proteomic profiling by mass spectrometry	TCGA-AA-A004-01A-22_W_VU_20121021_A0218_4J_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 39	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A004	tissue	run 583	proteomic profiling by mass spectrometry	TCGA-AA-A004-01A-22_W_VU_20121021_A0218_4J_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 39	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A004	tissue	run 584	proteomic profiling by mass spectrometry	TCGA-AA-A004-01A-22_W_VU_20121021_A0218_4J_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 39	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A004	tissue	run 585	proteomic profiling by mass spectrometry	TCGA-AA-A004-01A-22_W_VU_20121021_A0218_4J_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 40	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01C	tissue	run 586	proteomic profiling by mass spectrometry	TCGA-AA-A01C-01A-22_W_VU_20121015_A0218_4F_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 40	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01C	tissue	run 587	proteomic profiling by mass spectrometry	TCGA-AA-A01C-01A-22_W_VU_20121015_A0218_4F_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 40	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01C	tissue	run 588	proteomic profiling by mass spectrometry	TCGA-AA-A01C-01A-22_W_VU_20121015_A0218_4F_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 40	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01C	tissue	run 589	proteomic profiling by mass spectrometry	TCGA-AA-A01C-01A-22_W_VU_20121015_A0218_4F_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 40	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01C	tissue	run 590	proteomic profiling by mass spectrometry	TCGA-AA-A01C-01A-22_W_VU_20121015_A0218_4F_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 40	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01C	tissue	run 591	proteomic profiling by mass spectrometry	TCGA-AA-A01C-01A-22_W_VU_20121015_A0218_4F_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 40	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01C	tissue	run 592	proteomic profiling by mass spectrometry	TCGA-AA-A01C-01A-22_W_VU_20121015_A0218_4F_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 40	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01C	tissue	run 593	proteomic profiling by mass spectrometry	TCGA-AA-A01C-01A-22_W_VU_20121015_A0218_4F_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 40	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01C	tissue	run 594	proteomic profiling by mass spectrometry	TCGA-AA-A01C-01A-22_W_VU_20121015_A0218_4F_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 40	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01C	tissue	run 595	proteomic profiling by mass spectrometry	TCGA-AA-A01C-01A-22_W_VU_20121015_A0218_4F_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 40	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01C	tissue	run 596	proteomic profiling by mass spectrometry	TCGA-AA-A01C-01A-22_W_VU_20121016_A0218_4F_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 40	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01C	tissue	run 597	proteomic profiling by mass spectrometry	TCGA-AA-A01C-01A-22_W_VU_20121016_A0218_4F_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 40	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01C	tissue	run 598	proteomic profiling by mass spectrometry	TCGA-AA-A01C-01A-22_W_VU_20121016_A0218_4F_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 40	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01C	tissue	run 599	proteomic profiling by mass spectrometry	TCGA-AA-A01C-01A-22_W_VU_20121016_A0218_4F_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 40	Homo sapiens	Colon	75Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01C	tissue	run 600	proteomic profiling by mass spectrometry	TCGA-AA-A01C-01A-22_W_VU_20121016_A0218_4F_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 41	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01D	tissue	run 601	proteomic profiling by mass spectrometry	TCGA-AA-A01D-01A-23_W_VU_20121105_A0218_5I_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 41	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01D	tissue	run 602	proteomic profiling by mass spectrometry	TCGA-AA-A01D-01A-23_W_VU_20121105_A0218_5I_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 41	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01D	tissue	run 603	proteomic profiling by mass spectrometry	TCGA-AA-A01D-01A-23_W_VU_20121105_A0218_5I_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 41	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01D	tissue	run 604	proteomic profiling by mass spectrometry	TCGA-AA-A01D-01A-23_W_VU_20121105_A0218_5I_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 41	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01D	tissue	run 605	proteomic profiling by mass spectrometry	TCGA-AA-A01D-01A-23_W_VU_20121105_A0218_5I_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 41	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01D	tissue	run 606	proteomic profiling by mass spectrometry	TCGA-AA-A01D-01A-23_W_VU_20121106_A0218_5I_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 41	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01D	tissue	run 607	proteomic profiling by mass spectrometry	TCGA-AA-A01D-01A-23_W_VU_20121106_A0218_5I_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 41	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01D	tissue	run 608	proteomic profiling by mass spectrometry	TCGA-AA-A01D-01A-23_W_VU_20121106_A0218_5I_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 41	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01D	tissue	run 609	proteomic profiling by mass spectrometry	TCGA-AA-A01D-01A-23_W_VU_20121106_A0218_5I_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 41	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01D	tissue	run 610	proteomic profiling by mass spectrometry	TCGA-AA-A01D-01A-23_W_VU_20121106_A0218_5I_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 41	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01D	tissue	run 611	proteomic profiling by mass spectrometry	TCGA-AA-A01D-01A-23_W_VU_20121106_A0218_5I_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 41	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01D	tissue	run 612	proteomic profiling by mass spectrometry	TCGA-AA-A01D-01A-23_W_VU_20121106_A0218_5I_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 41	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01D	tissue	run 613	proteomic profiling by mass spectrometry	TCGA-AA-A01D-01A-23_W_VU_20121106_A0218_5I_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 41	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01D	tissue	run 614	proteomic profiling by mass spectrometry	TCGA-AA-A01D-01A-23_W_VU_20121106_A0218_5I_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 41	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01D	tissue	run 615	proteomic profiling by mass spectrometry	TCGA-AA-A01D-01A-23_W_VU_20121106_A0218_5I_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 42	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01F	tissue	run 616	proteomic profiling by mass spectrometry	TCGA-AA-A01F-01A-23_W_VU_20120727_A0218_1B_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 42	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01F	tissue	run 617	proteomic profiling by mass spectrometry	TCGA-AA-A01F-01A-23_W_VU_20120727_A0218_1B_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 42	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01F	tissue	run 618	proteomic profiling by mass spectrometry	TCGA-AA-A01F-01A-23_W_VU_20120727_A0218_1B_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 42	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01F	tissue	run 619	proteomic profiling by mass spectrometry	TCGA-AA-A01F-01A-23_W_VU_20120727_A0218_1B_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 42	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01F	tissue	run 620	proteomic profiling by mass spectrometry	TCGA-AA-A01F-01A-23_W_VU_20120727_A0218_1B_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 42	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01F	tissue	run 621	proteomic profiling by mass spectrometry	TCGA-AA-A01F-01A-23_W_VU_20120728_A0218_1B_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 42	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01F	tissue	run 622	proteomic profiling by mass spectrometry	TCGA-AA-A01F-01A-23_W_VU_20120728_A0218_1B_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 42	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01F	tissue	run 623	proteomic profiling by mass spectrometry	TCGA-AA-A01F-01A-23_W_VU_20120728_A0218_1B_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 42	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01F	tissue	run 624	proteomic profiling by mass spectrometry	TCGA-AA-A01F-01A-23_W_VU_20120728_A0218_1B_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 42	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01F	tissue	run 625	proteomic profiling by mass spectrometry	TCGA-AA-A01F-01A-23_W_VU_20120728_A0218_1B_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 42	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01F	tissue	run 626	proteomic profiling by mass spectrometry	TCGA-AA-A01F-01A-23_W_VU_20120728_A0218_1B_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 42	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01F	tissue	run 627	proteomic profiling by mass spectrometry	TCGA-AA-A01F-01A-23_W_VU_20120728_A0218_1B_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 42	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01F	tissue	run 628	proteomic profiling by mass spectrometry	TCGA-AA-A01F-01A-23_W_VU_20120728_A0218_1B_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 42	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01F	tissue	run 629	proteomic profiling by mass spectrometry	TCGA-AA-A01F-01A-23_W_VU_20120728_A0218_1B_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 42	Homo sapiens	Colon	72Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01F	tissue	run 630	proteomic profiling by mass spectrometry	TCGA-AA-A01F-01A-23_W_VU_20120728_A0218_1B_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 43	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01I	tissue	run 631	proteomic profiling by mass spectrometry	TCGA-AA-A01I-01A-12_W_VU_20121118_A0218_6E_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 43	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01I	tissue	run 632	proteomic profiling by mass spectrometry	TCGA-AA-A01I-01A-12_W_VU_20121118_A0218_6E_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 43	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01I	tissue	run 633	proteomic profiling by mass spectrometry	TCGA-AA-A01I-01A-12_W_VU_20121118_A0218_6E_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 43	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01I	tissue	run 634	proteomic profiling by mass spectrometry	TCGA-AA-A01I-01A-12_W_VU_20121118_A0218_6E_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 43	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01I	tissue	run 635	proteomic profiling by mass spectrometry	TCGA-AA-A01I-01A-12_W_VU_20121118_A0218_6E_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 43	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01I	tissue	run 636	proteomic profiling by mass spectrometry	TCGA-AA-A01I-01A-12_W_VU_20121118_A0218_6E_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 43	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01I	tissue	run 637	proteomic profiling by mass spectrometry	TCGA-AA-A01I-01A-12_W_VU_20121118_A0218_6E_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 43	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01I	tissue	run 638	proteomic profiling by mass spectrometry	TCGA-AA-A01I-01A-12_W_VU_20121118_A0218_6E_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 43	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01I	tissue	run 639	proteomic profiling by mass spectrometry	TCGA-AA-A01I-01A-12_W_VU_20121118_A0218_6E_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 43	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01I	tissue	run 640	proteomic profiling by mass spectrometry	TCGA-AA-A01I-01A-12_W_VU_20121118_A0218_6E_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 43	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01I	tissue	run 641	proteomic profiling by mass spectrometry	TCGA-AA-A01I-01A-12_W_VU_20121118_A0218_6E_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 43	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01I	tissue	run 642	proteomic profiling by mass spectrometry	TCGA-AA-A01I-01A-12_W_VU_20121119_A0218_6E_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 43	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01I	tissue	run 643	proteomic profiling by mass spectrometry	TCGA-AA-A01I-01A-12_W_VU_20121119_A0218_6E_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 43	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01I	tissue	run 644	proteomic profiling by mass spectrometry	TCGA-AA-A01I-01A-12_W_VU_20121119_A0218_6E_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 43	Homo sapiens	Colon	76Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01I	tissue	run 645	proteomic profiling by mass spectrometry	TCGA-AA-A01I-01A-12_W_VU_20121119_A0218_6E_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 44	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01K	tissue	run 646	proteomic profiling by mass spectrometry	TCGA-AA-A01K-01A-31_W_VU_20121116_A0218_6D_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 44	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01K	tissue	run 647	proteomic profiling by mass spectrometry	TCGA-AA-A01K-01A-31_W_VU_20121117_A0218_6D_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 44	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01K	tissue	run 648	proteomic profiling by mass spectrometry	TCGA-AA-A01K-01A-31_W_VU_20121117_A0218_6D_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 44	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01K	tissue	run 649	proteomic profiling by mass spectrometry	TCGA-AA-A01K-01A-31_W_VU_20121117_A0218_6D_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 44	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01K	tissue	run 650	proteomic profiling by mass spectrometry	TCGA-AA-A01K-01A-31_W_VU_20121117_A0218_6D_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 44	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01K	tissue	run 651	proteomic profiling by mass spectrometry	TCGA-AA-A01K-01A-31_W_VU_20121117_A0218_6D_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 44	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01K	tissue	run 652	proteomic profiling by mass spectrometry	TCGA-AA-A01K-01A-31_W_VU_20121117_A0218_6D_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 44	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01K	tissue	run 653	proteomic profiling by mass spectrometry	TCGA-AA-A01K-01A-31_W_VU_20121117_A0218_6D_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 44	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01K	tissue	run 654	proteomic profiling by mass spectrometry	TCGA-AA-A01K-01A-31_W_VU_20121117_A0218_6D_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 44	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01K	tissue	run 655	proteomic profiling by mass spectrometry	TCGA-AA-A01K-01A-31_W_VU_20121117_A0218_6D_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 44	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01K	tissue	run 656	proteomic profiling by mass spectrometry	TCGA-AA-A01K-01A-31_W_VU_20121117_A0218_6D_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 44	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01K	tissue	run 657	proteomic profiling by mass spectrometry	TCGA-AA-A01K-01A-31_W_VU_20121117_A0218_6D_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 44	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01K	tissue	run 658	proteomic profiling by mass spectrometry	TCGA-AA-A01K-01A-31_W_VU_20121117_A0218_6D_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 44	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01K	tissue	run 659	proteomic profiling by mass spectrometry	TCGA-AA-A01K-01A-31_W_VU_20121117_A0218_6D_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 44	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01K	tissue	run 660	proteomic profiling by mass spectrometry	TCGA-AA-A01K-01A-31_W_VU_20121117_A0218_6D_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 45	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01P	tissue	run 661	proteomic profiling by mass spectrometry	TCGA-AA-A01P-01A-23_W_VU_20121214_A0218_7I_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 45	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01P	tissue	run 662	proteomic profiling by mass spectrometry	TCGA-AA-A01P-01A-23_W_VU_20121214_A0218_7I_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 45	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01P	tissue	run 663	proteomic profiling by mass spectrometry	TCGA-AA-A01P-01A-23_W_VU_20121214_A0218_7I_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 45	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01P	tissue	run 664	proteomic profiling by mass spectrometry	TCGA-AA-A01P-01A-23_W_VU_20121214_A0218_7I_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 45	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01P	tissue	run 665	proteomic profiling by mass spectrometry	TCGA-AA-A01P-01A-23_W_VU_20121214_A0218_7I_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 45	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01P	tissue	run 666	proteomic profiling by mass spectrometry	TCGA-AA-A01P-01A-23_W_VU_20121215_A0218_7I_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 45	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01P	tissue	run 667	proteomic profiling by mass spectrometry	TCGA-AA-A01P-01A-23_W_VU_20121215_A0218_7I_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 45	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01P	tissue	run 668	proteomic profiling by mass spectrometry	TCGA-AA-A01P-01A-23_W_VU_20121215_A0218_7I_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 45	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01P	tissue	run 669	proteomic profiling by mass spectrometry	TCGA-AA-A01P-01A-23_W_VU_20121215_A0218_7I_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 45	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01P	tissue	run 670	proteomic profiling by mass spectrometry	TCGA-AA-A01P-01A-23_W_VU_20121215_A0218_7I_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 45	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01P	tissue	run 671	proteomic profiling by mass spectrometry	TCGA-AA-A01P-01A-23_W_VU_20121215_A0218_7I_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 45	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01P	tissue	run 672	proteomic profiling by mass spectrometry	TCGA-AA-A01P-01A-23_W_VU_20121215_A0218_7I_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 45	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01P	tissue	run 673	proteomic profiling by mass spectrometry	TCGA-AA-A01P-01A-23_W_VU_20121215_A0218_7I_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 45	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01P	tissue	run 674	proteomic profiling by mass spectrometry	TCGA-AA-A01P-01A-23_W_VU_20121215_A0218_7I_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 45	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01P	tissue	run 675	proteomic profiling by mass spectrometry	TCGA-AA-A01P-01A-23_W_VU_20121215_A0218_7I_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 46	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01R	tissue	run 676	proteomic profiling by mass spectrometry	TCGA-AA-A01R-01A-23_W_VU_20120829_A0218_2J_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 46	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01R	tissue	run 677	proteomic profiling by mass spectrometry	TCGA-AA-A01R-01A-23_W_VU_20120829_A0218_2J_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 46	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01R	tissue	run 678	proteomic profiling by mass spectrometry	TCGA-AA-A01R-01A-23_W_VU_20120829_A0218_2J_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 46	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01R	tissue	run 679	proteomic profiling by mass spectrometry	TCGA-AA-A01R-01A-23_W_VU_20120829_A0218_2J_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 46	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01R	tissue	run 680	proteomic profiling by mass spectrometry	TCGA-AA-A01R-01A-23_W_VU_20120829_A0218_2J_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 46	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01R	tissue	run 681	proteomic profiling by mass spectrometry	TCGA-AA-A01R-01A-23_W_VU_20120830_A0218_2J_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 46	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01R	tissue	run 682	proteomic profiling by mass spectrometry	TCGA-AA-A01R-01A-23_W_VU_20120830_A0218_2J_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 46	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01R	tissue	run 683	proteomic profiling by mass spectrometry	TCGA-AA-A01R-01A-23_W_VU_20120830_A0218_2J_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 46	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01R	tissue	run 684	proteomic profiling by mass spectrometry	TCGA-AA-A01R-01A-23_W_VU_20120830_A0218_2J_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 46	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01R	tissue	run 685	proteomic profiling by mass spectrometry	TCGA-AA-A01R-01A-23_W_VU_20120830_A0218_2J_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 46	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01R	tissue	run 686	proteomic profiling by mass spectrometry	TCGA-AA-A01R-01A-23_W_VU_20120830_A0218_2J_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 46	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01R	tissue	run 687	proteomic profiling by mass spectrometry	TCGA-AA-A01R-01A-23_W_VU_20120830_A0218_2J_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 46	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01R	tissue	run 688	proteomic profiling by mass spectrometry	TCGA-AA-A01R-01A-23_W_VU_20120830_A0218_2J_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 46	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01R	tissue	run 689	proteomic profiling by mass spectrometry	TCGA-AA-A01R-01A-23_W_VU_20120830_A0218_2J_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 46	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A01R	tissue	run 690	proteomic profiling by mass spectrometry	TCGA-AA-A01R-01A-23_W_VU_20120830_A0218_2J_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 47	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01S	tissue	run 691	proteomic profiling by mass spectrometry	TCGA-AA-A01S-01A-23_W_VU_20121121_A0218_6F_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 47	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01S	tissue	run 692	proteomic profiling by mass spectrometry	TCGA-AA-A01S-01A-23_W_VU_20121121_A0218_6F_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 47	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01S	tissue	run 693	proteomic profiling by mass spectrometry	TCGA-AA-A01S-01A-23_W_VU_20121121_A0218_6F_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 47	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01S	tissue	run 694	proteomic profiling by mass spectrometry	TCGA-AA-A01S-01A-23_W_VU_20121121_A0218_6F_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 47	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01S	tissue	run 695	proteomic profiling by mass spectrometry	TCGA-AA-A01S-01A-23_W_VU_20121121_A0218_6F_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 47	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01S	tissue	run 696	proteomic profiling by mass spectrometry	TCGA-AA-A01S-01A-23_W_VU_20121121_A0218_6F_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 47	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01S	tissue	run 697	proteomic profiling by mass spectrometry	TCGA-AA-A01S-01A-23_W_VU_20121121_A0218_6F_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 47	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01S	tissue	run 698	proteomic profiling by mass spectrometry	TCGA-AA-A01S-01A-23_W_VU_20121121_A0218_6F_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 47	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01S	tissue	run 699	proteomic profiling by mass spectrometry	TCGA-AA-A01S-01A-23_W_VU_20121121_A0218_6F_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 47	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01S	tissue	run 700	proteomic profiling by mass spectrometry	TCGA-AA-A01S-01A-23_W_VU_20121121_A0218_6F_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 47	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01S	tissue	run 701	proteomic profiling by mass spectrometry	TCGA-AA-A01S-01A-23_W_VU_20121121_A0218_6F_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 47	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01S	tissue	run 702	proteomic profiling by mass spectrometry	TCGA-AA-A01S-01A-23_W_VU_20121121_A0218_6F_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 47	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01S	tissue	run 703	proteomic profiling by mass spectrometry	TCGA-AA-A01S-01A-23_W_VU_20121122_A0218_6F_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 47	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01S	tissue	run 704	proteomic profiling by mass spectrometry	TCGA-AA-A01S-01A-23_W_VU_20121122_A0218_6F_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 47	Homo sapiens	Colon	47Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01S	tissue	run 705	proteomic profiling by mass spectrometry	TCGA-AA-A01S-01A-23_W_VU_20121122_A0218_6F_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 48	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01T	tissue	run 706	proteomic profiling by mass spectrometry	TCGA-AA-A01T-01A-23_W_VU_20130103_A0218_8H_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 48	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01T	tissue	run 707	proteomic profiling by mass spectrometry	TCGA-AA-A01T-01A-23_W_VU_20130103_A0218_8H_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 48	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01T	tissue	run 708	proteomic profiling by mass spectrometry	TCGA-AA-A01T-01A-23_W_VU_20130103_A0218_8H_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 48	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01T	tissue	run 709	proteomic profiling by mass spectrometry	TCGA-AA-A01T-01A-23_W_VU_20130103_A0218_8H_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 48	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01T	tissue	run 710	proteomic profiling by mass spectrometry	TCGA-AA-A01T-01A-23_W_VU_20130103_A0218_8H_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 48	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01T	tissue	run 711	proteomic profiling by mass spectrometry	TCGA-AA-A01T-01A-23_W_VU_20130103_A0218_8H_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 48	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01T	tissue	run 712	proteomic profiling by mass spectrometry	TCGA-AA-A01T-01A-23_W_VU_20130103_A0218_8H_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 48	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01T	tissue	run 713	proteomic profiling by mass spectrometry	TCGA-AA-A01T-01A-23_W_VU_20130103_A0218_8H_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 48	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01T	tissue	run 714	proteomic profiling by mass spectrometry	TCGA-AA-A01T-01A-23_W_VU_20130103_A0218_8H_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 48	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01T	tissue	run 715	proteomic profiling by mass spectrometry	TCGA-AA-A01T-01A-23_W_VU_20130104_A0218_8H_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 48	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01T	tissue	run 716	proteomic profiling by mass spectrometry	TCGA-AA-A01T-01A-23_W_VU_20130104_A0218_8H_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 48	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01T	tissue	run 717	proteomic profiling by mass spectrometry	TCGA-AA-A01T-01A-23_W_VU_20130104_A0218_8H_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 48	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01T	tissue	run 718	proteomic profiling by mass spectrometry	TCGA-AA-A01T-01A-23_W_VU_20130104_A0218_8H_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 48	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01T	tissue	run 719	proteomic profiling by mass spectrometry	TCGA-AA-A01T-01A-23_W_VU_20130104_A0218_8H_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 48	Homo sapiens	Colon	63Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01T	tissue	run 720	proteomic profiling by mass spectrometry	TCGA-AA-A01T-01A-23_W_VU_20130104_A0218_8H_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 49	Homo sapiens	Colon	59Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01V	tissue	run 721	proteomic profiling by mass spectrometry	TCGA-AA-A01V-01A-24_W_VU_20121124_A0218_6H_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 49	Homo sapiens	Colon	59Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01V	tissue	run 722	proteomic profiling by mass spectrometry	TCGA-AA-A01V-01A-24_W_VU_20121124_A0218_6H_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 49	Homo sapiens	Colon	59Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01V	tissue	run 723	proteomic profiling by mass spectrometry	TCGA-AA-A01V-01A-24_W_VU_20121124_A0218_6H_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 49	Homo sapiens	Colon	59Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01V	tissue	run 724	proteomic profiling by mass spectrometry	TCGA-AA-A01V-01A-24_W_VU_20121124_A0218_6H_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 49	Homo sapiens	Colon	59Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01V	tissue	run 725	proteomic profiling by mass spectrometry	TCGA-AA-A01V-01A-24_W_VU_20121124_A0218_6H_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 49	Homo sapiens	Colon	59Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01V	tissue	run 726	proteomic profiling by mass spectrometry	TCGA-AA-A01V-01A-24_W_VU_20121124_A0218_6H_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 49	Homo sapiens	Colon	59Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01V	tissue	run 727	proteomic profiling by mass spectrometry	TCGA-AA-A01V-01A-24_W_VU_20121124_A0218_6H_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 49	Homo sapiens	Colon	59Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01V	tissue	run 728	proteomic profiling by mass spectrometry	TCGA-AA-A01V-01A-24_W_VU_20121124_A0218_6H_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 49	Homo sapiens	Colon	59Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01V	tissue	run 729	proteomic profiling by mass spectrometry	TCGA-AA-A01V-01A-24_W_VU_20121125_A0218_6H_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 49	Homo sapiens	Colon	59Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01V	tissue	run 730	proteomic profiling by mass spectrometry	TCGA-AA-A01V-01A-24_W_VU_20121125_A0218_6H_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 49	Homo sapiens	Colon	59Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01V	tissue	run 731	proteomic profiling by mass spectrometry	TCGA-AA-A01V-01A-24_W_VU_20121125_A0218_6H_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 49	Homo sapiens	Colon	59Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01V	tissue	run 732	proteomic profiling by mass spectrometry	TCGA-AA-A01V-01A-24_W_VU_20121125_A0218_6H_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 49	Homo sapiens	Colon	59Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01V	tissue	run 733	proteomic profiling by mass spectrometry	TCGA-AA-A01V-01A-24_W_VU_20121125_A0218_6H_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 49	Homo sapiens	Colon	59Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01V	tissue	run 734	proteomic profiling by mass spectrometry	TCGA-AA-A01V-01A-24_W_VU_20121125_A0218_6H_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 49	Homo sapiens	Colon	59Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01V	tissue	run 735	proteomic profiling by mass spectrometry	TCGA-AA-A01V-01A-24_W_VU_20121125_A0218_6H_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 50	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01X	tissue	run 736	proteomic profiling by mass spectrometry	TCGA-AA-A01X-01A-23_W_VU_20120807_A0218_1H_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 50	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01X	tissue	run 737	proteomic profiling by mass spectrometry	TCGA-AA-A01X-01A-23_W_VU_20120807_A0218_1H_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 50	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01X	tissue	run 738	proteomic profiling by mass spectrometry	TCGA-AA-A01X-01A-23_W_VU_20120807_A0218_1H_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 50	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01X	tissue	run 739	proteomic profiling by mass spectrometry	TCGA-AA-A01X-01A-23_W_VU_20120807_A0218_1H_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 50	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01X	tissue	run 740	proteomic profiling by mass spectrometry	TCGA-AA-A01X-01A-23_W_VU_20120807_A0218_1H_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 50	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01X	tissue	run 741	proteomic profiling by mass spectrometry	TCGA-AA-A01X-01A-23_W_VU_20120807_A0218_1H_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 50	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01X	tissue	run 742	proteomic profiling by mass spectrometry	TCGA-AA-A01X-01A-23_W_VU_20120807_A0218_1H_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 50	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01X	tissue	run 743	proteomic profiling by mass spectrometry	TCGA-AA-A01X-01A-23_W_VU_20120807_A0218_1H_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 50	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01X	tissue	run 744	proteomic profiling by mass spectrometry	TCGA-AA-A01X-01A-23_W_VU_20120807_A0218_1H_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 50	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01X	tissue	run 745	proteomic profiling by mass spectrometry	TCGA-AA-A01X-01A-23_W_VU_20120807_A0218_1H_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 50	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01X	tissue	run 746	proteomic profiling by mass spectrometry	TCGA-AA-A01X-01A-23_W_VU_20120807_A0218_1H_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 50	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01X	tissue	run 747	proteomic profiling by mass spectrometry	TCGA-AA-A01X-01A-23_W_VU_20120807_A0218_1H_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 50	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01X	tissue	run 748	proteomic profiling by mass spectrometry	TCGA-AA-A01X-01A-23_W_VU_20120807_A0218_1H_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 50	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01X	tissue	run 749	proteomic profiling by mass spectrometry	TCGA-AA-A01X-01A-23_W_VU_20120807_A0218_1H_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 50	Homo sapiens	Colon	80Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01X	tissue	run 750	proteomic profiling by mass spectrometry	TCGA-AA-A01X-01A-23_W_VU_20120808_A0218_1H_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 51	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01Z	tissue	run 751	proteomic profiling by mass spectrometry	TCGA-AA-A01Z-01A-13_W_VU_20120907_A0218_3A_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 51	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01Z	tissue	run 752	proteomic profiling by mass spectrometry	TCGA-AA-A01Z-01A-13_W_VU_20120907_A0218_3A_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 51	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01Z	tissue	run 753	proteomic profiling by mass spectrometry	TCGA-AA-A01Z-01A-13_W_VU_20120907_A0218_3A_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 51	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01Z	tissue	run 754	proteomic profiling by mass spectrometry	TCGA-AA-A01Z-01A-13_W_VU_20120907_A0218_3A_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 51	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01Z	tissue	run 755	proteomic profiling by mass spectrometry	TCGA-AA-A01Z-01A-13_W_VU_20120907_A0218_3A_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 51	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01Z	tissue	run 756	proteomic profiling by mass spectrometry	TCGA-AA-A01Z-01A-13_W_VU_20120907_A0218_3A_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 51	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01Z	tissue	run 757	proteomic profiling by mass spectrometry	TCGA-AA-A01Z-01A-13_W_VU_20120907_A0218_3A_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 51	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01Z	tissue	run 758	proteomic profiling by mass spectrometry	TCGA-AA-A01Z-01A-13_W_VU_20120907_A0218_3A_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 51	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01Z	tissue	run 759	proteomic profiling by mass spectrometry	TCGA-AA-A01Z-01A-13_W_VU_20120907_A0218_3A_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 51	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01Z	tissue	run 760	proteomic profiling by mass spectrometry	TCGA-AA-A01Z-01A-13_W_VU_20120907_A0218_3A_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 51	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01Z	tissue	run 761	proteomic profiling by mass spectrometry	TCGA-AA-A01Z-01A-13_W_VU_20120907_A0218_3A_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 51	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01Z	tissue	run 762	proteomic profiling by mass spectrometry	TCGA-AA-A01Z-01A-13_W_VU_20120907_A0218_3A_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 51	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01Z	tissue	run 763	proteomic profiling by mass spectrometry	TCGA-AA-A01Z-01A-13_W_VU_20120907_A0218_3A_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 51	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01Z	tissue	run 764	proteomic profiling by mass spectrometry	TCGA-AA-A01Z-01A-13_W_VU_20120907_A0218_3A_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 51	Homo sapiens	Colon	68Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A01Z	tissue	run 765	proteomic profiling by mass spectrometry	TCGA-AA-A01Z-01A-13_W_VU_20120907_A0218_3A_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 52	Homo sapiens	Colon	46Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A010	tissue	run 766	proteomic profiling by mass spectrometry	TCGA-AA-A010-01A-31_W_VU_20120925_A0218_3J_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 52	Homo sapiens	Colon	46Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A010	tissue	run 767	proteomic profiling by mass spectrometry	TCGA-AA-A010-01A-31_W_VU_20120925_A0218_3J_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 52	Homo sapiens	Colon	46Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A010	tissue	run 768	proteomic profiling by mass spectrometry	TCGA-AA-A010-01A-31_W_VU_20120925_A0218_3J_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 52	Homo sapiens	Colon	46Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A010	tissue	run 769	proteomic profiling by mass spectrometry	TCGA-AA-A010-01A-31_W_VU_20120925_A0218_3J_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 52	Homo sapiens	Colon	46Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A010	tissue	run 770	proteomic profiling by mass spectrometry	TCGA-AA-A010-01A-31_W_VU_20120925_A0218_3J_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 52	Homo sapiens	Colon	46Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A010	tissue	run 771	proteomic profiling by mass spectrometry	TCGA-AA-A010-01A-31_W_VU_20120925_A0218_3J_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 52	Homo sapiens	Colon	46Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A010	tissue	run 772	proteomic profiling by mass spectrometry	TCGA-AA-A010-01A-31_W_VU_20120926_A0218_3J_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 52	Homo sapiens	Colon	46Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A010	tissue	run 773	proteomic profiling by mass spectrometry	TCGA-AA-A010-01A-31_W_VU_20120926_A0218_3J_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 52	Homo sapiens	Colon	46Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A010	tissue	run 774	proteomic profiling by mass spectrometry	TCGA-AA-A010-01A-31_W_VU_20120926_A0218_3J_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 52	Homo sapiens	Colon	46Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A010	tissue	run 775	proteomic profiling by mass spectrometry	TCGA-AA-A010-01A-31_W_VU_20120926_A0218_3J_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 52	Homo sapiens	Colon	46Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A010	tissue	run 776	proteomic profiling by mass spectrometry	TCGA-AA-A010-01A-31_W_VU_20120926_A0218_3J_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 52	Homo sapiens	Colon	46Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A010	tissue	run 777	proteomic profiling by mass spectrometry	TCGA-AA-A010-01A-31_W_VU_20120926_A0218_3J_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 52	Homo sapiens	Colon	46Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A010	tissue	run 778	proteomic profiling by mass spectrometry	TCGA-AA-A010-01A-31_W_VU_20120926_A0218_3J_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 52	Homo sapiens	Colon	46Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A010	tissue	run 779	proteomic profiling by mass spectrometry	TCGA-AA-A010-01A-31_W_VU_20120926_A0218_3J_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 52	Homo sapiens	Colon	46Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A010	tissue	run 780	proteomic profiling by mass spectrometry	TCGA-AA-A010-01A-31_W_VU_20120926_A0218_3J_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 53	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A017	tissue	run 781	proteomic profiling by mass spectrometry	TCGA-AA-A017-01A-22_W_VU_20120817_A0218_2B_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 53	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A017	tissue	run 782	proteomic profiling by mass spectrometry	TCGA-AA-A017-01A-22_W_VU_20120817_A0218_2B_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 53	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A017	tissue	run 783	proteomic profiling by mass spectrometry	TCGA-AA-A017-01A-22_W_VU_20120817_A0218_2B_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 53	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A017	tissue	run 784	proteomic profiling by mass spectrometry	TCGA-AA-A017-01A-22_W_VU_20120817_A0218_2B_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 53	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A017	tissue	run 785	proteomic profiling by mass spectrometry	TCGA-AA-A017-01A-22_W_VU_20120818_A0218_2B_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 53	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A017	tissue	run 786	proteomic profiling by mass spectrometry	TCGA-AA-A017-01A-22_W_VU_20120818_A0218_2B_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 53	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A017	tissue	run 787	proteomic profiling by mass spectrometry	TCGA-AA-A017-01A-22_W_VU_20120818_A0218_2B_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 53	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A017	tissue	run 788	proteomic profiling by mass spectrometry	TCGA-AA-A017-01A-22_W_VU_20120818_A0218_2B_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 53	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A017	tissue	run 789	proteomic profiling by mass spectrometry	TCGA-AA-A017-01A-22_W_VU_20120818_A0218_2B_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 53	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A017	tissue	run 790	proteomic profiling by mass spectrometry	TCGA-AA-A017-01A-22_W_VU_20120818_A0218_2B_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 53	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A017	tissue	run 791	proteomic profiling by mass spectrometry	TCGA-AA-A017-01A-22_W_VU_20120818_A0218_2B_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 53	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A017	tissue	run 792	proteomic profiling by mass spectrometry	TCGA-AA-A017-01A-22_W_VU_20120818_A0218_2B_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 53	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A017	tissue	run 793	proteomic profiling by mass spectrometry	TCGA-AA-A017-01A-22_W_VU_20120818_A0218_2B_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 53	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A017	tissue	run 794	proteomic profiling by mass spectrometry	TCGA-AA-A017-01A-22_W_VU_20120818_A0218_2B_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 53	Homo sapiens	Colon	57Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A017	tissue	run 795	proteomic profiling by mass spectrometry	TCGA-AA-A017-01A-22_W_VU_20120818_A0218_2B_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 54	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02E	tissue	run 796	proteomic profiling by mass spectrometry	TCGA-AA-A02E-01A-23_W_VU_20120908_A0218_3B_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 54	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02E	tissue	run 797	proteomic profiling by mass spectrometry	TCGA-AA-A02E-01A-23_W_VU_20120908_A0218_3B_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 54	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02E	tissue	run 798	proteomic profiling by mass spectrometry	TCGA-AA-A02E-01A-23_W_VU_20120908_A0218_3B_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 54	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02E	tissue	run 799	proteomic profiling by mass spectrometry	TCGA-AA-A02E-01A-23_W_VU_20120908_A0218_3B_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 54	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02E	tissue	run 800	proteomic profiling by mass spectrometry	TCGA-AA-A02E-01A-23_W_VU_20120908_A0218_3B_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 54	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02E	tissue	run 801	proteomic profiling by mass spectrometry	TCGA-AA-A02E-01A-23_W_VU_20120908_A0218_3B_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 54	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02E	tissue	run 802	proteomic profiling by mass spectrometry	TCGA-AA-A02E-01A-23_W_VU_20120908_A0218_3B_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 54	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02E	tissue	run 803	proteomic profiling by mass spectrometry	TCGA-AA-A02E-01A-23_W_VU_20120908_A0218_3B_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 54	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02E	tissue	run 804	proteomic profiling by mass spectrometry	TCGA-AA-A02E-01A-23_W_VU_20120908_A0218_3B_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 54	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02E	tissue	run 805	proteomic profiling by mass spectrometry	TCGA-AA-A02E-01A-23_W_VU_20120908_A0218_3B_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 54	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02E	tissue	run 806	proteomic profiling by mass spectrometry	TCGA-AA-A02E-01A-23_W_VU_20120909_A0218_3B_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 54	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02E	tissue	run 807	proteomic profiling by mass spectrometry	TCGA-AA-A02E-01A-23_W_VU_20120909_A0218_3B_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 54	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02E	tissue	run 808	proteomic profiling by mass spectrometry	TCGA-AA-A02E-01A-23_W_VU_20120909_A0218_3B_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 54	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02E	tissue	run 809	proteomic profiling by mass spectrometry	TCGA-AA-A02E-01A-23_W_VU_20120909_A0218_3B_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 54	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02E	tissue	run 810	proteomic profiling by mass spectrometry	TCGA-AA-A02E-01A-23_W_VU_20120909_A0218_3B_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 55	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02H	tissue	run 811	proteomic profiling by mass spectrometry	TCGA-AA-A02H-01A-32_W_VU_20121025_A0218_5B_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 55	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02H	tissue	run 812	proteomic profiling by mass spectrometry	TCGA-AA-A02H-01A-32_W_VU_20121025_A0218_5B_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 55	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02H	tissue	run 813	proteomic profiling by mass spectrometry	TCGA-AA-A02H-01A-32_W_VU_20121025_A0218_5B_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 55	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02H	tissue	run 814	proteomic profiling by mass spectrometry	TCGA-AA-A02H-01A-32_W_VU_20121025_A0218_5B_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 55	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02H	tissue	run 815	proteomic profiling by mass spectrometry	TCGA-AA-A02H-01A-32_W_VU_20121025_A0218_5B_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 55	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02H	tissue	run 816	proteomic profiling by mass spectrometry	TCGA-AA-A02H-01A-32_W_VU_20121025_A0218_5B_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 55	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02H	tissue	run 817	proteomic profiling by mass spectrometry	TCGA-AA-A02H-01A-32_W_VU_20121025_A0218_5B_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 55	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02H	tissue	run 818	proteomic profiling by mass spectrometry	TCGA-AA-A02H-01A-32_W_VU_20121025_A0218_5B_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 55	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02H	tissue	run 819	proteomic profiling by mass spectrometry	TCGA-AA-A02H-01A-32_W_VU_20121025_A0218_5B_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 55	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02H	tissue	run 820	proteomic profiling by mass spectrometry	TCGA-AA-A02H-01A-32_W_VU_20121025_A0218_5B_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 55	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02H	tissue	run 821	proteomic profiling by mass spectrometry	TCGA-AA-A02H-01A-32_W_VU_20121025_A0218_5B_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 55	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02H	tissue	run 822	proteomic profiling by mass spectrometry	TCGA-AA-A02H-01A-32_W_VU_20121025_A0218_5B_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 55	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02H	tissue	run 823	proteomic profiling by mass spectrometry	TCGA-AA-A02H-01A-32_W_VU_20121025_A0218_5B_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 55	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02H	tissue	run 824	proteomic profiling by mass spectrometry	TCGA-AA-A02H-01A-32_W_VU_20121025_A0218_5B_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 55	Homo sapiens	Colon	74Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02H	tissue	run 825	proteomic profiling by mass spectrometry	TCGA-AA-A02H-01A-32_W_VU_20121025_A0218_5B_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 56	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02J	tissue	run 826	proteomic profiling by mass spectrometry	TCGA-AA-A02J-01A-23_W_VU_20121126_A0218_6I_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 56	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02J	tissue	run 827	proteomic profiling by mass spectrometry	TCGA-AA-A02J-01A-23_W_VU_20121126_A0218_6I_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 56	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02J	tissue	run 828	proteomic profiling by mass spectrometry	TCGA-AA-A02J-01A-23_W_VU_20121126_A0218_6I_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 56	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02J	tissue	run 829	proteomic profiling by mass spectrometry	TCGA-AA-A02J-01A-23_W_VU_20121126_A0218_6I_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 56	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02J	tissue	run 830	proteomic profiling by mass spectrometry	TCGA-AA-A02J-01A-23_W_VU_20121126_A0218_6I_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 56	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02J	tissue	run 831	proteomic profiling by mass spectrometry	TCGA-AA-A02J-01A-23_W_VU_20121126_A0218_6I_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 56	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02J	tissue	run 832	proteomic profiling by mass spectrometry	TCGA-AA-A02J-01A-23_W_VU_20121126_A0218_6I_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 56	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02J	tissue	run 833	proteomic profiling by mass spectrometry	TCGA-AA-A02J-01A-23_W_VU_20121126_A0218_6I_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 56	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02J	tissue	run 834	proteomic profiling by mass spectrometry	TCGA-AA-A02J-01A-23_W_VU_20121126_A0218_6I_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 56	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02J	tissue	run 835	proteomic profiling by mass spectrometry	TCGA-AA-A02J-01A-23_W_VU_20121126_A0218_6I_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 56	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02J	tissue	run 836	proteomic profiling by mass spectrometry	TCGA-AA-A02J-01A-23_W_VU_20121126_A0218_6I_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 56	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02J	tissue	run 837	proteomic profiling by mass spectrometry	TCGA-AA-A02J-01A-23_W_VU_20121126_A0218_6I_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 56	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02J	tissue	run 838	proteomic profiling by mass spectrometry	TCGA-AA-A02J-01A-23_W_VU_20121126_A0218_6I_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 56	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02J	tissue	run 839	proteomic profiling by mass spectrometry	TCGA-AA-A02J-01A-23_W_VU_20121126_A0218_6I_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 56	Homo sapiens	Colon	70Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02J	tissue	run 840	proteomic profiling by mass spectrometry	TCGA-AA-A02J-01A-23_W_VU_20121127_A0218_6I_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 57	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02O	tissue	run 841	proteomic profiling by mass spectrometry	TCGA-AA-A02O-01A-23_W_VU_20130205_A0218_10A_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 57	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02O	tissue	run 842	proteomic profiling by mass spectrometry	TCGA-AA-A02O-01A-23_W_VU_20130205_A0218_10A_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 57	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02O	tissue	run 843	proteomic profiling by mass spectrometry	TCGA-AA-A02O-01A-23_W_VU_20130205_A0218_10A_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 57	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02O	tissue	run 844	proteomic profiling by mass spectrometry	TCGA-AA-A02O-01A-23_W_VU_20130205_A0218_10A_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 57	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02O	tissue	run 845	proteomic profiling by mass spectrometry	TCGA-AA-A02O-01A-23_W_VU_20130205_A0218_10A_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 57	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02O	tissue	run 846	proteomic profiling by mass spectrometry	TCGA-AA-A02O-01A-23_W_VU_20130206_A0218_10A_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 57	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02O	tissue	run 847	proteomic profiling by mass spectrometry	TCGA-AA-A02O-01A-23_W_VU_20130206_A0218_10A_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 57	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02O	tissue	run 848	proteomic profiling by mass spectrometry	TCGA-AA-A02O-01A-23_W_VU_20130207_A0218_10A_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 57	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02O	tissue	run 849	proteomic profiling by mass spectrometry	TCGA-AA-A02O-01A-23_W_VU_20130208_A0218_10A_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 57	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02O	tissue	run 850	proteomic profiling by mass spectrometry	TCGA-AA-A02O-01A-23_W_VU_20130208_A0218_10A_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 57	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02O	tissue	run 851	proteomic profiling by mass spectrometry	TCGA-AA-A02O-01A-23_W_VU_20130206_A0218_10A_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 57	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02O	tissue	run 852	proteomic profiling by mass spectrometry	TCGA-AA-A02O-01A-23_W_VU_20130206_A0218_10A_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 57	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02O	tissue	run 853	proteomic profiling by mass spectrometry	TCGA-AA-A02O-01A-23_W_VU_20130206_A0218_10A_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 57	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02O	tissue	run 854	proteomic profiling by mass spectrometry	TCGA-AA-A02O-01A-23_W_VU_20130206_A0218_10A_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 57	Homo sapiens	Colon	82Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02O	tissue	run 855	proteomic profiling by mass spectrometry	TCGA-AA-A02O-01A-23_W_VU_20130206_A0218_10A_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 58	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02R	tissue	run 856	proteomic profiling by mass spectrometry	TCGA-AA-A02R-01A-23_W_VU_20121104_A0218_5H_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 58	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02R	tissue	run 857	proteomic profiling by mass spectrometry	TCGA-AA-A02R-01A-23_W_VU_20121104_A0218_5H_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 58	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02R	tissue	run 858	proteomic profiling by mass spectrometry	TCGA-AA-A02R-01A-23_W_VU_20121104_A0218_5H_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 58	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02R	tissue	run 859	proteomic profiling by mass spectrometry	TCGA-AA-A02R-01A-23_W_VU_20121104_A0218_5H_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 58	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02R	tissue	run 860	proteomic profiling by mass spectrometry	TCGA-AA-A02R-01A-23_W_VU_20121104_A0218_5H_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 58	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02R	tissue	run 861	proteomic profiling by mass spectrometry	TCGA-AA-A02R-01A-23_W_VU_20121104_A0218_5H_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 58	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02R	tissue	run 862	proteomic profiling by mass spectrometry	TCGA-AA-A02R-01A-23_W_VU_20121104_A0218_5H_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 58	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02R	tissue	run 863	proteomic profiling by mass spectrometry	TCGA-AA-A02R-01A-23_W_VU_20121104_A0218_5H_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 58	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02R	tissue	run 864	proteomic profiling by mass spectrometry	TCGA-AA-A02R-01A-23_W_VU_20121104_A0218_5H_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 58	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02R	tissue	run 865	proteomic profiling by mass spectrometry	TCGA-AA-A02R-01A-23_W_VU_20121104_A0218_5H_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 58	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02R	tissue	run 866	proteomic profiling by mass spectrometry	TCGA-AA-A02R-01A-23_W_VU_20121105_A0218_5H_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 58	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02R	tissue	run 867	proteomic profiling by mass spectrometry	TCGA-AA-A02R-01A-23_W_VU_20121105_A0218_5H_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 58	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02R	tissue	run 868	proteomic profiling by mass spectrometry	TCGA-AA-A02R-01A-23_W_VU_20121105_A0218_5H_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 58	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02R	tissue	run 869	proteomic profiling by mass spectrometry	TCGA-AA-A02R-01A-23_W_VU_20121105_A0218_5H_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 58	Homo sapiens	Colon	84Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02R	tissue	run 870	proteomic profiling by mass spectrometry	TCGA-AA-A02R-01A-23_W_VU_20121105_A0218_5H_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 59	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02Y	tissue	run 871	proteomic profiling by mass spectrometry	TCGA-AA-A02Y-01A-31_W_VU_20120909_A0218_3C_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 59	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02Y	tissue	run 872	proteomic profiling by mass spectrometry	TCGA-AA-A02Y-01A-31_W_VU_20120909_A0218_3C_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 59	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02Y	tissue	run 873	proteomic profiling by mass spectrometry	TCGA-AA-A02Y-01A-31_W_VU_20120909_A0218_3C_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 59	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02Y	tissue	run 874	proteomic profiling by mass spectrometry	TCGA-AA-A02Y-01A-31_W_VU_20120909_A0218_3C_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 59	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02Y	tissue	run 875	proteomic profiling by mass spectrometry	TCGA-AA-A02Y-01A-31_W_VU_20120909_A0218_3C_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 59	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02Y	tissue	run 876	proteomic profiling by mass spectrometry	TCGA-AA-A02Y-01A-31_W_VU_20120909_A0218_3C_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 59	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02Y	tissue	run 877	proteomic profiling by mass spectrometry	TCGA-AA-A02Y-01A-31_W_VU_20120910_A0218_3C_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 59	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02Y	tissue	run 878	proteomic profiling by mass spectrometry	TCGA-AA-A02Y-01A-31_W_VU_20120910_A0218_3C_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 59	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02Y	tissue	run 879	proteomic profiling by mass spectrometry	TCGA-AA-A02Y-01A-31_W_VU_20120910_A0218_3C_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 59	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02Y	tissue	run 880	proteomic profiling by mass spectrometry	TCGA-AA-A02Y-01A-31_W_VU_20120910_A0218_3C_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 59	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02Y	tissue	run 881	proteomic profiling by mass spectrometry	TCGA-AA-A02Y-01A-31_W_VU_20120910_A0218_3C_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 59	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02Y	tissue	run 882	proteomic profiling by mass spectrometry	TCGA-AA-A02Y-01A-31_W_VU_20120910_A0218_3C_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 59	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02Y	tissue	run 883	proteomic profiling by mass spectrometry	TCGA-AA-A02Y-01A-31_W_VU_20120910_A0218_3C_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 59	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02Y	tissue	run 884	proteomic profiling by mass spectrometry	TCGA-AA-A02Y-01A-31_W_VU_20120910_A0218_3C_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 59	Homo sapiens	Colon	73Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A02Y	tissue	run 885	proteomic profiling by mass spectrometry	TCGA-AA-A02Y-01A-31_W_VU_20120910_A0218_3C_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 60	Homo sapiens	Colon	88Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A022	tissue	run 886	proteomic profiling by mass spectrometry	TCGA-AA-A022-01A-23_W_VU_20130118_A0218_9D_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 60	Homo sapiens	Colon	88Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A022	tissue	run 887	proteomic profiling by mass spectrometry	TCGA-AA-A022-01A-23_W_VU_20130118_A0218_9D_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 60	Homo sapiens	Colon	88Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A022	tissue	run 888	proteomic profiling by mass spectrometry	TCGA-AA-A022-01A-23_W_VU_20130118_A0218_9D_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 60	Homo sapiens	Colon	88Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A022	tissue	run 889	proteomic profiling by mass spectrometry	TCGA-AA-A022-01A-23_W_VU_20130118_A0218_9D_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 60	Homo sapiens	Colon	88Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A022	tissue	run 890	proteomic profiling by mass spectrometry	TCGA-AA-A022-01A-23_W_VU_20130118_A0218_9D_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 60	Homo sapiens	Colon	88Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A022	tissue	run 891	proteomic profiling by mass spectrometry	TCGA-AA-A022-01A-23_W_VU_20130119_A0218_9D_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 60	Homo sapiens	Colon	88Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A022	tissue	run 892	proteomic profiling by mass spectrometry	TCGA-AA-A022-01A-23_W_VU_20130119_A0218_9D_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 60	Homo sapiens	Colon	88Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A022	tissue	run 893	proteomic profiling by mass spectrometry	TCGA-AA-A022-01A-23_W_VU_20130119_A0218_9D_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 60	Homo sapiens	Colon	88Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A022	tissue	run 894	proteomic profiling by mass spectrometry	TCGA-AA-A022-01A-23_W_VU_20130119_A0218_9D_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 60	Homo sapiens	Colon	88Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A022	tissue	run 895	proteomic profiling by mass spectrometry	TCGA-AA-A022-01A-23_W_VU_20130119_A0218_9D_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 60	Homo sapiens	Colon	88Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A022	tissue	run 896	proteomic profiling by mass spectrometry	TCGA-AA-A022-01A-23_W_VU_20130119_A0218_9D_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 60	Homo sapiens	Colon	88Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A022	tissue	run 897	proteomic profiling by mass spectrometry	TCGA-AA-A022-01A-23_W_VU_20130119_A0218_9D_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 60	Homo sapiens	Colon	88Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A022	tissue	run 898	proteomic profiling by mass spectrometry	TCGA-AA-A022-01A-23_W_VU_20130119_A0218_9D_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 60	Homo sapiens	Colon	88Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A022	tissue	run 899	proteomic profiling by mass spectrometry	TCGA-AA-A022-01A-23_W_VU_20130119_A0218_9D_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 60	Homo sapiens	Colon	88Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A022	tissue	run 900	proteomic profiling by mass spectrometry	TCGA-AA-A022-01A-23_W_VU_20130119_A0218_9D_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 61	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A024	tissue	run 901	proteomic profiling by mass spectrometry	TCGA-AA-A024-01A-32_W_VU_20130114_A0218_9A_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 61	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A024	tissue	run 902	proteomic profiling by mass spectrometry	TCGA-AA-A024-01A-32_W_VU_20130114_A0218_9A_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 61	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A024	tissue	run 903	proteomic profiling by mass spectrometry	TCGA-AA-A024-01A-32_W_VU_20130114_A0218_9A_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 61	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A024	tissue	run 904	proteomic profiling by mass spectrometry	TCGA-AA-A024-01A-32_W_VU_20130115_A0218_9A_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 61	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A024	tissue	run 905	proteomic profiling by mass spectrometry	TCGA-AA-A024-01A-32_W_VU_20130115_A0218_9A_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 61	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A024	tissue	run 906	proteomic profiling by mass spectrometry	TCGA-AA-A024-01A-32_W_VU_20130115_A0218_9A_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 61	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A024	tissue	run 907	proteomic profiling by mass spectrometry	TCGA-AA-A024-01A-32_W_VU_20130115_A0218_9A_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 61	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A024	tissue	run 908	proteomic profiling by mass spectrometry	TCGA-AA-A024-01A-32_W_VU_20130115_A0218_9A_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 61	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A024	tissue	run 909	proteomic profiling by mass spectrometry	TCGA-AA-A024-01A-32_W_VU_20130115_A0218_9A_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 61	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A024	tissue	run 910	proteomic profiling by mass spectrometry	TCGA-AA-A024-01A-32_W_VU_20130115_A0218_9A_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 61	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A024	tissue	run 911	proteomic profiling by mass spectrometry	TCGA-AA-A024-01A-32_W_VU_20130115_A0218_9A_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 61	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A024	tissue	run 912	proteomic profiling by mass spectrometry	TCGA-AA-A024-01A-32_W_VU_20130115_A0218_9A_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 61	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A024	tissue	run 913	proteomic profiling by mass spectrometry	TCGA-AA-A024-01A-32_W_VU_20130115_A0218_9A_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 61	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A024	tissue	run 914	proteomic profiling by mass spectrometry	TCGA-AA-A024-01A-32_W_VU_20130115_A0218_9A_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 61	Homo sapiens	Colon	81Y	not applicable	not applicable	not available	not available	Male	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A024	tissue	run 915	proteomic profiling by mass spectrometry	TCGA-AA-A024-01A-32_W_VU_20130115_A0218_9A_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 62	Homo sapiens	Colon	67Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A029	tissue	run 916	proteomic profiling by mass spectrometry	TCGA-AA-A029-01A-41_W_VU_20121009_A0218_4C_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 62	Homo sapiens	Colon	67Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A029	tissue	run 917	proteomic profiling by mass spectrometry	TCGA-AA-A029-01A-41_W_VU_20121009_A0218_4C_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 62	Homo sapiens	Colon	67Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A029	tissue	run 918	proteomic profiling by mass spectrometry	TCGA-AA-A029-01A-41_W_VU_20121009_A0218_4C_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 62	Homo sapiens	Colon	67Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A029	tissue	run 919	proteomic profiling by mass spectrometry	TCGA-AA-A029-01A-41_W_VU_20121009_A0218_4C_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 62	Homo sapiens	Colon	67Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A029	tissue	run 920	proteomic profiling by mass spectrometry	TCGA-AA-A029-01A-41_W_VU_20121010_A0218_4C_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 62	Homo sapiens	Colon	67Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A029	tissue	run 921	proteomic profiling by mass spectrometry	TCGA-AA-A029-01A-41_W_VU_20121010_A0218_4C_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 62	Homo sapiens	Colon	67Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A029	tissue	run 922	proteomic profiling by mass spectrometry	TCGA-AA-A029-01A-41_W_VU_20121010_A0218_4C_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 62	Homo sapiens	Colon	67Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A029	tissue	run 923	proteomic profiling by mass spectrometry	TCGA-AA-A029-01A-41_W_VU_20121010_A0218_4C_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 62	Homo sapiens	Colon	67Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A029	tissue	run 924	proteomic profiling by mass spectrometry	TCGA-AA-A029-01A-41_W_VU_20121010_A0218_4C_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 62	Homo sapiens	Colon	67Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A029	tissue	run 925	proteomic profiling by mass spectrometry	TCGA-AA-A029-01A-41_W_VU_20121010_A0218_4C_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 62	Homo sapiens	Colon	67Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A029	tissue	run 926	proteomic profiling by mass spectrometry	TCGA-AA-A029-01A-41_W_VU_20121010_A0218_4C_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 62	Homo sapiens	Colon	67Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A029	tissue	run 927	proteomic profiling by mass spectrometry	TCGA-AA-A029-01A-41_W_VU_20121010_A0218_4C_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 62	Homo sapiens	Colon	67Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A029	tissue	run 928	proteomic profiling by mass spectrometry	TCGA-AA-A029-01A-41_W_VU_20121010_A0218_4C_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 62	Homo sapiens	Colon	67Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A029	tissue	run 929	proteomic profiling by mass spectrometry	TCGA-AA-A029-01A-41_W_VU_20121010_A0218_4C_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 62	Homo sapiens	Colon	67Y	not applicable	not applicable	not available	not available	Male	Colon Adenocarcinoma	not synthetic	TCGA-AA-A029	tissue	run 930	proteomic profiling by mass spectrometry	TCGA-AA-A029-01A-41_W_VU_20121010_A0218_4C_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 63	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A03F	tissue	run 931	proteomic profiling by mass spectrometry	TCGA-AA-A03F-01A-41_W_VU_20120923_A0218_3I_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 63	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A03F	tissue	run 932	proteomic profiling by mass spectrometry	TCGA-AA-A03F-01A-41_W_VU_20120923_A0218_3I_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 63	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A03F	tissue	run 933	proteomic profiling by mass spectrometry	TCGA-AA-A03F-01A-41_W_VU_20120923_A0218_3I_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 63	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A03F	tissue	run 934	proteomic profiling by mass spectrometry	TCGA-AA-A03F-01A-41_W_VU_20120923_A0218_3I_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 63	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A03F	tissue	run 935	proteomic profiling by mass spectrometry	TCGA-AA-A03F-01A-41_W_VU_20120923_A0218_3I_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 63	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A03F	tissue	run 936	proteomic profiling by mass spectrometry	TCGA-AA-A03F-01A-41_W_VU_20120923_A0218_3I_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 63	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A03F	tissue	run 937	proteomic profiling by mass spectrometry	TCGA-AA-A03F-01A-41_W_VU_20120923_A0218_3I_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 63	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A03F	tissue	run 938	proteomic profiling by mass spectrometry	TCGA-AA-A03F-01A-41_W_VU_20120923_A0218_3I_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 63	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A03F	tissue	run 939	proteomic profiling by mass spectrometry	TCGA-AA-A03F-01A-41_W_VU_20120923_A0218_3I_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 63	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A03F	tissue	run 940	proteomic profiling by mass spectrometry	TCGA-AA-A03F-01A-41_W_VU_20120923_A0218_3I_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 63	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A03F	tissue	run 941	proteomic profiling by mass spectrometry	TCGA-AA-A03F-01A-41_W_VU_20120923_A0218_3I_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 63	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A03F	tissue	run 942	proteomic profiling by mass spectrometry	TCGA-AA-A03F-01A-41_W_VU_20120923_A0218_3I_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 63	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A03F	tissue	run 943	proteomic profiling by mass spectrometry	TCGA-AA-A03F-01A-41_W_VU_20120924_A0218_3I_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 63	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A03F	tissue	run 944	proteomic profiling by mass spectrometry	TCGA-AA-A03F-01A-41_W_VU_20120924_A0218_3I_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 63	Homo sapiens	Colon	90Y	not applicable	not applicable	not available	not available	Female	Colon Mucinous Adenocarcinoma	not synthetic	TCGA-AA-A03F	tissue	run 945	proteomic profiling by mass spectrometry	TCGA-AA-A03F-01A-41_W_VU_20120924_A0218_3I_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 64	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A03J	tissue	run 946	proteomic profiling by mass spectrometry	TCGA-AA-A03J-01A-23_W_VU_20120809_A0218_1J_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 64	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A03J	tissue	run 947	proteomic profiling by mass spectrometry	TCGA-AA-A03J-01A-23_W_VU_20120809_A0218_1J_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 64	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A03J	tissue	run 948	proteomic profiling by mass spectrometry	TCGA-AA-A03J-01A-23_W_VU_20120809_A0218_1J_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 64	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A03J	tissue	run 949	proteomic profiling by mass spectrometry	TCGA-AA-A03J-01A-23_W_VU_20120809_A0218_1J_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 64	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A03J	tissue	run 950	proteomic profiling by mass spectrometry	TCGA-AA-A03J-01A-23_W_VU_20120809_A0218_1J_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 64	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A03J	tissue	run 951	proteomic profiling by mass spectrometry	TCGA-AA-A03J-01A-23_W_VU_20120810_A0218_1J_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 64	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A03J	tissue	run 952	proteomic profiling by mass spectrometry	TCGA-AA-A03J-01A-23_W_VU_20120810_A0218_1J_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 64	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A03J	tissue	run 953	proteomic profiling by mass spectrometry	TCGA-AA-A03J-01A-23_W_VU_20120810_A0218_1J_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 64	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A03J	tissue	run 954	proteomic profiling by mass spectrometry	TCGA-AA-A03J-01A-23_W_VU_20120810_A0218_1J_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 64	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A03J	tissue	run 955	proteomic profiling by mass spectrometry	TCGA-AA-A03J-01A-23_W_VU_20120810_A0218_1J_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 64	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A03J	tissue	run 956	proteomic profiling by mass spectrometry	TCGA-AA-A03J-01A-23_W_VU_20120810_A0218_1J_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 64	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A03J	tissue	run 957	proteomic profiling by mass spectrometry	TCGA-AA-A03J-01A-23_W_VU_20120810_A0218_1J_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 64	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A03J	tissue	run 958	proteomic profiling by mass spectrometry	TCGA-AA-A03J-01A-23_W_VU_20120810_A0218_1J_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 64	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A03J	tissue	run 959	proteomic profiling by mass spectrometry	TCGA-AA-A03J-01A-23_W_VU_20120810_A0218_1J_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 64	Homo sapiens	Colon	65Y	not applicable	not applicable	not available	not available	Female	Colon Adenocarcinoma	not synthetic	TCGA-AA-A03J	tissue	run 960	proteomic profiling by mass spectrometry	TCGA-AA-A03J-01A-23_W_VU_20120810_A0218_1J_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Colon
Sample 65	Homo sapiens	Rectum	48Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AF-2691	tissue	run 961	proteomic profiling by mass spectrometry	TCGA-AF-2691-01A-41_W_VU_20120726_A0218_1A_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 65	Homo sapiens	Rectum	48Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AF-2691	tissue	run 962	proteomic profiling by mass spectrometry	TCGA-AF-2691-01A-41_W_VU_20120726_A0218_1A_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 65	Homo sapiens	Rectum	48Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AF-2691	tissue	run 963	proteomic profiling by mass spectrometry	TCGA-AF-2691-01A-41_W_VU_20120726_A0218_1A_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 65	Homo sapiens	Rectum	48Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AF-2691	tissue	run 964	proteomic profiling by mass spectrometry	TCGA-AF-2691-01A-41_W_VU_20120726_A0218_1A_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 65	Homo sapiens	Rectum	48Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AF-2691	tissue	run 965	proteomic profiling by mass spectrometry	TCGA-AF-2691-01A-41_W_VU_20120726_A0218_1A_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 65	Homo sapiens	Rectum	48Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AF-2691	tissue	run 966	proteomic profiling by mass spectrometry	TCGA-AF-2691-01A-41_W_VU_20120726_A0218_1A_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 65	Homo sapiens	Rectum	48Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AF-2691	tissue	run 967	proteomic profiling by mass spectrometry	TCGA-AF-2691-01A-41_W_VU_20120726_A0218_1A_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 65	Homo sapiens	Rectum	48Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AF-2691	tissue	run 968	proteomic profiling by mass spectrometry	TCGA-AF-2691-01A-41_W_VU_20120726_A0218_1A_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 65	Homo sapiens	Rectum	48Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AF-2691	tissue	run 969	proteomic profiling by mass spectrometry	TCGA-AF-2691-01A-41_W_VU_20120726_A0218_1A_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 65	Homo sapiens	Rectum	48Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AF-2691	tissue	run 970	proteomic profiling by mass spectrometry	TCGA-AF-2691-01A-41_W_VU_20120726_A0218_1A_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 65	Homo sapiens	Rectum	48Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AF-2691	tissue	run 971	proteomic profiling by mass spectrometry	TCGA-AF-2691-01A-41_W_VU_20120727_A0218_1A_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 65	Homo sapiens	Rectum	48Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AF-2691	tissue	run 972	proteomic profiling by mass spectrometry	TCGA-AF-2691-01A-41_W_VU_20120727_A0218_1A_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 65	Homo sapiens	Rectum	48Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AF-2691	tissue	run 973	proteomic profiling by mass spectrometry	TCGA-AF-2691-01A-41_W_VU_20120727_A0218_1A_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 65	Homo sapiens	Rectum	48Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AF-2691	tissue	run 974	proteomic profiling by mass spectrometry	TCGA-AF-2691-01A-41_W_VU_20120727_A0218_1A_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 65	Homo sapiens	Rectum	48Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AF-2691	tissue	run 975	proteomic profiling by mass spectrometry	TCGA-AF-2691-01A-41_W_VU_20120727_A0218_1A_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 66	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Female	not available	not synthetic	TCGA-AF-2692	tissue	run 976	proteomic profiling by mass spectrometry	TCGA-AF-2692-01A-41_W_VU_20120910_A0218_3D_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 66	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Female	not available	not synthetic	TCGA-AF-2692	tissue	run 977	proteomic profiling by mass spectrometry	TCGA-AF-2692-01A-41_W_VU_20120911_A0218_3D_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 66	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Female	not available	not synthetic	TCGA-AF-2692	tissue	run 978	proteomic profiling by mass spectrometry	TCGA-AF-2692-01A-41_W_VU_20120911_A0218_3D_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 66	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Female	not available	not synthetic	TCGA-AF-2692	tissue	run 979	proteomic profiling by mass spectrometry	TCGA-AF-2692-01A-41_W_VU_20120911_A0218_3D_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 66	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Female	not available	not synthetic	TCGA-AF-2692	tissue	run 980	proteomic profiling by mass spectrometry	TCGA-AF-2692-01A-41_W_VU_20120911_A0218_3D_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 66	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Female	not available	not synthetic	TCGA-AF-2692	tissue	run 981	proteomic profiling by mass spectrometry	TCGA-AF-2692-01A-41_W_VU_20120911_A0218_3D_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 66	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Female	not available	not synthetic	TCGA-AF-2692	tissue	run 982	proteomic profiling by mass spectrometry	TCGA-AF-2692-01A-41_W_VU_20120911_A0218_3D_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 66	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Female	not available	not synthetic	TCGA-AF-2692	tissue	run 983	proteomic profiling by mass spectrometry	TCGA-AF-2692-01A-41_W_VU_20120911_A0218_3D_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 66	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Female	not available	not synthetic	TCGA-AF-2692	tissue	run 984	proteomic profiling by mass spectrometry	TCGA-AF-2692-01A-41_W_VU_20120911_A0218_3D_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 66	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Female	not available	not synthetic	TCGA-AF-2692	tissue	run 985	proteomic profiling by mass spectrometry	TCGA-AF-2692-01A-41_W_VU_20120911_A0218_3D_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 66	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Female	not available	not synthetic	TCGA-AF-2692	tissue	run 986	proteomic profiling by mass spectrometry	TCGA-AF-2692-01A-41_W_VU_20120911_A0218_3D_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 66	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Female	not available	not synthetic	TCGA-AF-2692	tissue	run 987	proteomic profiling by mass spectrometry	TCGA-AF-2692-01A-41_W_VU_20120911_A0218_3D_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 66	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Female	not available	not synthetic	TCGA-AF-2692	tissue	run 988	proteomic profiling by mass spectrometry	TCGA-AF-2692-01A-41_W_VU_20120911_A0218_3D_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 66	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Female	not available	not synthetic	TCGA-AF-2692	tissue	run 989	proteomic profiling by mass spectrometry	TCGA-AF-2692-01A-41_W_VU_20120911_A0218_3D_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 66	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Female	not available	not synthetic	TCGA-AF-2692	tissue	run 990	proteomic profiling by mass spectrometry	TCGA-AF-2692-01A-41_W_VU_20120911_A0218_3D_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 67	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AF-3400	tissue	run 991	proteomic profiling by mass spectrometry	TCGA-AF-3400-01A-41_W_VU_20120820_A0218_2D_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 67	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AF-3400	tissue	run 992	proteomic profiling by mass spectrometry	TCGA-AF-3400-01A-41_W_VU_20120820_A0218_2D_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 67	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AF-3400	tissue	run 993	proteomic profiling by mass spectrometry	TCGA-AF-3400-01A-41_W_VU_20120820_A0218_2D_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 67	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AF-3400	tissue	run 994	proteomic profiling by mass spectrometry	TCGA-AF-3400-01A-41_W_VU_20120820_A0218_2D_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 67	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AF-3400	tissue	run 995	proteomic profiling by mass spectrometry	TCGA-AF-3400-01A-41_W_VU_20120820_A0218_2D_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 67	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AF-3400	tissue	run 996	proteomic profiling by mass spectrometry	TCGA-AF-3400-01A-41_W_VU_20120820_A0218_2D_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 67	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AF-3400	tissue	run 997	proteomic profiling by mass spectrometry	TCGA-AF-3400-01A-41_W_VU_20120820_A0218_2D_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 67	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AF-3400	tissue	run 998	proteomic profiling by mass spectrometry	TCGA-AF-3400-01A-41_W_VU_20120820_A0218_2D_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 67	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AF-3400	tissue	run 999	proteomic profiling by mass spectrometry	TCGA-AF-3400-01A-41_W_VU_20120820_A0218_2D_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 67	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AF-3400	tissue	run 1000	proteomic profiling by mass spectrometry	TCGA-AF-3400-01A-41_W_VU_20120821_A0218_2D_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 67	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AF-3400	tissue	run 1001	proteomic profiling by mass spectrometry	TCGA-AF-3400-01A-41_W_VU_20120821_A0218_2D_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 67	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AF-3400	tissue	run 1002	proteomic profiling by mass spectrometry	TCGA-AF-3400-01A-41_W_VU_20120821_A0218_2D_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 67	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AF-3400	tissue	run 1003	proteomic profiling by mass spectrometry	TCGA-AF-3400-01A-41_W_VU_20120821_A0218_2D_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 67	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AF-3400	tissue	run 1004	proteomic profiling by mass spectrometry	TCGA-AF-3400-01A-41_W_VU_20120821_A0218_2D_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 67	Homo sapiens	Rectum	54Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AF-3400	tissue	run 1005	proteomic profiling by mass spectrometry	TCGA-AF-3400-01A-41_W_VU_20120821_A0218_2D_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 68	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AF-3913	tissue	run 1006	proteomic profiling by mass spectrometry	TCGA-AF-3913-01A-12_W_VU_20121026_A0218_5C_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 68	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AF-3913	tissue	run 1007	proteomic profiling by mass spectrometry	TCGA-AF-3913-01A-12_W_VU_20121026_A0218_5C_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 68	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AF-3913	tissue	run 1008	proteomic profiling by mass spectrometry	TCGA-AF-3913-01A-12_W_VU_20121026_A0218_5C_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 68	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AF-3913	tissue	run 1009	proteomic profiling by mass spectrometry	TCGA-AF-3913-01A-12_W_VU_20121026_A0218_5C_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 68	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AF-3913	tissue	run 1010	proteomic profiling by mass spectrometry	TCGA-AF-3913-01A-12_W_VU_20121026_A0218_5C_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 68	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AF-3913	tissue	run 1011	proteomic profiling by mass spectrometry	TCGA-AF-3913-01A-12_W_VU_20121026_A0218_5C_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 68	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AF-3913	tissue	run 1012	proteomic profiling by mass spectrometry	TCGA-AF-3913-01A-12_W_VU_20121026_A0218_5C_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 68	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AF-3913	tissue	run 1013	proteomic profiling by mass spectrometry	TCGA-AF-3913-01A-12_W_VU_20121026_A0218_5C_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 68	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AF-3913	tissue	run 1014	proteomic profiling by mass spectrometry	TCGA-AF-3913-01A-12_W_VU_20121026_A0218_5C_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 68	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AF-3913	tissue	run 1015	proteomic profiling by mass spectrometry	TCGA-AF-3913-01A-12_W_VU_20121027_A0218_5C_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 68	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AF-3913	tissue	run 1016	proteomic profiling by mass spectrometry	TCGA-AF-3913-01A-12_W_VU_20121027_A0218_5C_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 68	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AF-3913	tissue	run 1017	proteomic profiling by mass spectrometry	TCGA-AF-3913-01A-12_W_VU_20121027_A0218_5C_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 68	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AF-3913	tissue	run 1018	proteomic profiling by mass spectrometry	TCGA-AF-3913-01A-12_W_VU_20121027_A0218_5C_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 68	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AF-3913	tissue	run 1019	proteomic profiling by mass spectrometry	TCGA-AF-3913-01A-12_W_VU_20121027_A0218_5C_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 68	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AF-3913	tissue	run 1020	proteomic profiling by mass spectrometry	TCGA-AF-3913-01A-12_W_VU_20121027_A0218_5C_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 69	Homo sapiens	Rectum	89Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3574	tissue	run 1021	proteomic profiling by mass spectrometry	TCGA-AG-3574-01A-22_W_VU_20121207_A0218_7E_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 69	Homo sapiens	Rectum	89Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3574	tissue	run 1022	proteomic profiling by mass spectrometry	TCGA-AG-3574-01A-22_W_VU_20121207_A0218_7E_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 69	Homo sapiens	Rectum	89Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3574	tissue	run 1023	proteomic profiling by mass spectrometry	TCGA-AG-3574-01A-22_W_VU_20121207_A0218_7E_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 69	Homo sapiens	Rectum	89Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3574	tissue	run 1024	proteomic profiling by mass spectrometry	TCGA-AG-3574-01A-22_W_VU_20121207_A0218_7E_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 69	Homo sapiens	Rectum	89Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3574	tissue	run 1025	proteomic profiling by mass spectrometry	TCGA-AG-3574-01A-22_W_VU_20121207_A0218_7E_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 69	Homo sapiens	Rectum	89Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3574	tissue	run 1026	proteomic profiling by mass spectrometry	TCGA-AG-3574-01A-22_W_VU_20121207_A0218_7E_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 69	Homo sapiens	Rectum	89Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3574	tissue	run 1027	proteomic profiling by mass spectrometry	TCGA-AG-3574-01A-22_W_VU_20121207_A0218_7E_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 69	Homo sapiens	Rectum	89Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3574	tissue	run 1028	proteomic profiling by mass spectrometry	TCGA-AG-3574-01A-22_W_VU_20121207_A0218_7E_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 69	Homo sapiens	Rectum	89Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3574	tissue	run 1029	proteomic profiling by mass spectrometry	TCGA-AG-3574-01A-22_W_VU_20121207_A0218_7E_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 69	Homo sapiens	Rectum	89Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3574	tissue	run 1030	proteomic profiling by mass spectrometry	TCGA-AG-3574-01A-22_W_VU_20121207_A0218_7E_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 69	Homo sapiens	Rectum	89Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3574	tissue	run 1031	proteomic profiling by mass spectrometry	TCGA-AG-3574-01A-22_W_VU_20121207_A0218_7E_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 69	Homo sapiens	Rectum	89Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3574	tissue	run 1032	proteomic profiling by mass spectrometry	TCGA-AG-3574-01A-22_W_VU_20121208_A0218_7E_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 69	Homo sapiens	Rectum	89Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3574	tissue	run 1033	proteomic profiling by mass spectrometry	TCGA-AG-3574-01A-22_W_VU_20121208_A0218_7E_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 69	Homo sapiens	Rectum	89Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3574	tissue	run 1034	proteomic profiling by mass spectrometry	TCGA-AG-3574-01A-22_W_VU_20121208_A0218_7E_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 69	Homo sapiens	Rectum	89Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3574	tissue	run 1035	proteomic profiling by mass spectrometry	TCGA-AG-3574-01A-22_W_VU_20121208_A0218_7E_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 70	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3580	tissue	run 1036	proteomic profiling by mass spectrometry	TCGA-AG-3580-01A-22_W_VU_20121224_A0218_8C_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 70	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3580	tissue	run 1037	proteomic profiling by mass spectrometry	TCGA-AG-3580-01A-22_W_VU_20121224_A0218_8C_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 70	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3580	tissue	run 1038	proteomic profiling by mass spectrometry	TCGA-AG-3580-01A-22_W_VU_20121224_A0218_8C_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 70	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3580	tissue	run 1039	proteomic profiling by mass spectrometry	TCGA-AG-3580-01A-22_W_VU_20121224_A0218_8C_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 70	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3580	tissue	run 1040	proteomic profiling by mass spectrometry	TCGA-AG-3580-01A-22_W_VU_20121224_A0218_8C_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 70	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3580	tissue	run 1041	proteomic profiling by mass spectrometry	TCGA-AG-3580-01A-22_W_VU_20121224_A0218_8C_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 70	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3580	tissue	run 1042	proteomic profiling by mass spectrometry	TCGA-AG-3580-01A-22_W_VU_20121224_A0218_8C_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 70	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3580	tissue	run 1043	proteomic profiling by mass spectrometry	TCGA-AG-3580-01A-22_W_VU_20121224_A0218_8C_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 70	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3580	tissue	run 1044	proteomic profiling by mass spectrometry	TCGA-AG-3580-01A-22_W_VU_20121224_A0218_8C_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 70	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3580	tissue	run 1045	proteomic profiling by mass spectrometry	TCGA-AG-3580-01A-22_W_VU_20121225_A0218_8C_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 70	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3580	tissue	run 1046	proteomic profiling by mass spectrometry	TCGA-AG-3580-01A-22_W_VU_20121225_A0218_8C_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 70	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3580	tissue	run 1047	proteomic profiling by mass spectrometry	TCGA-AG-3580-01A-22_W_VU_20121225_A0218_8C_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 70	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3580	tissue	run 1048	proteomic profiling by mass spectrometry	TCGA-AG-3580-01A-22_W_VU_20121225_A0218_8C_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 70	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3580	tissue	run 1049	proteomic profiling by mass spectrometry	TCGA-AG-3580-01A-22_W_VU_20121225_A0218_8C_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 70	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3580	tissue	run 1050	proteomic profiling by mass spectrometry	TCGA-AG-3580-01A-22_W_VU_20121225_A0218_8C_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 71	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3584	tissue	run 1051	proteomic profiling by mass spectrometry	TCGA-AG-3584-01A-22_W_VU_20121007_A0218_4A_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 71	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3584	tissue	run 1052	proteomic profiling by mass spectrometry	TCGA-AG-3584-01A-22_W_VU_20121007_A0218_4A_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 71	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3584	tissue	run 1053	proteomic profiling by mass spectrometry	TCGA-AG-3584-01A-22_W_VU_20121007_A0218_4A_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 71	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3584	tissue	run 1054	proteomic profiling by mass spectrometry	TCGA-AG-3584-01A-22_W_VU_20121007_A0218_4A_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 71	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3584	tissue	run 1055	proteomic profiling by mass spectrometry	TCGA-AG-3584-01A-22_W_VU_20121007_A0218_4A_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 71	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3584	tissue	run 1056	proteomic profiling by mass spectrometry	TCGA-AG-3584-01A-22_W_VU_20121007_A0218_4A_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 71	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3584	tissue	run 1057	proteomic profiling by mass spectrometry	TCGA-AG-3584-01A-22_W_VU_20121007_A0218_4A_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 71	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3584	tissue	run 1058	proteomic profiling by mass spectrometry	TCGA-AG-3584-01A-22_W_VU_20121007_A0218_4A_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 71	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3584	tissue	run 1059	proteomic profiling by mass spectrometry	TCGA-AG-3584-01A-22_W_VU_20121007_A0218_4A_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 71	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3584	tissue	run 1060	proteomic profiling by mass spectrometry	TCGA-AG-3584-01A-22_W_VU_20121007_A0218_4A_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 71	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3584	tissue	run 1061	proteomic profiling by mass spectrometry	TCGA-AG-3584-01A-22_W_VU_20121007_A0218_4A_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 71	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3584	tissue	run 1062	proteomic profiling by mass spectrometry	TCGA-AG-3584-01A-22_W_VU_20121007_A0218_4A_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 71	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3584	tissue	run 1063	proteomic profiling by mass spectrometry	TCGA-AG-3584-01A-22_W_VU_20121007_A0218_4A_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 71	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3584	tissue	run 1064	proteomic profiling by mass spectrometry	TCGA-AG-3584-01A-22_W_VU_20121008_A0218_4A_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 71	Homo sapiens	Rectum	60Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3584	tissue	run 1065	proteomic profiling by mass spectrometry	TCGA-AG-3584-01A-22_W_VU_20121008_A0218_4A_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 72	Homo sapiens	Rectum	72Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3593	tissue	run 1066	proteomic profiling by mass spectrometry	TCGA-AG-3593-01A-22_W_VU_20120920_A0218_3G_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 72	Homo sapiens	Rectum	72Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3593	tissue	run 1067	proteomic profiling by mass spectrometry	TCGA-AG-3593-01A-22_W_VU_20120920_A0218_3G_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 72	Homo sapiens	Rectum	72Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3593	tissue	run 1068	proteomic profiling by mass spectrometry	TCGA-AG-3593-01A-22_W_VU_20120920_A0218_3G_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 72	Homo sapiens	Rectum	72Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3593	tissue	run 1069	proteomic profiling by mass spectrometry	TCGA-AG-3593-01A-22_W_VU_20120920_A0218_3G_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 72	Homo sapiens	Rectum	72Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3593	tissue	run 1070	proteomic profiling by mass spectrometry	TCGA-AG-3593-01A-22_W_VU_20120920_A0218_3G_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 72	Homo sapiens	Rectum	72Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3593	tissue	run 1071	proteomic profiling by mass spectrometry	TCGA-AG-3593-01A-22_W_VU_20120920_A0218_3G_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 72	Homo sapiens	Rectum	72Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3593	tissue	run 1072	proteomic profiling by mass spectrometry	TCGA-AG-3593-01A-22_W_VU_20120921_A0218_3G_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 72	Homo sapiens	Rectum	72Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3593	tissue	run 1073	proteomic profiling by mass spectrometry	TCGA-AG-3593-01A-22_W_VU_20120921_A0218_3G_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 72	Homo sapiens	Rectum	72Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3593	tissue	run 1074	proteomic profiling by mass spectrometry	TCGA-AG-3593-01A-22_W_VU_20120921_A0218_3G_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 72	Homo sapiens	Rectum	72Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3593	tissue	run 1075	proteomic profiling by mass spectrometry	TCGA-AG-3593-01A-22_W_VU_20120921_A0218_3G_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 72	Homo sapiens	Rectum	72Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3593	tissue	run 1076	proteomic profiling by mass spectrometry	TCGA-AG-3593-01A-22_W_VU_20120921_A0218_3G_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 72	Homo sapiens	Rectum	72Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3593	tissue	run 1077	proteomic profiling by mass spectrometry	TCGA-AG-3593-01A-22_W_VU_20120921_A0218_3G_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 72	Homo sapiens	Rectum	72Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3593	tissue	run 1078	proteomic profiling by mass spectrometry	TCGA-AG-3593-01A-22_W_VU_20120921_A0218_3G_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 72	Homo sapiens	Rectum	72Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3593	tissue	run 1079	proteomic profiling by mass spectrometry	TCGA-AG-3593-01A-22_W_VU_20120921_A0218_3G_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 72	Homo sapiens	Rectum	72Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-3593	tissue	run 1080	proteomic profiling by mass spectrometry	TCGA-AG-3593-01A-22_W_VU_20120921_A0218_3G_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 73	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-3594	tissue	run 1081	proteomic profiling by mass spectrometry	TCGA-AG-3594-01A-12_W_VU_20121011_A0218_4D_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 73	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-3594	tissue	run 1082	proteomic profiling by mass spectrometry	TCGA-AG-3594-01A-12_W_VU_20121011_A0218_4D_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 73	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-3594	tissue	run 1083	proteomic profiling by mass spectrometry	TCGA-AG-3594-01A-12_W_VU_20121011_A0218_4D_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 73	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-3594	tissue	run 1084	proteomic profiling by mass spectrometry	TCGA-AG-3594-01A-12_W_VU_20121011_A0218_4D_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 73	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-3594	tissue	run 1085	proteomic profiling by mass spectrometry	TCGA-AG-3594-01A-12_W_VU_20121011_A0218_4D_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 73	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-3594	tissue	run 1086	proteomic profiling by mass spectrometry	TCGA-AG-3594-01A-12_W_VU_20121011_A0218_4D_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 73	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-3594	tissue	run 1087	proteomic profiling by mass spectrometry	TCGA-AG-3594-01A-12_W_VU_20121011_A0218_4D_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 73	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-3594	tissue	run 1088	proteomic profiling by mass spectrometry	TCGA-AG-3594-01A-12_W_VU_20121011_A0218_4D_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 73	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-3594	tissue	run 1089	proteomic profiling by mass spectrometry	TCGA-AG-3594-01A-12_W_VU_20121011_A0218_4D_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 73	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-3594	tissue	run 1090	proteomic profiling by mass spectrometry	TCGA-AG-3594-01A-12_W_VU_20121011_A0218_4D_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 73	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-3594	tissue	run 1091	proteomic profiling by mass spectrometry	TCGA-AG-3594-01A-12_W_VU_20121011_A0218_4D_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 73	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-3594	tissue	run 1092	proteomic profiling by mass spectrometry	TCGA-AG-3594-01A-12_W_VU_20121011_A0218_4D_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 73	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-3594	tissue	run 1093	proteomic profiling by mass spectrometry	TCGA-AG-3594-01A-12_W_VU_20121011_A0218_4D_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 73	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-3594	tissue	run 1094	proteomic profiling by mass spectrometry	TCGA-AG-3594-01A-12_W_VU_20121012_A0218_4D_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 73	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-3594	tissue	run 1095	proteomic profiling by mass spectrometry	TCGA-AG-3594-01A-12_W_VU_20121012_A0218_4D_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 74	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-4007	tissue	run 1096	proteomic profiling by mass spectrometry	TCGA-AG-4007-01A-22_W_VU_20120731_A0218_1E_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 74	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-4007	tissue	run 1097	proteomic profiling by mass spectrometry	TCGA-AG-4007-01A-22_W_VU_20120731_A0218_1E_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 74	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-4007	tissue	run 1098	proteomic profiling by mass spectrometry	TCGA-AG-4007-01A-22_W_VU_20120731_A0218_1E_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 74	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-4007	tissue	run 1099	proteomic profiling by mass spectrometry	TCGA-AG-4007-01A-22_W_VU_20120731_A0218_1E_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 74	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-4007	tissue	run 1100	proteomic profiling by mass spectrometry	TCGA-AG-4007-01A-22_W_VU_20120731_A0218_1E_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 74	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-4007	tissue	run 1101	proteomic profiling by mass spectrometry	TCGA-AG-4007-01A-22_W_VU_20120801_A0218_1E_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 74	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-4007	tissue	run 1102	proteomic profiling by mass spectrometry	TCGA-AG-4007-01A-22_W_VU_20120801_A0218_1E_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 74	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-4007	tissue	run 1103	proteomic profiling by mass spectrometry	TCGA-AG-4007-01A-22_W_VU_20120801_A0218_1E_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 74	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-4007	tissue	run 1104	proteomic profiling by mass spectrometry	TCGA-AG-4007-01A-22_W_VU_20120801_A0218_1E_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 74	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-4007	tissue	run 1105	proteomic profiling by mass spectrometry	TCGA-AG-4007-01A-22_W_VU_20120801_A0218_1E_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 74	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-4007	tissue	run 1106	proteomic profiling by mass spectrometry	TCGA-AG-4007-01A-22_W_VU_20120801_A0218_1E_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 74	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-4007	tissue	run 1107	proteomic profiling by mass spectrometry	TCGA-AG-4007-01A-22_W_VU_20120801_A0218_1E_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 74	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-4007	tissue	run 1108	proteomic profiling by mass spectrometry	TCGA-AG-4007-01A-22_W_VU_20120801_A0218_1E_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 74	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-4007	tissue	run 1109	proteomic profiling by mass spectrometry	TCGA-AG-4007-01A-22_W_VU_20120801_A0218_1E_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 74	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-4007	tissue	run 1110	proteomic profiling by mass spectrometry	TCGA-AG-4007-01A-22_W_VU_20120801_A0218_1E_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 75	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00C	tissue	run 1111	proteomic profiling by mass spectrometry	TCGA-AG-A00C-01A-23_W_VU_20120729_A0218_1C_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 75	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00C	tissue	run 1112	proteomic profiling by mass spectrometry	TCGA-AG-A00C-01A-23_W_VU_20120729_A0218_1C_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 75	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00C	tissue	run 1113	proteomic profiling by mass spectrometry	TCGA-AG-A00C-01A-23_W_VU_20120729_A0218_1C_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 75	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00C	tissue	run 1114	proteomic profiling by mass spectrometry	TCGA-AG-A00C-01A-23_W_VU_20120729_A0218_1C_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 75	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00C	tissue	run 1115	proteomic profiling by mass spectrometry	TCGA-AG-A00C-01A-23_W_VU_20120729_A0218_1C_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 75	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00C	tissue	run 1116	proteomic profiling by mass spectrometry	TCGA-AG-A00C-01A-23_W_VU_20120729_A0218_1C_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 75	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00C	tissue	run 1117	proteomic profiling by mass spectrometry	TCGA-AG-A00C-01A-23_W_VU_20120729_A0218_1C_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 75	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00C	tissue	run 1118	proteomic profiling by mass spectrometry	TCGA-AG-A00C-01A-23_W_VU_20120729_A0218_1C_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 75	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00C	tissue	run 1119	proteomic profiling by mass spectrometry	TCGA-AG-A00C-01A-23_W_VU_20120729_A0218_1C_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 75	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00C	tissue	run 1120	proteomic profiling by mass spectrometry	TCGA-AG-A00C-01A-23_W_VU_20120729_A0218_1C_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 75	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00C	tissue	run 1121	proteomic profiling by mass spectrometry	TCGA-AG-A00C-01A-23_W_VU_20120729_A0218_1C_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 75	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00C	tissue	run 1122	proteomic profiling by mass spectrometry	TCGA-AG-A00C-01A-23_W_VU_20120729_A0218_1C_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 75	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00C	tissue	run 1123	proteomic profiling by mass spectrometry	TCGA-AG-A00C-01A-23_W_VU_20120729_A0218_1C_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 75	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00C	tissue	run 1124	proteomic profiling by mass spectrometry	TCGA-AG-A00C-01A-23_W_VU_20120729_A0218_1C_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 75	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00C	tissue	run 1125	proteomic profiling by mass spectrometry	TCGA-AG-A00C-01A-23_W_VU_20120729_A0218_1C_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 76	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1126	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-22_W_VU_20121201_A0218_7A_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 76	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1127	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-22_W_VU_20121202_A0218_7A_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 76	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1128	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-22_W_VU_20121202_A0218_7A_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 76	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1129	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-22_W_VU_20121202_A0218_7A_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 76	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1130	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-22_W_VU_20121202_A0218_7A_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 76	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1131	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-22_W_VU_20121202_A0218_7A_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 76	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1132	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-22_W_VU_20121202_A0218_7A_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 76	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1133	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-22_W_VU_20121202_A0218_7A_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 76	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1134	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-22_W_VU_20121202_A0218_7A_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 76	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1135	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-22_W_VU_20121202_A0218_7A_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 76	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1136	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-22_W_VU_20121202_A0218_7A_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 76	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1137	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-22_W_VU_20121202_A0218_7A_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 76	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1138	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-22_W_VU_20121202_A0218_7A_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 76	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1139	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-22_W_VU_20121202_A0218_7A_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 76	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1140	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-22_W_VU_20121202_A0218_7A_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 77	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1141	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-31_W_VU_20121008_A0218_4B_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 77	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1142	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-31_W_VU_20121008_A0218_4B_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 77	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1143	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-31_W_VU_20121008_A0218_4B_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 77	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1144	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-31_W_VU_20121008_A0218_4B_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 77	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1145	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-31_W_VU_20121008_A0218_4B_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 77	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1146	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-31_W_VU_20121008_A0218_4B_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 77	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1147	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-31_W_VU_20121008_A0218_4B_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 77	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1148	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-31_W_VU_20121008_A0218_4B_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 77	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1149	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-31_W_VU_20121009_A0218_4B_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 77	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1150	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-31_W_VU_20121009_A0218_4B_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 77	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1151	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-31_W_VU_20121009_A0218_4B_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 77	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1152	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-31_W_VU_20121009_A0218_4B_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 77	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1153	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-31_W_VU_20121009_A0218_4B_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 77	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1154	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-31_W_VU_20121009_A0218_4B_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 77	Homo sapiens	Rectum	75Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00H	tissue	run 1155	proteomic profiling by mass spectrometry	TCGA-AG-A00H-01A-31_W_VU_20121009_A0218_4B_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 78	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00Y	tissue	run 1156	proteomic profiling by mass spectrometry	TCGA-AG-A00Y-01A-12_W_VU_20121016_A0218_4G_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 78	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00Y	tissue	run 1157	proteomic profiling by mass spectrometry	TCGA-AG-A00Y-01A-12_W_VU_20121016_A0218_4G_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 78	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00Y	tissue	run 1158	proteomic profiling by mass spectrometry	TCGA-AG-A00Y-01A-12_W_VU_20121016_A0218_4G_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 78	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00Y	tissue	run 1159	proteomic profiling by mass spectrometry	TCGA-AG-A00Y-01A-12_W_VU_20121016_A0218_4G_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 78	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00Y	tissue	run 1160	proteomic profiling by mass spectrometry	TCGA-AG-A00Y-01A-12_W_VU_20121016_A0218_4G_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 78	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00Y	tissue	run 1161	proteomic profiling by mass spectrometry	TCGA-AG-A00Y-01A-12_W_VU_20121017_A0218_4G_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 78	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00Y	tissue	run 1162	proteomic profiling by mass spectrometry	TCGA-AG-A00Y-01A-12_W_VU_20121017_A0218_4G_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 78	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00Y	tissue	run 1163	proteomic profiling by mass spectrometry	TCGA-AG-A00Y-01A-12_W_VU_20121017_A0218_4G_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 78	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00Y	tissue	run 1164	proteomic profiling by mass spectrometry	TCGA-AG-A00Y-01A-12_W_VU_20121017_A0218_4G_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 78	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00Y	tissue	run 1165	proteomic profiling by mass spectrometry	TCGA-AG-A00Y-01A-12_W_VU_20121017_A0218_4G_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 78	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00Y	tissue	run 1166	proteomic profiling by mass spectrometry	TCGA-AG-A00Y-01A-12_W_VU_20121017_A0218_4G_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 78	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00Y	tissue	run 1167	proteomic profiling by mass spectrometry	TCGA-AG-A00Y-01A-12_W_VU_20121017_A0218_4G_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 78	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00Y	tissue	run 1168	proteomic profiling by mass spectrometry	TCGA-AG-A00Y-01A-12_W_VU_20121017_A0218_4G_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 78	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00Y	tissue	run 1169	proteomic profiling by mass spectrometry	TCGA-AG-A00Y-01A-12_W_VU_20121017_A0218_4G_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 78	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A00Y	tissue	run 1170	proteomic profiling by mass spectrometry	TCGA-AG-A00Y-01A-12_W_VU_20121017_A0218_4G_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 79	Homo sapiens	Rectum	35Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A002	tissue	run 1171	proteomic profiling by mass spectrometry	TCGA-AG-A002-01A-23_W_VU_20121211_A0218_7G_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 79	Homo sapiens	Rectum	35Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A002	tissue	run 1172	proteomic profiling by mass spectrometry	TCGA-AG-A002-01A-23_W_VU_20121211_A0218_7G_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 79	Homo sapiens	Rectum	35Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A002	tissue	run 1173	proteomic profiling by mass spectrometry	TCGA-AG-A002-01A-23_W_VU_20121211_A0218_7G_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 79	Homo sapiens	Rectum	35Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A002	tissue	run 1174	proteomic profiling by mass spectrometry	TCGA-AG-A002-01A-23_W_VU_20121211_A0218_7G_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 79	Homo sapiens	Rectum	35Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A002	tissue	run 1175	proteomic profiling by mass spectrometry	TCGA-AG-A002-01A-23_W_VU_20121211_A0218_7G_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 79	Homo sapiens	Rectum	35Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A002	tissue	run 1176	proteomic profiling by mass spectrometry	TCGA-AG-A002-01A-23_W_VU_20121211_A0218_7G_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 79	Homo sapiens	Rectum	35Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A002	tissue	run 1177	proteomic profiling by mass spectrometry	TCGA-AG-A002-01A-23_W_VU_20121212_A0218_7G_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 79	Homo sapiens	Rectum	35Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A002	tissue	run 1178	proteomic profiling by mass spectrometry	TCGA-AG-A002-01A-23_W_VU_20121212_A0218_7G_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 79	Homo sapiens	Rectum	35Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A002	tissue	run 1179	proteomic profiling by mass spectrometry	TCGA-AG-A002-01A-23_W_VU_20121212_A0218_7G_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 79	Homo sapiens	Rectum	35Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A002	tissue	run 1180	proteomic profiling by mass spectrometry	TCGA-AG-A002-01A-23_W_VU_20121212_A0218_7G_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 79	Homo sapiens	Rectum	35Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A002	tissue	run 1181	proteomic profiling by mass spectrometry	TCGA-AG-A002-01A-23_W_VU_20121212_A0218_7G_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 79	Homo sapiens	Rectum	35Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A002	tissue	run 1182	proteomic profiling by mass spectrometry	TCGA-AG-A002-01A-23_W_VU_20121212_A0218_7G_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 79	Homo sapiens	Rectum	35Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A002	tissue	run 1183	proteomic profiling by mass spectrometry	TCGA-AG-A002-01A-23_W_VU_20121212_A0218_7G_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 79	Homo sapiens	Rectum	35Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A002	tissue	run 1184	proteomic profiling by mass spectrometry	TCGA-AG-A002-01A-23_W_VU_20121212_A0218_7G_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 79	Homo sapiens	Rectum	35Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A002	tissue	run 1185	proteomic profiling by mass spectrometry	TCGA-AG-A002-01A-23_W_VU_20121212_A0218_7G_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 80	Homo sapiens	Rectum	50Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A008	tissue	run 1186	proteomic profiling by mass spectrometry	TCGA-AG-A008-01A-23_W_VU_20130127_A0218_9G_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 80	Homo sapiens	Rectum	50Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A008	tissue	run 1187	proteomic profiling by mass spectrometry	TCGA-AG-A008-01A-23_W_VU_20130127_A0218_9G_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 80	Homo sapiens	Rectum	50Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A008	tissue	run 1188	proteomic profiling by mass spectrometry	TCGA-AG-A008-01A-23_W_VU_20130127_A0218_9G_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 80	Homo sapiens	Rectum	50Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A008	tissue	run 1189	proteomic profiling by mass spectrometry	TCGA-AG-A008-01A-23_W_VU_20130127_A0218_9G_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 80	Homo sapiens	Rectum	50Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A008	tissue	run 1190	proteomic profiling by mass spectrometry	TCGA-AG-A008-01A-23_W_VU_20130127_A0218_9G_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 80	Homo sapiens	Rectum	50Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A008	tissue	run 1191	proteomic profiling by mass spectrometry	TCGA-AG-A008-01A-23_W_VU_20130127_A0218_9G_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 80	Homo sapiens	Rectum	50Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A008	tissue	run 1192	proteomic profiling by mass spectrometry	TCGA-AG-A008-01A-23_W_VU_20130127_A0218_9G_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 80	Homo sapiens	Rectum	50Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A008	tissue	run 1193	proteomic profiling by mass spectrometry	TCGA-AG-A008-01A-23_W_VU_20130127_A0218_9G_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 80	Homo sapiens	Rectum	50Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A008	tissue	run 1194	proteomic profiling by mass spectrometry	TCGA-AG-A008-01A-23_W_VU_20130127_A0218_9G_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 80	Homo sapiens	Rectum	50Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A008	tissue	run 1195	proteomic profiling by mass spectrometry	TCGA-AG-A008-01A-23_W_VU_20130127_A0218_9G_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 80	Homo sapiens	Rectum	50Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A008	tissue	run 1196	proteomic profiling by mass spectrometry	TCGA-AG-A008-01A-23_W_VU_20130127_A0218_9G_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 80	Homo sapiens	Rectum	50Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A008	tissue	run 1197	proteomic profiling by mass spectrometry	TCGA-AG-A008-01A-23_W_VU_20130127_A0218_9G_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 80	Homo sapiens	Rectum	50Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A008	tissue	run 1198	proteomic profiling by mass spectrometry	TCGA-AG-A008-01A-23_W_VU_20130128_A0218_9G_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 80	Homo sapiens	Rectum	50Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A008	tissue	run 1199	proteomic profiling by mass spectrometry	TCGA-AG-A008-01A-23_W_VU_20130128_A0218_9G_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 80	Homo sapiens	Rectum	50Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A008	tissue	run 1200	proteomic profiling by mass spectrometry	TCGA-AG-A008-01A-23_W_VU_20130128_A0218_9G_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 81	Homo sapiens	Rectum	59Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01J	tissue	run 1201	proteomic profiling by mass spectrometry	TCGA-AG-A01J-01A-22_W_VU_20121231_A0218_8F_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 81	Homo sapiens	Rectum	59Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01J	tissue	run 1202	proteomic profiling by mass spectrometry	TCGA-AG-A01J-01A-22_W_VU_20121231_A0218_8F_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 81	Homo sapiens	Rectum	59Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01J	tissue	run 1203	proteomic profiling by mass spectrometry	TCGA-AG-A01J-01A-22_W_VU_20121231_A0218_8F_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 81	Homo sapiens	Rectum	59Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01J	tissue	run 1204	proteomic profiling by mass spectrometry	TCGA-AG-A01J-01A-22_W_VU_20121231_A0218_8F_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 81	Homo sapiens	Rectum	59Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01J	tissue	run 1205	proteomic profiling by mass spectrometry	TCGA-AG-A01J-01A-22_W_VU_20121231_A0218_8F_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 81	Homo sapiens	Rectum	59Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01J	tissue	run 1206	proteomic profiling by mass spectrometry	TCGA-AG-A01J-01A-22_W_VU_20121231_A0218_8F_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 81	Homo sapiens	Rectum	59Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01J	tissue	run 1207	proteomic profiling by mass spectrometry	TCGA-AG-A01J-01A-22_W_VU_20121231_A0218_8F_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 81	Homo sapiens	Rectum	59Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01J	tissue	run 1208	proteomic profiling by mass spectrometry	TCGA-AG-A01J-01A-22_W_VU_20121231_A0218_8F_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 81	Homo sapiens	Rectum	59Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01J	tissue	run 1209	proteomic profiling by mass spectrometry	TCGA-AG-A01J-01A-22_W_VU_20121231_A0218_8F_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 81	Homo sapiens	Rectum	59Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01J	tissue	run 1210	proteomic profiling by mass spectrometry	TCGA-AG-A01J-01A-22_W_VU_20121231_A0218_8F_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 81	Homo sapiens	Rectum	59Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01J	tissue	run 1211	proteomic profiling by mass spectrometry	TCGA-AG-A01J-01A-22_W_VU_20121231_A0218_8F_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 81	Homo sapiens	Rectum	59Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01J	tissue	run 1212	proteomic profiling by mass spectrometry	TCGA-AG-A01J-01A-22_W_VU_20121231_A0218_8F_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 81	Homo sapiens	Rectum	59Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01J	tissue	run 1213	proteomic profiling by mass spectrometry	TCGA-AG-A01J-01A-22_W_VU_20121231_A0218_8F_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 81	Homo sapiens	Rectum	59Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01J	tissue	run 1214	proteomic profiling by mass spectrometry	TCGA-AG-A01J-01A-22_W_VU_20121231_A0218_8F_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 81	Homo sapiens	Rectum	59Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01J	tissue	run 1215	proteomic profiling by mass spectrometry	TCGA-AG-A01J-01A-22_W_VU_20121231_A0218_8F_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 82	Homo sapiens	Rectum	58Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01L	tissue	run 1216	proteomic profiling by mass spectrometry	TCGA-AG-A01L-01A-22_W_VU_20130129_A0218_9H_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 82	Homo sapiens	Rectum	58Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01L	tissue	run 1217	proteomic profiling by mass spectrometry	TCGA-AG-A01L-01A-22_W_VU_20130130_A0218_9H_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 82	Homo sapiens	Rectum	58Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01L	tissue	run 1218	proteomic profiling by mass spectrometry	TCGA-AG-A01L-01A-22_W_VU_20130129_A0218_9H_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 82	Homo sapiens	Rectum	58Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01L	tissue	run 1219	proteomic profiling by mass spectrometry	TCGA-AG-A01L-01A-22_W_VU_20130129_A0218_9H_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 82	Homo sapiens	Rectum	58Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01L	tissue	run 1220	proteomic profiling by mass spectrometry	TCGA-AG-A01L-01A-22_W_VU_20130129_A0218_9H_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 82	Homo sapiens	Rectum	58Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01L	tissue	run 1221	proteomic profiling by mass spectrometry	TCGA-AG-A01L-01A-22_W_VU_20130129_A0218_9H_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 82	Homo sapiens	Rectum	58Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01L	tissue	run 1222	proteomic profiling by mass spectrometry	TCGA-AG-A01L-01A-22_W_VU_20130130_A0218_9H_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 82	Homo sapiens	Rectum	58Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01L	tissue	run 1223	proteomic profiling by mass spectrometry	TCGA-AG-A01L-01A-22_W_VU_20130130_A0218_9H_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 82	Homo sapiens	Rectum	58Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01L	tissue	run 1224	proteomic profiling by mass spectrometry	TCGA-AG-A01L-01A-22_W_VU_20130130_A0218_9H_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 82	Homo sapiens	Rectum	58Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01L	tissue	run 1225	proteomic profiling by mass spectrometry	TCGA-AG-A01L-01A-22_W_VU_20130130_A0218_9H_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 82	Homo sapiens	Rectum	58Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01L	tissue	run 1226	proteomic profiling by mass spectrometry	TCGA-AG-A01L-01A-22_W_VU_20130130_A0218_9H_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 82	Homo sapiens	Rectum	58Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01L	tissue	run 1227	proteomic profiling by mass spectrometry	TCGA-AG-A01L-01A-22_W_VU_20130130_A0218_9H_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 82	Homo sapiens	Rectum	58Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01L	tissue	run 1228	proteomic profiling by mass spectrometry	TCGA-AG-A01L-01A-22_W_VU_20130130_A0218_9H_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 82	Homo sapiens	Rectum	58Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01L	tissue	run 1229	proteomic profiling by mass spectrometry	TCGA-AG-A01L-01A-22_W_VU_20130130_A0218_9H_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 82	Homo sapiens	Rectum	58Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01L	tissue	run 1230	proteomic profiling by mass spectrometry	TCGA-AG-A01L-01A-22_W_VU_20130130_A0218_9H_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 83	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01N	tissue	run 1231	proteomic profiling by mass spectrometry	TCGA-AG-A01N-01A-23_W_VU_20130104_A0218_8I_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 83	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01N	tissue	run 1232	proteomic profiling by mass spectrometry	TCGA-AG-A01N-01A-23_W_VU_20130104_A0218_8I_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 83	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01N	tissue	run 1233	proteomic profiling by mass spectrometry	TCGA-AG-A01N-01A-23_W_VU_20130104_A0218_8I_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 83	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01N	tissue	run 1234	proteomic profiling by mass spectrometry	TCGA-AG-A01N-01A-23_W_VU_20130104_A0218_8I_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 83	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01N	tissue	run 1235	proteomic profiling by mass spectrometry	TCGA-AG-A01N-01A-23_W_VU_20130105_A0218_8I_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 83	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01N	tissue	run 1236	proteomic profiling by mass spectrometry	TCGA-AG-A01N-01A-23_W_VU_20130105_A0218_8I_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 83	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01N	tissue	run 1237	proteomic profiling by mass spectrometry	TCGA-AG-A01N-01A-23_W_VU_20130105_A0218_8I_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 83	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01N	tissue	run 1238	proteomic profiling by mass spectrometry	TCGA-AG-A01N-01A-23_W_VU_20130105_A0218_8I_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 83	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01N	tissue	run 1239	proteomic profiling by mass spectrometry	TCGA-AG-A01N-01A-23_W_VU_20130105_A0218_8I_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 83	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01N	tissue	run 1240	proteomic profiling by mass spectrometry	TCGA-AG-A01N-01A-23_W_VU_20130105_A0218_8I_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 83	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01N	tissue	run 1241	proteomic profiling by mass spectrometry	TCGA-AG-A01N-01A-23_W_VU_20130105_A0218_8I_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 83	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01N	tissue	run 1242	proteomic profiling by mass spectrometry	TCGA-AG-A01N-01A-23_W_VU_20130105_A0218_8I_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 83	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01N	tissue	run 1243	proteomic profiling by mass spectrometry	TCGA-AG-A01N-01A-23_W_VU_20130105_A0218_8I_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 83	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01N	tissue	run 1244	proteomic profiling by mass spectrometry	TCGA-AG-A01N-01A-23_W_VU_20130105_A0218_8I_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 83	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01N	tissue	run 1245	proteomic profiling by mass spectrometry	TCGA-AG-A01N-01A-23_W_VU_20130105_A0218_8I_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 84	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01W	tissue	run 1246	proteomic profiling by mass spectrometry	TCGA-AG-A01W-01A-23_W_VU_20121115_A0218_6C_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 84	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01W	tissue	run 1247	proteomic profiling by mass spectrometry	TCGA-AG-A01W-01A-23_W_VU_20121115_A0218_6C_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 84	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01W	tissue	run 1248	proteomic profiling by mass spectrometry	TCGA-AG-A01W-01A-23_W_VU_20121115_A0218_6C_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 84	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01W	tissue	run 1249	proteomic profiling by mass spectrometry	TCGA-AG-A01W-01A-23_W_VU_20121115_A0218_6C_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 84	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01W	tissue	run 1250	proteomic profiling by mass spectrometry	TCGA-AG-A01W-01A-23_W_VU_20121115_A0218_6C_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 84	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01W	tissue	run 1251	proteomic profiling by mass spectrometry	TCGA-AG-A01W-01A-23_W_VU_20121115_A0218_6C_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 84	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01W	tissue	run 1252	proteomic profiling by mass spectrometry	TCGA-AG-A01W-01A-23_W_VU_20121116_A0218_6C_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 84	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01W	tissue	run 1253	proteomic profiling by mass spectrometry	TCGA-AG-A01W-01A-23_W_VU_20121116_A0218_6C_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 84	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01W	tissue	run 1254	proteomic profiling by mass spectrometry	TCGA-AG-A01W-01A-23_W_VU_20121116_A0218_6C_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 84	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01W	tissue	run 1255	proteomic profiling by mass spectrometry	TCGA-AG-A01W-01A-23_W_VU_20121116_A0218_6C_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 84	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01W	tissue	run 1256	proteomic profiling by mass spectrometry	TCGA-AG-A01W-01A-23_W_VU_20121116_A0218_6C_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 84	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01W	tissue	run 1257	proteomic profiling by mass spectrometry	TCGA-AG-A01W-01A-23_W_VU_20121116_A0218_6C_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 84	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01W	tissue	run 1258	proteomic profiling by mass spectrometry	TCGA-AG-A01W-01A-23_W_VU_20121116_A0218_6C_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 84	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01W	tissue	run 1259	proteomic profiling by mass spectrometry	TCGA-AG-A01W-01A-23_W_VU_20121116_A0218_6C_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 84	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01W	tissue	run 1260	proteomic profiling by mass spectrometry	TCGA-AG-A01W-01A-23_W_VU_20121116_A0218_6C_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 85	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01Y	tissue	run 1261	proteomic profiling by mass spectrometry	TCGA-AG-A01Y-01A-43_W_VU_20120825_A0218_2G_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 85	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01Y	tissue	run 1262	proteomic profiling by mass spectrometry	TCGA-AG-A01Y-01A-43_W_VU_20120825_A0218_2G_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 85	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01Y	tissue	run 1263	proteomic profiling by mass spectrometry	TCGA-AG-A01Y-01A-43_W_VU_20120825_A0218_2G_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 85	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01Y	tissue	run 1264	proteomic profiling by mass spectrometry	TCGA-AG-A01Y-01A-43_W_VU_20120825_A0218_2G_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 85	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01Y	tissue	run 1265	proteomic profiling by mass spectrometry	TCGA-AG-A01Y-01A-43_W_VU_20120825_A0218_2G_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 85	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01Y	tissue	run 1266	proteomic profiling by mass spectrometry	TCGA-AG-A01Y-01A-43_W_VU_20120826_A0218_2G_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 85	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01Y	tissue	run 1267	proteomic profiling by mass spectrometry	TCGA-AG-A01Y-01A-43_W_VU_20120826_A0218_2G_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 85	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01Y	tissue	run 1268	proteomic profiling by mass spectrometry	TCGA-AG-A01Y-01A-43_W_VU_20120826_A0218_2G_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 85	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01Y	tissue	run 1269	proteomic profiling by mass spectrometry	TCGA-AG-A01Y-01A-43_W_VU_20120826_A0218_2G_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 85	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01Y	tissue	run 1270	proteomic profiling by mass spectrometry	TCGA-AG-A01Y-01A-43_W_VU_20120826_A0218_2G_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 85	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01Y	tissue	run 1271	proteomic profiling by mass spectrometry	TCGA-AG-A01Y-01A-43_W_VU_20120826_A0218_2G_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 85	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01Y	tissue	run 1272	proteomic profiling by mass spectrometry	TCGA-AG-A01Y-01A-43_W_VU_20120826_A0218_2G_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 85	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01Y	tissue	run 1273	proteomic profiling by mass spectrometry	TCGA-AG-A01Y-01A-43_W_VU_20120826_A0218_2G_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 85	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01Y	tissue	run 1274	proteomic profiling by mass spectrometry	TCGA-AG-A01Y-01A-43_W_VU_20120826_A0218_2G_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 85	Homo sapiens	Rectum	49Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A01Y	tissue	run 1275	proteomic profiling by mass spectrometry	TCGA-AG-A01Y-01A-43_W_VU_20120826_A0218_2G_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 86	Homo sapiens	Rectum	80Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A011	tissue	run 1276	proteomic profiling by mass spectrometry	TCGA-AG-A011-01A-32_W_VU_20120828_A0218_2I_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 86	Homo sapiens	Rectum	80Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A011	tissue	run 1277	proteomic profiling by mass spectrometry	TCGA-AG-A011-01A-32_W_VU_20120828_A0218_2I_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 86	Homo sapiens	Rectum	80Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A011	tissue	run 1278	proteomic profiling by mass spectrometry	TCGA-AG-A011-01A-32_W_VU_20120828_A0218_2I_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 86	Homo sapiens	Rectum	80Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A011	tissue	run 1279	proteomic profiling by mass spectrometry	TCGA-AG-A011-01A-32_W_VU_20120828_A0218_2I_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 86	Homo sapiens	Rectum	80Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A011	tissue	run 1280	proteomic profiling by mass spectrometry	TCGA-AG-A011-01A-32_W_VU_20120828_A0218_2I_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 86	Homo sapiens	Rectum	80Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A011	tissue	run 1281	proteomic profiling by mass spectrometry	TCGA-AG-A011-01A-32_W_VU_20120828_A0218_2I_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 86	Homo sapiens	Rectum	80Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A011	tissue	run 1282	proteomic profiling by mass spectrometry	TCGA-AG-A011-01A-32_W_VU_20120828_A0218_2I_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 86	Homo sapiens	Rectum	80Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A011	tissue	run 1283	proteomic profiling by mass spectrometry	TCGA-AG-A011-01A-32_W_VU_20120828_A0218_2I_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 86	Homo sapiens	Rectum	80Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A011	tissue	run 1284	proteomic profiling by mass spectrometry	TCGA-AG-A011-01A-32_W_VU_20120828_A0218_2I_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 86	Homo sapiens	Rectum	80Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A011	tissue	run 1285	proteomic profiling by mass spectrometry	TCGA-AG-A011-01A-32_W_VU_20120828_A0218_2I_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 86	Homo sapiens	Rectum	80Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A011	tissue	run 1286	proteomic profiling by mass spectrometry	TCGA-AG-A011-01A-32_W_VU_20120829_A0218_2I_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 86	Homo sapiens	Rectum	80Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A011	tissue	run 1287	proteomic profiling by mass spectrometry	TCGA-AG-A011-01A-32_W_VU_20120829_A0218_2I_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 86	Homo sapiens	Rectum	80Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A011	tissue	run 1288	proteomic profiling by mass spectrometry	TCGA-AG-A011-01A-32_W_VU_20120829_A0218_2I_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 86	Homo sapiens	Rectum	80Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A011	tissue	run 1289	proteomic profiling by mass spectrometry	TCGA-AG-A011-01A-32_W_VU_20120829_A0218_2I_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 86	Homo sapiens	Rectum	80Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A011	tissue	run 1290	proteomic profiling by mass spectrometry	TCGA-AG-A011-01A-32_W_VU_20120829_A0218_2I_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 87	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A014	tissue	run 1291	proteomic profiling by mass spectrometry	TCGA-AG-A014-01A-12_W_VU_20120824_A0218_2F_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 87	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A014	tissue	run 1292	proteomic profiling by mass spectrometry	TCGA-AG-A014-01A-12_W_VU_20120824_A0218_2F_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 87	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A014	tissue	run 1293	proteomic profiling by mass spectrometry	TCGA-AG-A014-01A-12_W_VU_20120824_A0218_2F_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 87	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A014	tissue	run 1294	proteomic profiling by mass spectrometry	TCGA-AG-A014-01A-12_W_VU_20120824_A0218_2F_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 87	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A014	tissue	run 1295	proteomic profiling by mass spectrometry	TCGA-AG-A014-01A-12_W_VU_20120824_A0218_2F_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 87	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A014	tissue	run 1296	proteomic profiling by mass spectrometry	TCGA-AG-A014-01A-12_W_VU_20120824_A0218_2F_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 87	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A014	tissue	run 1297	proteomic profiling by mass spectrometry	TCGA-AG-A014-01A-12_W_VU_20120824_A0218_2F_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 87	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A014	tissue	run 1298	proteomic profiling by mass spectrometry	TCGA-AG-A014-01A-12_W_VU_20120824_A0218_2F_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 87	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A014	tissue	run 1299	proteomic profiling by mass spectrometry	TCGA-AG-A014-01A-12_W_VU_20120824_A0218_2F_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 87	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A014	tissue	run 1300	proteomic profiling by mass spectrometry	TCGA-AG-A014-01A-12_W_VU_20120825_A0218_2F_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 87	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A014	tissue	run 1301	proteomic profiling by mass spectrometry	TCGA-AG-A014-01A-12_W_VU_20120825_A0218_2F_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 87	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A014	tissue	run 1302	proteomic profiling by mass spectrometry	TCGA-AG-A014-01A-12_W_VU_20120825_A0218_2F_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 87	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A014	tissue	run 1303	proteomic profiling by mass spectrometry	TCGA-AG-A014-01A-12_W_VU_20120825_A0218_2F_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 87	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A014	tissue	run 1304	proteomic profiling by mass spectrometry	TCGA-AG-A014-01A-12_W_VU_20120825_A0218_2F_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 87	Homo sapiens	Rectum	86Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A014	tissue	run 1305	proteomic profiling by mass spectrometry	TCGA-AG-A014-01A-12_W_VU_20120825_A0218_2F_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 88	Homo sapiens	Rectum	64Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A015	tissue	run 1306	proteomic profiling by mass spectrometry	TCGA-AG-A015-01A-51_W_VU_20120921_A0218_3H_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 88	Homo sapiens	Rectum	64Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A015	tissue	run 1307	proteomic profiling by mass spectrometry	TCGA-AG-A015-01A-51_W_VU_20120921_A0218_3H_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 88	Homo sapiens	Rectum	64Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A015	tissue	run 1308	proteomic profiling by mass spectrometry	TCGA-AG-A015-01A-51_W_VU_20120922_A0218_3H_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 88	Homo sapiens	Rectum	64Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A015	tissue	run 1309	proteomic profiling by mass spectrometry	TCGA-AG-A015-01A-51_W_VU_20120922_A0218_3H_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 88	Homo sapiens	Rectum	64Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A015	tissue	run 1310	proteomic profiling by mass spectrometry	TCGA-AG-A015-01A-51_W_VU_20120922_A0218_3H_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 88	Homo sapiens	Rectum	64Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A015	tissue	run 1311	proteomic profiling by mass spectrometry	TCGA-AG-A015-01A-51_W_VU_20120922_A0218_3H_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 88	Homo sapiens	Rectum	64Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A015	tissue	run 1312	proteomic profiling by mass spectrometry	TCGA-AG-A015-01A-51_W_VU_20120922_A0218_3H_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 88	Homo sapiens	Rectum	64Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A015	tissue	run 1313	proteomic profiling by mass spectrometry	TCGA-AG-A015-01A-51_W_VU_20120922_A0218_3H_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 88	Homo sapiens	Rectum	64Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A015	tissue	run 1314	proteomic profiling by mass spectrometry	TCGA-AG-A015-01A-51_W_VU_20120922_A0218_3H_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 88	Homo sapiens	Rectum	64Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A015	tissue	run 1315	proteomic profiling by mass spectrometry	TCGA-AG-A015-01A-51_W_VU_20120922_A0218_3H_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 88	Homo sapiens	Rectum	64Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A015	tissue	run 1316	proteomic profiling by mass spectrometry	TCGA-AG-A015-01A-51_W_VU_20120922_A0218_3H_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 88	Homo sapiens	Rectum	64Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A015	tissue	run 1317	proteomic profiling by mass spectrometry	TCGA-AG-A015-01A-51_W_VU_20120922_A0218_3H_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 88	Homo sapiens	Rectum	64Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A015	tissue	run 1318	proteomic profiling by mass spectrometry	TCGA-AG-A015-01A-51_W_VU_20120922_A0218_3H_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 88	Homo sapiens	Rectum	64Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A015	tissue	run 1319	proteomic profiling by mass spectrometry	TCGA-AG-A015-01A-51_W_VU_20120922_A0218_3H_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 88	Homo sapiens	Rectum	64Y	not applicable	not applicable	not available	not available	Female	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A015	tissue	run 1320	proteomic profiling by mass spectrometry	TCGA-AG-A015-01A-51_W_VU_20120922_A0218_3H_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 89	Homo sapiens	Rectum	55Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A016	tissue	run 1321	proteomic profiling by mass spectrometry	TCGA-AG-A016-01A-23_W_VU_20120730_A0218_1D_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 89	Homo sapiens	Rectum	55Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A016	tissue	run 1322	proteomic profiling by mass spectrometry	TCGA-AG-A016-01A-23_W_VU_20120730_A0218_1D_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 89	Homo sapiens	Rectum	55Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A016	tissue	run 1323	proteomic profiling by mass spectrometry	TCGA-AG-A016-01A-23_W_VU_20120730_A0218_1D_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 89	Homo sapiens	Rectum	55Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A016	tissue	run 1324	proteomic profiling by mass spectrometry	TCGA-AG-A016-01A-23_W_VU_20120730_A0218_1D_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 89	Homo sapiens	Rectum	55Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A016	tissue	run 1325	proteomic profiling by mass spectrometry	TCGA-AG-A016-01A-23_W_VU_20120730_A0218_1D_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 89	Homo sapiens	Rectum	55Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A016	tissue	run 1326	proteomic profiling by mass spectrometry	TCGA-AG-A016-01A-23_W_VU_20120730_A0218_1D_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 89	Homo sapiens	Rectum	55Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A016	tissue	run 1327	proteomic profiling by mass spectrometry	TCGA-AG-A016-01A-23_W_VU_20120730_A0218_1D_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 89	Homo sapiens	Rectum	55Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A016	tissue	run 1328	proteomic profiling by mass spectrometry	TCGA-AG-A016-01A-23_W_VU_20120730_A0218_1D_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 89	Homo sapiens	Rectum	55Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A016	tissue	run 1329	proteomic profiling by mass spectrometry	TCGA-AG-A016-01A-23_W_VU_20120730_A0218_1D_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 89	Homo sapiens	Rectum	55Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A016	tissue	run 1330	proteomic profiling by mass spectrometry	TCGA-AG-A016-01A-23_W_VU_20120730_A0218_1D_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 89	Homo sapiens	Rectum	55Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A016	tissue	run 1331	proteomic profiling by mass spectrometry	TCGA-AG-A016-01A-23_W_VU_20120731_A0218_1D_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 89	Homo sapiens	Rectum	55Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A016	tissue	run 1332	proteomic profiling by mass spectrometry	TCGA-AG-A016-01A-23_W_VU_20120731_A0218_1D_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 89	Homo sapiens	Rectum	55Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A016	tissue	run 1333	proteomic profiling by mass spectrometry	TCGA-AG-A016-01A-23_W_VU_20120731_A0218_1D_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 89	Homo sapiens	Rectum	55Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A016	tissue	run 1334	proteomic profiling by mass spectrometry	TCGA-AG-A016-01A-23_W_VU_20120731_A0218_1D_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 89	Homo sapiens	Rectum	55Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A016	tissue	run 1335	proteomic profiling by mass spectrometry	TCGA-AG-A016-01A-23_W_VU_20120731_A0218_1D_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 90	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02N	tissue	run 1336	proteomic profiling by mass spectrometry	TCGA-AG-A02N-01A-31_W_VU_20120819_A0218_2C_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 90	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02N	tissue	run 1337	proteomic profiling by mass spectrometry	TCGA-AG-A02N-01A-31_W_VU_20120819_A0218_2C_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 90	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02N	tissue	run 1338	proteomic profiling by mass spectrometry	TCGA-AG-A02N-01A-31_W_VU_20120819_A0218_2C_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 90	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02N	tissue	run 1339	proteomic profiling by mass spectrometry	TCGA-AG-A02N-01A-31_W_VU_20120819_A0218_2C_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 90	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02N	tissue	run 1340	proteomic profiling by mass spectrometry	TCGA-AG-A02N-01A-31_W_VU_20120819_A0218_2C_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 90	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02N	tissue	run 1341	proteomic profiling by mass spectrometry	TCGA-AG-A02N-01A-31_W_VU_20120819_A0218_2C_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 90	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02N	tissue	run 1342	proteomic profiling by mass spectrometry	TCGA-AG-A02N-01A-31_W_VU_20120819_A0218_2C_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 90	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02N	tissue	run 1343	proteomic profiling by mass spectrometry	TCGA-AG-A02N-01A-31_W_VU_20120819_A0218_2C_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 90	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02N	tissue	run 1344	proteomic profiling by mass spectrometry	TCGA-AG-A02N-01A-31_W_VU_20120819_A0218_2C_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 90	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02N	tissue	run 1345	proteomic profiling by mass spectrometry	TCGA-AG-A02N-01A-31_W_VU_20120819_A0218_2C_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 90	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02N	tissue	run 1346	proteomic profiling by mass spectrometry	TCGA-AG-A02N-01A-31_W_VU_20120819_A0218_2C_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 90	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02N	tissue	run 1347	proteomic profiling by mass spectrometry	TCGA-AG-A02N-01A-31_W_VU_20120819_A0218_2C_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 90	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02N	tissue	run 1348	proteomic profiling by mass spectrometry	TCGA-AG-A02N-01A-31_W_VU_20120819_A0218_2C_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 90	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02N	tissue	run 1349	proteomic profiling by mass spectrometry	TCGA-AG-A02N-01A-31_W_VU_20120819_A0218_2C_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 90	Homo sapiens	Rectum	67Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02N	tissue	run 1350	proteomic profiling by mass spectrometry	TCGA-AG-A02N-01A-31_W_VU_20120820_A0218_2C_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 91	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02X	tissue	run 1351	proteomic profiling by mass spectrometry	TCGA-AG-A02X-01A-32_W_VU_20130213_A0218_10D_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 91	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02X	tissue	run 1352	proteomic profiling by mass spectrometry	TCGA-AG-A02X-01A-32_W_VU_20130213_A0218_10D_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 91	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02X	tissue	run 1353	proteomic profiling by mass spectrometry	TCGA-AG-A02X-01A-32_W_VU_20130214_A0218_10D_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 91	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02X	tissue	run 1354	proteomic profiling by mass spectrometry	TCGA-AG-A02X-01A-32_W_VU_20130213_A0218_10D_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 91	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02X	tissue	run 1355	proteomic profiling by mass spectrometry	TCGA-AG-A02X-01A-32_W_VU_20130213_A0218_10D_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 91	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02X	tissue	run 1356	proteomic profiling by mass spectrometry	TCGA-AG-A02X-01A-32_W_VU_20130213_A0218_10D_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 91	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02X	tissue	run 1357	proteomic profiling by mass spectrometry	TCGA-AG-A02X-01A-32_W_VU_20130213_A0218_10D_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 91	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02X	tissue	run 1358	proteomic profiling by mass spectrometry	TCGA-AG-A02X-01A-32_W_VU_20130213_A0218_10D_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 91	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02X	tissue	run 1359	proteomic profiling by mass spectrometry	TCGA-AG-A02X-01A-32_W_VU_20130213_A0218_10D_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 91	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02X	tissue	run 1360	proteomic profiling by mass spectrometry	TCGA-AG-A02X-01A-32_W_VU_20130213_A0218_10D_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 91	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02X	tissue	run 1361	proteomic profiling by mass spectrometry	TCGA-AG-A02X-01A-32_W_VU_20130213_A0218_10D_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 91	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02X	tissue	run 1362	proteomic profiling by mass spectrometry	TCGA-AG-A02X-01A-32_W_VU_20130214_A0218_10D_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 91	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02X	tissue	run 1363	proteomic profiling by mass spectrometry	TCGA-AG-A02X-01A-32_W_VU_20130214_A0218_10D_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 91	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02X	tissue	run 1364	proteomic profiling by mass spectrometry	TCGA-AG-A02X-01A-32_W_VU_20130214_A0218_10D_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 91	Homo sapiens	Rectum	77Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A02X	tissue	run 1365	proteomic profiling by mass spectrometry	TCGA-AG-A02X-01A-32_W_VU_20130214_A0218_10D_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 92	Homo sapiens	Rectum	57Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A020	tissue	run 1366	proteomic profiling by mass spectrometry	TCGA-AG-A020-01A-23_W_VU_20130214_A0218_10E_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 92	Homo sapiens	Rectum	57Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A020	tissue	run 1367	proteomic profiling by mass spectrometry	TCGA-AG-A020-01A-23_W_VU_20130214_A0218_10E_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 92	Homo sapiens	Rectum	57Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A020	tissue	run 1368	proteomic profiling by mass spectrometry	TCGA-AG-A020-01A-23_W_VU_20130215_A0218_10E_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 92	Homo sapiens	Rectum	57Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A020	tissue	run 1369	proteomic profiling by mass spectrometry	TCGA-AG-A020-01A-23_W_VU_20130215_A0218_10E_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 92	Homo sapiens	Rectum	57Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A020	tissue	run 1370	proteomic profiling by mass spectrometry	TCGA-AG-A020-01A-23_W_VU_20130215_A0218_10E_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 92	Homo sapiens	Rectum	57Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A020	tissue	run 1371	proteomic profiling by mass spectrometry	TCGA-AG-A020-01A-23_W_VU_20130215_A0218_10E_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 92	Homo sapiens	Rectum	57Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A020	tissue	run 1372	proteomic profiling by mass spectrometry	TCGA-AG-A020-01A-23_W_VU_20130215_A0218_10E_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 92	Homo sapiens	Rectum	57Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A020	tissue	run 1373	proteomic profiling by mass spectrometry	TCGA-AG-A020-01A-23_W_VU_20130215_A0218_10E_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 92	Homo sapiens	Rectum	57Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A020	tissue	run 1374	proteomic profiling by mass spectrometry	TCGA-AG-A020-01A-23_W_VU_20130215_A0218_10E_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 92	Homo sapiens	Rectum	57Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A020	tissue	run 1375	proteomic profiling by mass spectrometry	TCGA-AG-A020-01A-23_W_VU_20130215_A0218_10E_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 92	Homo sapiens	Rectum	57Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A020	tissue	run 1376	proteomic profiling by mass spectrometry	TCGA-AG-A020-01A-23_W_VU_20130215_A0218_10E_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 92	Homo sapiens	Rectum	57Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A020	tissue	run 1377	proteomic profiling by mass spectrometry	TCGA-AG-A020-01A-23_W_VU_20130215_A0218_10E_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 92	Homo sapiens	Rectum	57Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A020	tissue	run 1378	proteomic profiling by mass spectrometry	TCGA-AG-A020-01A-23_W_VU_20130215_A0218_10E_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 92	Homo sapiens	Rectum	57Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A020	tissue	run 1379	proteomic profiling by mass spectrometry	TCGA-AG-A020-01A-23_W_VU_20130215_A0218_10E_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 92	Homo sapiens	Rectum	57Y	not applicable	not applicable	not available	not available	Female	Rectal Mucinous Adenocarcinoma	not synthetic	TCGA-AG-A020	tissue	run 1380	proteomic profiling by mass spectrometry	TCGA-AG-A020-01A-23_W_VU_20130215_A0218_10E_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 93	Homo sapiens	Rectum	66Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A026	tissue	run 1381	proteomic profiling by mass spectrometry	TCGA-AG-A026-01A-71_W_VU_20121023_A0218_5A_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 93	Homo sapiens	Rectum	66Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A026	tissue	run 1382	proteomic profiling by mass spectrometry	TCGA-AG-A026-01A-71_W_VU_20121023_A0218_5A_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 93	Homo sapiens	Rectum	66Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A026	tissue	run 1383	proteomic profiling by mass spectrometry	TCGA-AG-A026-01A-71_W_VU_20121023_A0218_5A_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 93	Homo sapiens	Rectum	66Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A026	tissue	run 1384	proteomic profiling by mass spectrometry	TCGA-AG-A026-01A-71_W_VU_20121023_A0218_5A_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 93	Homo sapiens	Rectum	66Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A026	tissue	run 1385	proteomic profiling by mass spectrometry	TCGA-AG-A026-01A-71_W_VU_20121023_A0218_5A_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 93	Homo sapiens	Rectum	66Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A026	tissue	run 1386	proteomic profiling by mass spectrometry	TCGA-AG-A026-01A-71_W_VU_20121023_A0218_5A_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 93	Homo sapiens	Rectum	66Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A026	tissue	run 1387	proteomic profiling by mass spectrometry	TCGA-AG-A026-01A-71_W_VU_20121024_A0218_5A_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 93	Homo sapiens	Rectum	66Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A026	tissue	run 1388	proteomic profiling by mass spectrometry	TCGA-AG-A026-01A-71_W_VU_20121024_A0218_5A_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 93	Homo sapiens	Rectum	66Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A026	tissue	run 1389	proteomic profiling by mass spectrometry	TCGA-AG-A026-01A-71_W_VU_20121024_A0218_5A_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 93	Homo sapiens	Rectum	66Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A026	tissue	run 1390	proteomic profiling by mass spectrometry	TCGA-AG-A026-01A-71_W_VU_20121024_A0218_5A_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 93	Homo sapiens	Rectum	66Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A026	tissue	run 1391	proteomic profiling by mass spectrometry	TCGA-AG-A026-01A-71_W_VU_20121024_A0218_5A_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 93	Homo sapiens	Rectum	66Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A026	tissue	run 1392	proteomic profiling by mass spectrometry	TCGA-AG-A026-01A-71_W_VU_20121024_A0218_5A_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 93	Homo sapiens	Rectum	66Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A026	tissue	run 1393	proteomic profiling by mass spectrometry	TCGA-AG-A026-01A-71_W_VU_20121024_A0218_5A_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 93	Homo sapiens	Rectum	66Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A026	tissue	run 1394	proteomic profiling by mass spectrometry	TCGA-AG-A026-01A-71_W_VU_20121024_A0218_5A_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 93	Homo sapiens	Rectum	66Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A026	tissue	run 1395	proteomic profiling by mass spectrometry	TCGA-AG-A026-01A-71_W_VU_20121024_A0218_5A_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 94	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A032	tissue	run 1396	proteomic profiling by mass spectrometry	TCGA-AG-A032-01A-31_W_VU_20121108_A0218_5J_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 94	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A032	tissue	run 1397	proteomic profiling by mass spectrometry	TCGA-AG-A032-01A-31_W_VU_20121108_A0218_5J_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 94	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A032	tissue	run 1398	proteomic profiling by mass spectrometry	TCGA-AG-A032-01A-31_W_VU_20121108_A0218_5J_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 94	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A032	tissue	run 1399	proteomic profiling by mass spectrometry	TCGA-AG-A032-01A-31_W_VU_20121108_A0218_5J_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 94	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A032	tissue	run 1400	proteomic profiling by mass spectrometry	TCGA-AG-A032-01A-31_W_VU_20121108_A0218_5J_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 94	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A032	tissue	run 1401	proteomic profiling by mass spectrometry	TCGA-AG-A032-01A-31_W_VU_20121108_A0218_5J_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 94	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A032	tissue	run 1402	proteomic profiling by mass spectrometry	TCGA-AG-A032-01A-31_W_VU_20121109_A0218_5J_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 94	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A032	tissue	run 1403	proteomic profiling by mass spectrometry	TCGA-AG-A032-01A-31_W_VU_20121109_A0218_5J_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 94	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A032	tissue	run 1404	proteomic profiling by mass spectrometry	TCGA-AG-A032-01A-31_W_VU_20121109_A0218_5J_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 94	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A032	tissue	run 1405	proteomic profiling by mass spectrometry	TCGA-AG-A032-01A-31_W_VU_20121109_A0218_5J_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 94	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A032	tissue	run 1406	proteomic profiling by mass spectrometry	TCGA-AG-A032-01A-31_W_VU_20121109_A0218_5J_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 94	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A032	tissue	run 1407	proteomic profiling by mass spectrometry	TCGA-AG-A032-01A-31_W_VU_20121109_A0218_5J_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 94	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A032	tissue	run 1408	proteomic profiling by mass spectrometry	TCGA-AG-A032-01A-31_W_VU_20121109_A0218_5J_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 94	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A032	tissue	run 1409	proteomic profiling by mass spectrometry	TCGA-AG-A032-01A-31_W_VU_20121109_A0218_5J_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 94	Homo sapiens	Rectum	68Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A032	tissue	run 1410	proteomic profiling by mass spectrometry	TCGA-AG-A032-01A-31_W_VU_20121109_A0218_5J_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 95	Homo sapiens	Rectum	71Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A036	tissue	run 1411	proteomic profiling by mass spectrometry	TCGA-AG-A036-01A-22_W_VU_20120805_A0218_1G_R_FR01.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	1	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 95	Homo sapiens	Rectum	71Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A036	tissue	run 1412	proteomic profiling by mass spectrometry	TCGA-AG-A036-01A-22_W_VU_20120805_A0218_1G_R_FR02.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	2	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 95	Homo sapiens	Rectum	71Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A036	tissue	run 1413	proteomic profiling by mass spectrometry	TCGA-AG-A036-01A-22_W_VU_20120805_A0218_1G_R_FR03.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	3	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 95	Homo sapiens	Rectum	71Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A036	tissue	run 1414	proteomic profiling by mass spectrometry	TCGA-AG-A036-01A-22_W_VU_20120805_A0218_1G_R_FR04.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	4	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 95	Homo sapiens	Rectum	71Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A036	tissue	run 1415	proteomic profiling by mass spectrometry	TCGA-AG-A036-01A-22_W_VU_20120806_A0218_1G_R_FR05.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	5	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 95	Homo sapiens	Rectum	71Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A036	tissue	run 1416	proteomic profiling by mass spectrometry	TCGA-AG-A036-01A-22_W_VU_20120806_A0218_1G_R_FR06.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	6	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 95	Homo sapiens	Rectum	71Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A036	tissue	run 1417	proteomic profiling by mass spectrometry	TCGA-AG-A036-01A-22_W_VU_20120806_A0218_1G_R_FR07.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	7	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 95	Homo sapiens	Rectum	71Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A036	tissue	run 1418	proteomic profiling by mass spectrometry	TCGA-AG-A036-01A-22_W_VU_20120806_A0218_1G_R_FR08.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	8	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 95	Homo sapiens	Rectum	71Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A036	tissue	run 1419	proteomic profiling by mass spectrometry	TCGA-AG-A036-01A-22_W_VU_20120806_A0218_1G_R_FR09.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	9	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 95	Homo sapiens	Rectum	71Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A036	tissue	run 1420	proteomic profiling by mass spectrometry	TCGA-AG-A036-01A-22_W_VU_20120806_A0218_1G_R_FR10.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	10	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 95	Homo sapiens	Rectum	71Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A036	tissue	run 1421	proteomic profiling by mass spectrometry	TCGA-AG-A036-01A-22_W_VU_20120806_A0218_1G_R_FR11.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	11	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 95	Homo sapiens	Rectum	71Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A036	tissue	run 1422	proteomic profiling by mass spectrometry	TCGA-AG-A036-01A-22_W_VU_20120806_A0218_1G_R_FR12.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	12	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 95	Homo sapiens	Rectum	71Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A036	tissue	run 1423	proteomic profiling by mass spectrometry	TCGA-AG-A036-01A-22_W_VU_20120806_A0218_1G_R_FR13.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	13	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 95	Homo sapiens	Rectum	71Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A036	tissue	run 1424	proteomic profiling by mass spectrometry	TCGA-AG-A036-01A-22_W_VU_20120806_A0218_1G_R_FR14.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	14	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
Sample 95	Homo sapiens	Rectum	71Y	not applicable	not applicable	not available	not available	Male	Rectal Adenocarcinoma	not synthetic	TCGA-AG-A036	tissue	run 1425	proteomic profiling by mass spectrometry	TCGA-AG-A036-01A-22_W_VU_20120806_A0218_1G_R_FR15.raw	NT=Reversed-phase chromatography (RP);AC=PRIDE:000056	15	AC=MS:1000484; NT=Orbitrap	NT=LTQ Orbitrap Velos;AC=MS:1001742	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1001251;NT=Trypsin	AC=MS:1002038;NT=label free sample	not available	35% NCE	20 ppm	0.5 Da	Rectum
